<?xml version="1.0"?>


<!DOCTYPE rdf:RDF [
    <!ENTITY owl "http://www.w3.org/2002/07/owl#" >
    <!ENTITY xsd "http://www.w3.org/2001/XMLSchema#" >
    <!ENTITY rdfs "http://www.w3.org/2000/01/rdf-schema#" >
    <!ENTITY dto "http://www.drugtargetontology.org/dto#" >
    <!ENTITY rdf "http://www.w3.org/1999/02/22-rdf-syntax-ns#" >
]>


<rdf:RDF xmlns="http://www.drugtargetontology.org/dto#"
     xml:base="http://www.drugtargetontology.org/dto"
     xmlns:dto="http://www.drugtargetontology.org/dto#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <owl:Ontology rdf:about="http://www.drugtargetontology.org/dto/vocabulary_ic_protein"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://www.drugtargetontology.org/dto#definition -->

    <owl:AnnotationProperty rdf:about="&dto;definition"/>
    


    <!-- http://www.drugtargetontology.org/dto#geneSynonyms -->

    <owl:AnnotationProperty rdf:about="&dto;geneSynonyms"/>
    


    <!-- http://www.drugtargetontology.org/dto#symbol -->

    <owl:AnnotationProperty rdf:about="&dto;symbol"/>
    


    <!-- http://www.drugtargetontology.org/dto#uniprot_xref -->

    <owl:AnnotationProperty rdf:about="&dto;uniprot_xref"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://www.drugtargetontology.org/dto#DTO_000100 -->

    <owl:Class rdf:about="&dto;DTO_000100"/>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00103000 -->

    <owl:Class rdf:about="&dto;DTO_00103000">
        <rdfs:label>ion channel</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_000100"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118718 -->

    <owl:Class rdf:about="&dto;DTO_00118718">
        <rdfs:label>ligand-gated ion channel </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118719 -->

    <owl:Class rdf:about="&dto;DTO_00118719">
        <rdfs:label>anoctamin family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118720 -->

    <owl:Class rdf:about="&dto;DTO_00118720">
        <rdfs:label>amiloride-sensitive sodium channel </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118721 -->

    <owl:Class rdf:about="&dto;DTO_00118721">
        <rdfs:label>bestrophin family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118722 -->

    <owl:Class rdf:about="&dto;DTO_00118722">
        <rdfs:label>calcium channel subunit alpha-2/delta family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118723 -->

    <owl:Class rdf:about="&dto;DTO_00118723">
        <rdfs:label>calcium channel alpha-1 subunit </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118724 -->

    <owl:Class rdf:about="&dto;DTO_00118724">
        <rdfs:label>calcium channel beta subunit family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118725 -->

    <owl:Class rdf:about="&dto;DTO_00118725">
        <rdfs:label>fam26 family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118726 -->

    <owl:Class rdf:about="&dto;DTO_00118726">
        <rdfs:label>pmp-22/emp/mp20 family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118727 -->

    <owl:Class rdf:about="&dto;DTO_00118727">
        <rdfs:label>abc transporter superfamily</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118728 -->

    <owl:Class rdf:about="&dto;DTO_00118728">
        <rdfs:label>clcr family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    <!-- http://www.drugtargetontology.org/dto#DTO_00410001188--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001188"><rdfs:label xml:lang="en">1.A.1.15.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001187"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001484--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001484"><rdfs:label xml:lang="en">protein->ion channel->sodium channel auxiliary subunit scn4b ->sodium channel subunit beta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001483"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001451--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001451"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 1 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001287--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001287"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily D member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001286"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000238--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000238"><rdfs:label xml:lang="en">cation channel, sperm associated 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000237"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000299--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000299"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Chloride channel> ClC chloride channel> H(+)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000298"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001283--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001283"><rdfs:label xml:lang="en">1.A.1.2.3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001282"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000308--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000308"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000307"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000414--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000414"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor beta subunit> Neuronal acetylcholine receptor subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000413"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001875--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001875"><rdfs:label xml:lang="en">Ion</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000867"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000894--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000894"><rdfs:label xml:lang="en">protein->ion channel->polycystin family->polycystic kidney disease protein 1-like 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000893"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001543--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001543"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily C; member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001542"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001031--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001031"><rdfs:label xml:lang="en">Q9UGI6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000946--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000946"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 15</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001152--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001152"><rdfs:label xml:lang="en">potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001151"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001672--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001672"><rdfs:label xml:lang="en">transmembrane protein 38B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001671"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000621--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000621"><rdfs:label xml:lang="en">A8MPY1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001484--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001484"><rdfs:label xml:lang="en">sodium channel; voltage-gated; type IV; alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001453"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000053--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000053"><rdfs:label xml:lang="en">acid-sensing (proton-gated) ion channel family member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000052"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000612--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000612"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit pi</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000611"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000319--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000319"><rdfs:label xml:lang="en">chloride channel 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000318"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000541--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000541"><rdfs:label xml:lang="en">P47869</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000773--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000773"><rdfs:label xml:lang="en">InsP3 receptor family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000772"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000086--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000086"><rdfs:label xml:lang="en">protein->ion channel->bestrophin family->bestrophin-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000075"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000711--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000711"><rdfs:label xml:lang="en">Q8TCU5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000404--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000404"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Neuronal acetylcholine receptor subunit alpha-9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000403"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001371--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001371"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily h member 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001242--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001242"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily A member 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001241"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000247--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000247"><rdfs:label xml:lang="en">CATSPER3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000246"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001461--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001461"><rdfs:label xml:lang="en">O60939</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000396--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000396"><rdfs:label xml:lang="en">Q9UGM1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000048--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000048"><rdfs:label xml:lang="en">acid-sensing (proton-gated) ion channel family member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000047"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001163--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001163"><rdfs:label xml:lang="en">potassium channel KCNE family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001162"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001592--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001592"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily V, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001591"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000258--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000258"><rdfs:label xml:lang="en">protein->ion channel->cation channel sperm-associated ->cation channel sperm-associated protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000156--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000156"><rdfs:label xml:lang="en">Q9BXT2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001341--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001341"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily h member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000133--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000133"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, gamma subunit 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000132"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000462--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000462"><rdfs:label xml:lang="en">CNGB3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000461"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000252--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000252"><rdfs:label xml:lang="en">CATSPER4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000251"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001312--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001312"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily G, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001311"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001221--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001221"><rdfs:label xml:lang="en">8.A.5.1.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001220"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001546--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001546"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->short transient receptor potential channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001567--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001567"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily M, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001566"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000418--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000418"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000491--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000491"><rdfs:label xml:lang="en">O00168</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000187--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000187"><rdfs:label xml:lang="en">CACNA1S</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000186"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000705--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000705"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> NMDA receptor> Glutamate receptor ionotropic, NMDA 2C</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000704"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001546--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001546"><rdfs:label xml:lang="en">Q9UL62</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000408--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000408"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->acetylcholine receptor subunit beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001426--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001426"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->amiloride-sensitive sodium channel subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001537--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001537"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily C, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001536"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000788--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000788"><rdfs:label xml:lang="en">recoverin family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000787"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001374--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001374"><rdfs:label xml:lang="en">P2X receptors</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001373"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001692--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001692"><rdfs:label xml:lang="en">two pore segment channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001691"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001172--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001172"><rdfs:label xml:lang="en">potassium voltage-gated channel, Isk-related family, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001171"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000213--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000213"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent t-type calcium channel subunit alpha-1g</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001789--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001789"><rdfs:label xml:lang="en">gap junction protein; alpha 8; 50kDa (connexin 50)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000983--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000983"><rdfs:label xml:lang="en">potassium channel; subfamily K; member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000957"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001207--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001207"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shab-related subfamily, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001206"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001236--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001236"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily a member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000787--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000787"><rdfs:label xml:lang="en">Kv channel interacting protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000786"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000424--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000424"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->Acetylcholine receptor subunit delta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000423"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000571--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000571"><rdfs:label xml:lang="en">P47870</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001603--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001603"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily V; member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001602"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000364--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000364"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Acetylcholine receptor subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000363"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000848--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000848"><rdfs:label xml:lang="en">Proteins> Transporter> Transmembrane 1-electron transfer carriers> NADPH oxidase 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000847"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000892--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000892"><rdfs:label xml:lang="en">polycystic kidney disease 1-like 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000891"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000233--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000233"><rdfs:label xml:lang="en">calcium homeostasis modulator 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000232"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000183--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000183"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent l-type calcium channel subunit alpha-1d</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001626--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001626"><rdfs:label xml:lang="en">Q8TDI7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000099--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000099"><rdfs:label xml:lang="en">Calcium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000098"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000023--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000023"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->5-hydroxytryptamine receptor 3c</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000671--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000671"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, kainate 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000491--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000491"><rdfs:label xml:lang="en">protein->ion channel->fam26 family->protein fam26f</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000225"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000452--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000452"><rdfs:label xml:lang="en">CNGA4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000451"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000197--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000197"><rdfs:label xml:lang="en">CACNA1A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000196"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001606--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001606"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily v member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001806--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001806"><rdfs:label xml:lang="en">Q01098</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000361--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000361"><rdfs:label xml:lang="en">Nicotinic acetylcholine receptors</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000010"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001417--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001417"><rdfs:label xml:lang="en">ryanodine receptor 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001416"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000236--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000236"><rdfs:label xml:lang="en">protein->ion channel->fam26 family->calcium homeostasis modulator protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000225"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001261--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001261"><rdfs:label xml:lang="en">P17658</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001481--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001481"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 4 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000479--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000479"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium homeostasis modulator ca(2+) channel (calhm-c) family->Protein FAM26D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000478"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001106--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001106"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->g protein-activated inward rectifier potassium channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000802--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000802"><rdfs:label xml:lang="en">Kv channel interacting protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000801"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000009--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000009"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->5-hydroxytryptamine receptor 3a</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000008"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000142--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000142"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit gamma family> Voltage-dependent calcium channel gamma-2 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000141"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000956--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000956"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 17</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001151--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001151"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily s member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000006--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000006"><rdfs:label xml:lang="en">FamilyAnnotation_IUPHAR</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000005"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000199--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000199"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->voltage-dependent P/Q-type calcium channel subunit alpha-1a</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000198"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000179--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000179"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel alpha-1 subunit family->CACNA1D subfamily->voltage-dependent L-type calcium channel subunit alpha-1d</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000178"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000527--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000527"><rdfs:label xml:lang="en">G protein-coupled receptor 89A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000526"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000121--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000121"><rdfs:label xml:lang="en">protein->ion channel->calcium channel beta subunit family->voltage-dependent l-type calcium channel subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000115"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001382--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001382"><rdfs:label xml:lang="en">purinergic receptor P2X, ligand-gated ion channel, 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001381"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001109--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001109"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel; subfamily J; member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001108"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000424--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000424"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor beta subunit> Neuronal acetylcholine receptor subunit beta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000423"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001392--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001392"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> P2X receptor> P2X purinoceptor 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001391"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001501--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001501"><rdfs:label xml:lang="en">Q9Y5Y9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000158--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000158"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, gamma subunit 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000157"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000842--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000842"><rdfs:label xml:lang="en">mucolipin 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000841"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000432--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000432"><rdfs:label xml:lang="en">CHRNG</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000431"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000671--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000671"><rdfs:label xml:lang="en">Q13003</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001616--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001616"><rdfs:label xml:lang="en">Q9H1D0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000401--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000401"><rdfs:label xml:lang="en">P11230</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000866--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000866"><rdfs:label xml:lang="en">Q96RD6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000683--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000683"><rdfs:label xml:lang="en">glutamate receptor; ionotropic; kainate 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000682"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001242--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001242"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001241"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000216--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000216"><rdfs:label xml:lang="en">Q9P0X4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000474--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000474"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Chloride channel> Cystic fibrosis transmembrane conductance regulator> Cystic fibrosis transmembrane conductance regulator</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000473"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000702--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000702"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, N-methyl D-aspartate 2C</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000701"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001032--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001032"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Calcium-activated potassium channel> Small conductance calcium-activated potassium channel protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001031"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000422--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000422"><rdfs:label xml:lang="en">CHRND</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000421"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001627--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001627"><rdfs:label xml:lang="en">transmembrane channel-like 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001626"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000067--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000067"><rdfs:label xml:lang="en">ANO6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000066"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000512--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000512"><rdfs:label xml:lang="en">FXYD domain containing ion transport regulator 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000511"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000419--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000419"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily->Beta-4/CHRNB4 sub-subfamily->Neuronal acetylcholine receptor subunit beta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000418"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001631--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001631"><rdfs:label xml:lang="en">Q7Z5M5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000767--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000767"><rdfs:label xml:lang="en">hyperpolarization activated cyclic nucleotide-gated potassium channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000766"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001542--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001542"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily C, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001541"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001249--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001249"><rdfs:label xml:lang="en">potassium voltage-gated channel; shaker-related subfamily; member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001238"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001292--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001292"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shaw-related subfamily, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001291"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000353--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000353"><rdfs:label xml:lang="en">chloride intracellular channel 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000352"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000956--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000956"><rdfs:label xml:lang="en">Q7Z418</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001514--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001514"><rdfs:label xml:lang="en">Sodium leak channel, non-selective</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001513"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000567--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000567"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit alpha-6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000566"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000359--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000359"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->Acetylcholine receptor subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000358"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000020--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000020"><rdfs:label xml:lang="en">Cation</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001061--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001061"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->atp-sensitive inward rectifier potassium channel 12</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000374--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000374"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily->Alpha-3/CHRNA3 sub-subfamily->Neuronal acetylcholine receptor subunit alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000373"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000712--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000712"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, N-methyl-D-aspartate 3A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000711"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001471--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001471"><rdfs:label xml:lang="en">Q9NY72</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000402--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000402"><rdfs:label xml:lang="en">CHRNB1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000401"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001726--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001726"><rdfs:label xml:lang="en">O94778</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000007--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000007"><rdfs:label xml:lang="en">Type_IUPHAR</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000006"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000726--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000726"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->glycine receptor subunit alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001182--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001182"><rdfs:label xml:lang="en">potassium voltage-gated channel, KQT-like subfamily, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001181"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000236--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000236"><rdfs:label xml:lang="en">Q8NEC5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000127--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000127"><rdfs:label xml:lang="en">CACNB4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000126"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000847--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000847"><rdfs:label xml:lang="en">NADPH oxidase 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000846"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000453--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000453"><rdfs:label xml:lang="en">protein->ion channel->cyclic nucleotide-gated cation channel ->cyclic nucleotide-gated cation channel alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000792--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000792"><rdfs:label xml:lang="en">Kv channel interacting protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000791"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001041--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001041"><rdfs:label xml:lang="en">P48048</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001040"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000077--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000077"><rdfs:label xml:lang="en">BEST2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000076"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001573--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001573"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily M; member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001572"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001017--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001017"><rdfs:label xml:lang="en">potassium channel, subfamily V, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001252--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001252"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily A member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001251"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001444--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001444"><rdfs:label xml:lang="en">Voltage-gated sodium channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001443"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000556--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000556"><rdfs:label xml:lang="en">P31644</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000346--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000346"><rdfs:label xml:lang="en">protein->ion channel->chloride channel clic family->chloride intracellular channel protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000330"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000261--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000261"><rdfs:label xml:lang="en">protein->ion channel->clcr family->calcium-activated chloride channel regulator 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000260"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000774--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000774"><rdfs:label xml:lang="en">IP<sub>3</sub> receptor</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000773"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000043--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000043"><rdfs:label xml:lang="en">acid-sensing (proton-gated) ion channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000042"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000771--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000771"><rdfs:label xml:lang="en">Q14643</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000763"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001111--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001111"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->g protein-activated inward rectifier potassium channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001856--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001856"><rdfs:label xml:lang="en">Q9BX84</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001714"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000656--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000656"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, delta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001611--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001611"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily v member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000274--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000274"><rdfs:label xml:lang="en">protein->ion channel->anion channel->epithelial chloride channel (e-clc) family->Calcium-activated chloride channel regulator 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000273"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000687--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000687"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, N-methyl D-aspartate 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000686"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000682--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000682"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, kainate 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000681"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000394--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000394"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Neuronal acetylcholine receptor subunit alpha-6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000393"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000923--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000923"><rdfs:label xml:lang="en">two pore domain potassium channel (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000922"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001636--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001636"><rdfs:label xml:lang="en">Q7Z404</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000493--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000493"><rdfs:label xml:lang="en">FXYD domain containing ion transport regulator 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000492"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000996--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000996"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001092--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001092"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001091"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000167--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000167"><rdfs:label xml:lang="en">CACNG8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000166"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000028--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000028"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->5-hydroxytryptamine receptor 3d</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000318--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000318"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive Ka</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000317"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001502--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001502"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type X, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001501"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000089--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000089"><rdfs:label xml:lang="en">protein->ion channel->anion channel->anion channel-forming bestrophin (bestrophin) family->bestrophin 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000088"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000557--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000557"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit alpha-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000556"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000126--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000126"><rdfs:label xml:lang="en">O00305</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000327--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000327"><rdfs:label xml:lang="en">CLIC1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000326"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000394--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000394"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->Neuronal acetylcholine receptor subunit alpha-7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000393"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000071--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000071"><rdfs:label xml:lang="en">O76090</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000076--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000076"><rdfs:label xml:lang="en">Q8NFU1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000024--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000024"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->5-hydroxytryptamine receptor 3d</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000023"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000221--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000221"><rdfs:label xml:lang="en">Q8IU99</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000333--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000333"><rdfs:label xml:lang="en">chloride intracellular channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000332"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000976--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000976"><rdfs:label xml:lang="en">O95279</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001561--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001561"><rdfs:label xml:lang="en">Q7Z4N2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000010--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000010"><rdfs:label xml:lang="en">ligand-gated ion channel (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000009"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001027--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001027"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Calcium-activated potassium channel> Small conductance calcium-activated potassium channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001026"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000957--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000957"><rdfs:label xml:lang="en">1.A.1.8.2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000956"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001135--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001135"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium-activated potassium channel auxiliary subunit slowpoke-beta family> Calcium-activated potassium channel subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001134"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001162--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001162"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily S member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001161"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000488--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000488"><rdfs:label xml:lang="en">family with sequence similarity 26, member F</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000487"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001282--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001282"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shal-related subfamily, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001281"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001042--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001042"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Calcium-activated potassium channel> Intermediate conductance calcium-activated potassium channel protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001041"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000108--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000108"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, alpha 2/delta subunit 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000107"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000439--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000439"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor gamma subunit> Acetylcholine receptor subunit gamma</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000438"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001875--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001875"><rdfs:label xml:lang="en">Ion</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000872"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000041--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000041"><rdfs:label xml:lang="en">Q9UHC3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000040"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000338--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000338"><rdfs:label xml:lang="en">chloride intracellular channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000337"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001199--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001199"><rdfs:label xml:lang="en">potassium voltage-gated channel; KQT-like subfamily; member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001198"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001262--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001262"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily A member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001261"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000342--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000342"><rdfs:label xml:lang="en">CLIC4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000341"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000171--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000171"><rdfs:label xml:lang="en">Q13936</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000389--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000389"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily->Alpha-6/CHRNA6 sub-subfamily->Neuronal acetylcholine receptor subunit alpha-6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000388"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000751--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000751"><rdfs:label xml:lang="en">O60741</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000786--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000786"><rdfs:label xml:lang="en">Q9NZI2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001591--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001591"><rdfs:label xml:lang="en">Q8NER1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001669--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001669"><rdfs:label xml:lang="en">protein->ion channel->tmem38 family->trimeric intracellular cation channel type a</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001668"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001256--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001256"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily a member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000786--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000786"><rdfs:label xml:lang="en">protein->ion channel->insp3 receptor family->inositol 1,4,5-trisphosphate receptor type 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001582--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001582"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily M, member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001581"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000151--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000151"><rdfs:label xml:lang="en">Q9UF02</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000447--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000447"><rdfs:label xml:lang="en">CNGA3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000446"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000106--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000106"><rdfs:label xml:lang="en">protein->ion channel->calcium channel subunit alpha-2/delta family->voltage-dependent calcium channel subunit alpha-2/delta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000095"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000322--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000322"><rdfs:label xml:lang="en">CLCNKB</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000321"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001107--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001107"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001106"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001421--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001421"><rdfs:label xml:lang="en">P37088</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000481--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000481"><rdfs:label xml:lang="en">protein->ion channel->fam26 family->protein fam26d</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000225"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001251--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001251"><rdfs:label xml:lang="en">P22459</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000547--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000547"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit alpha-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000546"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000194--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000194"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent L-type calcium channel subunit alpha-1S</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000193"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000288--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000288"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000287"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000303--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000303"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000302"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000167--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000167"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit gamma family> Voltage-dependent calcium channel gamma-7 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000166"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001521--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001521"><rdfs:label xml:lang="en">Q9BXS9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001447--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001447"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 8 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001446"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000214--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000214"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->voltage-dependent T-type calcium channel subunit alpha-1h</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000213"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001714--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001714"><rdfs:label xml:lang="en">Water</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000111--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000111"><rdfs:label xml:lang="en">protein->ion channel->calcium channel subunit alpha-2/delta family->voltage-dependent calcium channel subunit alpha-2/delta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000095"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000281--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000281"><rdfs:label xml:lang="en">protein->ion channel->chloride channel mclc family->chloride channel clic-like protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000280"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000010--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000010"><rdfs:label xml:lang="en">TCID</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000009"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000231--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000231"><rdfs:label xml:lang="en">protein->ion channel->fam26 family->calcium homeostasis modulator protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000225"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000012--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000012"><rdfs:label xml:lang="en">HTR3B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000011"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000443--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000443"><rdfs:label xml:lang="en">cyclic nucleotide gated channel alpha 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000442"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000632--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000632"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, AMPA 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000631"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001181--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001181"><rdfs:label xml:lang="en">P51787</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000259--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000259"><rdfs:label xml:lang="en">protein->ion channel->anion channel->epithelial chloride channel (e-clc) family->Calcium-activated chloride channel regulator 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000258"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001264--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001264"><rdfs:label xml:lang="en">potassium voltage-gated channel; shaker-related subfamily; member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001238"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001721--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001721"><rdfs:label xml:lang="en">O75712</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001714"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001656--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001656"><rdfs:label xml:lang="en">Q8IU68</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001261--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001261"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily a member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000101--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000101"><rdfs:label xml:lang="en">protein->ion channel->calcium channel subunit alpha-2/delta family->voltage-dependent calcium channel subunit alpha-2/delta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000095"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000036--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000036"><rdfs:label xml:lang="en">Acid-sensing (proton-gated) ion channels (ASICs)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000035"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000311--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000311"><rdfs:label xml:lang="en">P51798</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001331--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001331"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily g member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001101--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001101"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->inward rectifier potassium channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000571--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000571"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000841--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000841"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->mucolipin-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000162--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000162"><rdfs:label xml:lang="en">CACNG7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000161"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001644--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001644"><rdfs:label xml:lang="en">protein->ion channel->tmc family->transmembrane channel-like protein 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001623"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000697--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000697"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> NMDA receptor> Glutamate receptor ionotropic, NMDA 2A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000696"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000924--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000924"><rdfs:label xml:lang="en">Two-P potassium channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000923"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000148--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000148"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, gamma subunit 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000147"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001711--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001711"><rdfs:label xml:lang="en">O14520</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000646--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000646"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001071--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001071"><rdfs:label xml:lang="en">Q99712</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001611--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001611"><rdfs:label xml:lang="en">Q9NQA5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001654--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001654"><rdfs:label xml:lang="en">protein->ion channel->tmc family->transmembrane channel-like protein 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001623"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000667--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000667"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> Kainate receptor> Glutamate receptor ionotropic, kainate 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000666"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000701--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000701"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, nmda 2b</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000042--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000042"><rdfs:label xml:lang="en">ASIC3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000041"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000204--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000204"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent P</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000203"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000049--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000049"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->amiloride-sensitive sodium channel family->ASIC4 subfamily->acid-sensing ion channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000048"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000519--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000519"><rdfs:label xml:lang="en">protein->ion channel->fxyd family->putative fxyd domain-containing ion transport regulator 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000495"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001302--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001302"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shaw-related subfamily, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001301"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001512--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001512"><rdfs:label xml:lang="en">sodium leak channel, non-selective</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001511"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000941--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000941"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 13</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001351--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001351"><rdfs:label xml:lang="en">Q8NCM2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000537--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000537"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, alpha 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000536"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001542--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001542"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Short transient receptor potential channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001541"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000123--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000123"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, beta 3 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000122"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000881--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000881"><rdfs:label xml:lang="en">Q9H5I5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001022--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001022"><rdfs:label xml:lang="en">potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001021"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001409--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001409"><rdfs:label xml:lang="en">Ryanodine receptor</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001408"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001141--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001141"><rdfs:label xml:lang="en">Q86W47</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001525--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001525"><rdfs:label xml:lang="en">2.A.53.2.7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001524"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001047--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001047"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> ATP-sensitive inward rectifier potassium channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001046"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000871--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000871"><rdfs:label xml:lang="en">protein->ion channel->pannexin family->pannexin-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001297--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001297"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily C member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001296"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000287--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000287"><rdfs:label xml:lang="en">CLCN2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000286"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000932--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000932"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Two-pore domain potassium channel> Potassium channel subfamily K member 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000931"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000642--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000642"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, AMPA 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000641"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000134--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000134"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel auxiliary subunit 1-8 (cca) family->Voltage-dependent calcium channel gamma-1 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000133"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001446--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001446"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 8 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000358--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000358"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 1 (muscle)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000357"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000168--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000168"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, gamma subunit 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000167"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000037--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000037"><rdfs:label xml:lang="en">ASIC2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000036"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000248--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000248"><rdfs:label xml:lang="en">cation channel, sperm associated 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000247"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000951--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000951"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 16</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000722--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000722"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> NMDA receptor> Glutamate receptor ionotropic, NMDA 3B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000721"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001366--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001366"><rdfs:label xml:lang="en">Q96L42</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000514--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000514"><rdfs:label xml:lang="en">protein->ion channel->fxyd family->fxyd domain-containing ion transport regulator 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000495"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000023--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000023"><rdfs:label xml:lang="en">5-hydroxytryptamine (serotonin) receptor 3D, ionotropic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000022"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000147--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000147"><rdfs:label xml:lang="en">CACNG4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000146"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000592--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000592"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, gamma 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000591"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001571--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001571"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily m member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001291--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001291"><rdfs:label xml:lang="en">Q96PR1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000602--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000602"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit gamma-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000601"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001387--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001387"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> P2X receptor> P2X purinoceptor 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001386"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001161--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001161"><rdfs:label xml:lang="en">P15382</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000063--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000063"><rdfs:label xml:lang="en">anoctamin 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000534--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000534"><rdfs:label xml:lang="en">protein->ion channel->golgi ph regulator ->golgi ph regulator b</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000528"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000297--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000297"><rdfs:label xml:lang="en">CLCN4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000296"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000318--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000318"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->h(+)/cl(-) exchange transporter 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000587--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000587"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, epsilon</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000586"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000244--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000244"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->Cation channel sperm-associated protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000243"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001377--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001377"><rdfs:label xml:lang="en">purinergic receptor P2X, ligand-gated ion channel, 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001376"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001386--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001386"><rdfs:label xml:lang="en">protein->ion channel->p2x receptor family->p2x purinoceptor 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001571--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001571"><rdfs:label xml:lang="en">Q9HCF6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000040"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000403--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000403"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, beta 1 (muscle)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000402"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000002--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000002"><rdfs:label xml:lang="en">Gene_Name</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000001"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000172--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000172"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit gamma family> Voltage-dependent calcium channel gamma-8 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000171"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001587--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001587"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily M, member 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001586"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000116--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000116"><rdfs:label xml:lang="en">Q08289</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000582--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000582"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000581"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000497--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000497"><rdfs:label xml:lang="en">FXYD3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000496"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001815--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001815"><rdfs:label xml:lang="en">Anion, Water</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001814"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000016--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000016"><rdfs:label xml:lang="en">Potassium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000015"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000459--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000459"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->cyclic nucleotide-gated cation channel family->Cyclic nucleotide-gated cation channel beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000458"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000717--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000717"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> NMDA receptor> Glutamate receptor ionotropic, NMDA 3A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000716"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001366--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001366"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily h member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001453--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001453"><rdfs:label xml:lang="en">1.A.1.10.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001452"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001057--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001057"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 12</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001056"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001586--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001586"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily M; member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001585"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000572--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000572"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000571"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001701--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001701"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->two pore calcium channel protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000706--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000706"><rdfs:label xml:lang="en">O15399</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000566--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000566"><rdfs:label xml:lang="en">P18505</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000328--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000328"><rdfs:label xml:lang="en">chloride intracellular channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000327"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000044--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000044"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->amiloride-sensitive sodium channel family->ASIC3 subfamily->acid-sensing ion channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000043"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000476--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000476"><rdfs:label xml:lang="en">Q5JW98</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001431--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001431"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->amiloride-sensitive sodium channel subunit beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000627--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000627"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, theta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000626"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000011--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000011"><rdfs:label xml:lang="en">5-HT<sub>3</sub> receptors</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000010"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000463--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000463"><rdfs:label xml:lang="en">protein->ion channel->cyclic nucleotide-gated cation channel ->cyclic nucleotide-gated cation channel beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000631--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000631"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit theta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000279--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000279"><rdfs:label xml:lang="en">protein->ion channel->anion channel->intracellular chloride channel (icc) family->Chloride channel CLIC-like protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000278"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001466--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001466"><rdfs:label xml:lang="en">sodium channel; voltage-gated; type II; beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001465"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000038--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000038"><rdfs:label xml:lang="en">acid-sensing (proton-gated) ion channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000037"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000991--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000991"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000091--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000091"><rdfs:label xml:lang="en">P54289</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000378--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000378"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 4 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000377"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000621--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000621"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit rho-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000761--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000761"><rdfs:label xml:lang="en">Q9P1Z3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000760"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001552--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001552"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Short transient receptor potential channel 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001551"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000414--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000414"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily->Beta-3/CHRNB3 sub-subfamily->Neuronal acetylcholine receptor subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000413"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000118--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000118"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, beta 2 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000117"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000276--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000276"><rdfs:label xml:lang="en">protein->ion channel->clcr family->calcium-activated chloride channel regulator 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000260"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000413--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000413"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, beta 3 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000412"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000572--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000572"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, beta 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000571"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000064--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000064"><rdfs:label xml:lang="en">protein->ion channel->anion channel->calcium-dependent chloride channel (ca-clc) family->Anoctamin-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000063"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000661--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000661"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, delta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000098--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000098"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; alpha 2/delta subunit 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000097"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001634--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001634"><rdfs:label xml:lang="en">protein->ion channel->tmc family->transmembrane channel-like protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001623"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001652--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001652"><rdfs:label xml:lang="en">transmembrane channel-like 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001651"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000341--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000341"><rdfs:label xml:lang="en">Q9Y696</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000077--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000077"><rdfs:label xml:lang="en">vitelliform macular dystrophy (Best disease; bestrophin)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000076"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000163--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000163"><rdfs:label xml:lang="en">8.A.16.1.2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000162"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001463--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001463"><rdfs:label xml:lang="en">sodium channel auxiliary subunit SCN2B (TC 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001462"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000791--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000791"><rdfs:label xml:lang="en">Q9NS61</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000958--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000958"><rdfs:label xml:lang="en">potassium channel; subfamily K; member 17</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000957"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001794--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001794"><rdfs:label xml:lang="en">aquaporin 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001317--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001317"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily G, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001316"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001496--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001496"><rdfs:label xml:lang="en">Q01118</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001551--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001551"><rdfs:label xml:lang="en">Q9Y210</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001067--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001067"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 14</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001066"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000532--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000532"><rdfs:label xml:lang="en">G protein-coupled receptor 89B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000531"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000636--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000636"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000606--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000606"><rdfs:label xml:lang="en">O00591</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000472--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000472"><rdfs:label xml:lang="en">CYBB</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000471"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000546--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000546"><rdfs:label xml:lang="en">P34903</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000272--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000272"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Chloride channel> Epithelial chloride channel> Calcium-activated chloride channel regulator family member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000271"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001524--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001524"><rdfs:label xml:lang="en">protein->ion channel->slc26a/sulp transporter ->solute carrier family 26 member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001518"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000159--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000159"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel auxiliary subunit 1-8 (cca) family->Voltage-dependent calcium channel gamma-6 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000158"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000117--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000117"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit beta family> Voltage-dependent L-type calcium channel subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000116"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000253--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000253"><rdfs:label xml:lang="en">cation channel, sperm associated 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000252"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000627--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000627"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit rho-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000626"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001761--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001761"><rdfs:label xml:lang="en">P30301</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001211--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001211"><rdfs:label xml:lang="en">Q92953</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000504--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000504"><rdfs:label xml:lang="en">protein->ion channel->anion channel->fxyd family->FXYD domain-containing ion transport regulator 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000503"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000893--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000893"><rdfs:label xml:lang="en">polycystin family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000892"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001267--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001267"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily A member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001266"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000122--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000122"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit beta family> Voltage-dependent L-type calcium channel subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000121"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000857--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000857"><rdfs:label xml:lang="en">ORAI calcium release-activated calcium modulator 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000856"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001326--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001326"><rdfs:label xml:lang="en">Q8TDN1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000797--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000797"><rdfs:label xml:lang="en">Kv channel interacting protein 3, calsenilin</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000796"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001482--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001482"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type IV, beta subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001481"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000307--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000307"><rdfs:label xml:lang="en">CLCN6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000306"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000398--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000398"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 9 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000397"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000437--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000437"><rdfs:label xml:lang="en">CNGA1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000436"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000444--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000444"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->cyclic nucleotide-gated cation channel family->CNGA2 subfamily->Cyclic nucleotide-gated olfactory channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000443"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000496--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000496"><rdfs:label xml:lang="en">Q14802</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000636--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000636"><rdfs:label xml:lang="en">P42262</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000016--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000016"><rdfs:label xml:lang="en">Potassium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000438"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000178--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000178"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, L type, alpha 1D subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000861--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000861"><rdfs:label xml:lang="en">Q96RD7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001562--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001562"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily M, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001561"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001256--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001256"><rdfs:label xml:lang="en">P22460</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000826--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000826"><rdfs:label xml:lang="en">Q8NE86</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000033--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000033"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->5-hydroxytryptamine receptor 3e</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000731--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000731"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->glycine receptor subunit alpha-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001336--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001336"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily h member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001602--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001602"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily V, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001601"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000496--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000496"><rdfs:label xml:lang="en">protein->ion channel->fxyd family->phospholemman</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000495"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001443--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001443"><rdfs:label xml:lang="en">sodium channel (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001442"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000102--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000102"><rdfs:label xml:lang="en">CACNA2D3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000101"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001436--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001436"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->amiloride-sensitive sodium channel subunit delta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000921--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000921"><rdfs:label xml:lang="en">O00180</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001467--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001467"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type III, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001466"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000246--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000246"><rdfs:label xml:lang="en">Q86XQ3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001127--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001127"><rdfs:label xml:lang="en">potassium large conductance calcium-activated channel, subfamily M, alpha member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001126"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001197--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001197"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily KQT member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001196"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001327--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001327"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily G, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001326"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000032--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000032"><rdfs:label xml:lang="en">ASIC1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000031"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000137--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000137"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit gamma family> Voltage-dependent calcium channel gamma-1 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000136"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000416--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000416"><rdfs:label xml:lang="en">P30926</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001286--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001286"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily d member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000757--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000757"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Cyclic nucleotide-regulated channel> Potassium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000756"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001081--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001081"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->inward rectifier potassium channel 16</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001257--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001257"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001256"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000686--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000686"><rdfs:label xml:lang="en">Q05586</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000143--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000143"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, gamma subunit 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000142"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000492--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000492"><rdfs:label xml:lang="en">FXYD1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000491"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001866--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001866"><rdfs:label xml:lang="en">Q9UKL4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000427--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000427"><rdfs:label xml:lang="en">CHRNE</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000426"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001447--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001447"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type I, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001446"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000368--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000368"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit alpha-10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000622--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000622"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit rho-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000621"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000212--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000212"><rdfs:label xml:lang="en">CACNA1H</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000211"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000922--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000922"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000921"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001102--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001102"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001101"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001026--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001026"><rdfs:label xml:lang="en">Q9H2S1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001572--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001572"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily M, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001571"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000646--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000646"><rdfs:label xml:lang="en">P48058</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000761--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000761"><rdfs:label xml:lang="en">protein->ion channel->potassium channel hcn family->potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000101--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000101"><rdfs:label xml:lang="en">Q8IZS8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000221--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000221"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; alpha 1H subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000220"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000494--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000494"><rdfs:label xml:lang="en">protein->ion channel->anion channel->fxyd family->Phospholemman</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000493"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000846--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000846"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->mucolipin-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000323--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000323"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->chloride channel protein clc-ka</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000509--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000509"><rdfs:label xml:lang="en">protein->ion channel->fxyd family->fxyd domain-containing ion transport regulator 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000495"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000243--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000243"><rdfs:label xml:lang="en">protein->ion channel->cation channel sperm-associated ->cation channel sperm-associated protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001482--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001482"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 4 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001481"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000244--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000244"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> CatSper and Two-Pore channels> Cation channel sperm-associated protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000243"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001022--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001022"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily V member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001021"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001411--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001411"><rdfs:label xml:lang="en">protein->ion channel->ryanodine receptor ->ryanodine receptor 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000434--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000434"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor epsilon subunit> Acetylcholine receptor subunit epsilon</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000433"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000371--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000371"><rdfs:label xml:lang="en">P32297</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000343--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000343"><rdfs:label xml:lang="en">chloride intracellular channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000342"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000531--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000531"><rdfs:label xml:lang="en">P0CG08</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000530"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001769--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001769"><rdfs:label xml:lang="en">gap junction protein; alpha 4; 37kDa (connexin 37)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000067--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000067"><rdfs:label xml:lang="en">Chloride</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000066"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001437--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001437"><rdfs:label xml:lang="en">sodium channel, non-voltage-gated 1, gamma subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001436"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000061--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000061"><rdfs:label xml:lang="en">Calcium activated chloride channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000060"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001097--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001097"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> G protein-activated inward rectifier potassium channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001096"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000441--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000441"><rdfs:label xml:lang="en">Cyclic nucleotide-regulated channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000440"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001702--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001702"><rdfs:label xml:lang="en">zinc activated ligand-gated ion channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001701"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000224--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000224"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium homeostasis modulator ca(2+) channel (calhm-c) family->Calcium homeostasis modulator protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000223"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000506--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000506"><rdfs:label xml:lang="en">Q96DB9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000836--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000836"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->mucolipin-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001144--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001144"><rdfs:label xml:lang="en">protein->ion channel->kcnmb ->calcium-activated potassium channel subunit beta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001123"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000314--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000314"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->chloride carrier/channel (clc) family->ClC-7/CLCN7 subfamily->H(+)/Cl(-) exchange transporter 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000313"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000676--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000676"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, kainate 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001859--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001859"><rdfs:label xml:lang="en">protein->kinase->protein kinase->atypical group->chak family->transient receptor potential cation channel subfamily m member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000641--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000641"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001376--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001376"><rdfs:label xml:lang="en">protein->ion channel->p2x receptor family->p2x purinoceptor 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001284--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001284"><rdfs:label xml:lang="en">potassium voltage-gated channel; Shal-related subfamily; member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001283"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000331--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000331"><rdfs:label xml:lang="en">protein->ion channel->chloride channel clic family->chloride intracellular channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000330"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000481--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000481"><rdfs:label xml:lang="en">Q8N5C1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001522--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001522"><rdfs:label xml:lang="en">solute carrier family 26 (anion exchanger), member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001521"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000701--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000701"><rdfs:label xml:lang="en">Q14957</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000932--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000932"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 12</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000931"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001186--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001186"><rdfs:label xml:lang="en">O43526</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001212--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001212"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shab-related subfamily, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001211"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000067--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000067"><rdfs:label xml:lang="en">Chloride</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000333"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000542--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000542"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000541"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001746--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001746"><rdfs:label xml:lang="en">P17302</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000281--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000281"><rdfs:label xml:lang="en">P35523</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000377--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000377"><rdfs:label xml:lang="en">CHRNA4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000376"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000393--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000393"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit alpha-6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001302--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001302"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily C member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001301"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000067--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000067"><rdfs:label xml:lang="en">Chloride</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000328"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000240--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000240"><rdfs:label xml:lang="en">cation channel sperm-associated (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000239"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000771--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000771"><rdfs:label xml:lang="en">protein->ion channel->potassium channel hcn family->potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000271--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000271"><rdfs:label xml:lang="en">protein->ion channel->clcr family->calcium-activated chloride channel regulator family member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000260"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000682--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000682"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> Kainate receptor> Glutamate receptor ionotropic, kainate 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000681"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000323--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000323"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive Kb</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000322"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001282--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001282"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily D member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001281"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000712--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000712"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> NMDA receptor> Glutamate receptor ionotropic, NMDA 2D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000711"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001357--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001357"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily H (eag-related), member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001356"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001597--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001597"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily V, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001596"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000626--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000626"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit rho-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001254--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001254"><rdfs:label xml:lang="en">potassium voltage-gated channel; shaker-related subfamily; member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001238"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001232--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001232"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001231"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001397--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001397"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> P2X receptor> P2X purinoceptor 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001396"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001601--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001601"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily v member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001252--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001252"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001251"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001034--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001034"><rdfs:label xml:lang="en">potassium intermediate/small conductance calcium-activated channel; subfamily N; member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001033"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000213--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000213"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, T type, alpha 1H subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000212"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000164--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000164"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; gamma subunit 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000163"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000616--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000616"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit rho-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000586--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000586"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit delta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000796--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000796"><rdfs:label xml:lang="en">Q9Y2W7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000163--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000163"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, gamma subunit 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000162"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000741--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000741"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->glycine receptor subunit alpha-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000192--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000192"><rdfs:label xml:lang="en">CACNA1B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000191"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000260--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000260"><rdfs:label xml:lang="en">CLCR family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000259"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000777--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000777"><rdfs:label xml:lang="en">inositol 1,4,5-trisphosphate receptor, type 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000776"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001006--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001006"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium channel subfamily t member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001352--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001352"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily H member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001351"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001657--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001657"><rdfs:label xml:lang="en">transmembrane channel-like 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001656"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000054--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000054"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->amiloride-sensitive sodium channel family->ASIC5 subfamily->acid-sensing ion channel 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000053"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000191--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000191"><rdfs:label xml:lang="en">Q00975</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000018--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000018"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->5-hydroxytryptamine receptor 3b</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001043--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001043"><rdfs:label xml:lang="en">inward rectifier-type potassium channel (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001042"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000392--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000392"><rdfs:label xml:lang="en">CHRNA7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000391"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001032--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001032"><rdfs:label xml:lang="en">potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001031"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000552--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000552"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000551"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001102--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001102"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> Inward rectifier potassium channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001101"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001465--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001465"><rdfs:label xml:lang="en">8.A.18.1.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001464"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001624--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001624"><rdfs:label xml:lang="en">protein->ion channel->tmc family->transmembrane channel-like protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001623"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000384--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000384"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Neuronal acetylcholine receptor subunit alpha-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000383"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001291--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001291"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily c member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001057--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001057"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> ATP-sensitive inward rectifier potassium channel 11</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001056"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001166--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001166"><rdfs:label xml:lang="en">Q9Y6J6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000151--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000151"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-4 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000827--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000827"><rdfs:label xml:lang="en">mitochondrial calcium uniporter</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000826"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001684--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001684"><rdfs:label xml:lang="en">protein->ion channel->tweety family->protein tweety homolog 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001678"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001046--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001046"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->atp-sensitive inward rectifier potassium channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001531--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001531"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily a member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001402--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001402"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> P2X receptor> P2X purinoceptor 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001401"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000011--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000011"><rdfs:label xml:lang="en">O95264</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000010"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000201--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000201"><rdfs:label xml:lang="en">Q15878</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000336--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000336"><rdfs:label xml:lang="en">O95833</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000477--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000477"><rdfs:label xml:lang="en">FAM26D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000476"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001306--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001306"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily c member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001257--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001257"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily A member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001256"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000006--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000006"><rdfs:label xml:lang="en">P46098</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000005"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000051--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000051"><rdfs:label xml:lang="en">Q9NY37</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001632--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001632"><rdfs:label xml:lang="en">transmembrane channel-like 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001631"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001391--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001391"><rdfs:label xml:lang="en">Q93086</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000074--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000074"><rdfs:label xml:lang="en">protein->ion channel->anion channel->anion channel-forming bestrophin (bestrophin) family->bestrophin 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000073"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001277--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001277"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shal-related subfamily, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001276"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001516--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001516"><rdfs:label xml:lang="en">protein->ion channel->cation-nonselective channel family->sodium leak channel non-selective protein</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000556--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000556"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit alpha-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000349--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000349"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->intracellular chloride channel (clic) family->Chloride intracellular channel protein 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000348"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000596--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000596"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit gamma-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001332--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001332"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily G member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001331"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000388--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000388"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 6 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000387"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000131--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000131"><rdfs:label xml:lang="en">Q06432</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000457--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000457"><rdfs:label xml:lang="en">CNGB1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000456"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001497--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001497"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type VII, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001496"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000097--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000097"><rdfs:label xml:lang="en">CACNA2D2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000096"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001212--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001212"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily B member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001211"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000846--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000846"><rdfs:label xml:lang="en">Q9Y5S8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001206--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001206"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily kqt member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000059--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000059"><rdfs:label xml:lang="en">protein->ion channel->anion channel->calcium-dependent chloride channel (ca-clc) family->Anoctamin-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000058"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001086--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001086"><rdfs:label xml:lang="en">P63252</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001427--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001427"><rdfs:label xml:lang="en">sodium channel, non-voltage-gated 1, beta subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001426"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001704--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001704"><rdfs:label xml:lang="en">ZAC</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000010"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001744--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001744"><rdfs:label xml:lang="en">gap junction protein; beta 1; 32kDa (connexin 32; Charcot-Marie-Tooth neuropathy; X-linked)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000499--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000499"><rdfs:label xml:lang="en">protein->ion channel->anion channel->fxyd family->FXYD domain-containing ion transport regulator 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000498"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001154--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001154"><rdfs:label xml:lang="en">potassium voltage-gated channel; delayed-rectifier; subfamily S; member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001153"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000936--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000936"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 12</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000103--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000103"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, alpha 2/delta subunit 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000102"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000961--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000961"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 18</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001454--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001454"><rdfs:label xml:lang="en">protein->ion channel->sodium channel auxiliary subunit scn1b ->sodium channel subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001453"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000033--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000033"><rdfs:label xml:lang="en">acid-sensing (proton-gated) ion channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000032"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000911--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000911"><rdfs:label xml:lang="en">protein->ion channel->polycystin family->polycystic kidney disease 2-like 1 protein</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000738--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000738"><rdfs:label xml:lang="en">glycine receptor; alpha 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000737"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000758--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000758"><rdfs:label xml:lang="en">Potassium; Sodium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000757"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000781--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000781"><rdfs:label xml:lang="en">Q14573</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000257--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000257"><rdfs:label xml:lang="en">CLCA1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000256"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000339--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000339"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->intracellular chloride channel (clic) family->Chloride intracellular channel protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000338"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001204--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001204"><rdfs:label xml:lang="en">potassium voltage-gated channel; KQT-like subfamily; member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001203"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000277--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000277"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Chloride channel> Epithelial chloride channel> Calcium-activated chloride channel regulator 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000276"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000648--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000648"><rdfs:label xml:lang="en">glutamate receptor; ionotrophic; AMPA 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000647"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000912--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000912"><rdfs:label xml:lang="en">polycystic kidney disease 2-like 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000911"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001337--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001337"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily H member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001336"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000526--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000526"><rdfs:label xml:lang="en">B7ZAQ6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000456--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000456"><rdfs:label xml:lang="en">TCDB says voltage gated (http://ebi2.uniprot.org/uniprot/Q16281)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001311--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001311"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily f member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000476--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000476"><rdfs:label xml:lang="en">cytochrome b-245; beta polypeptide (chronic granulomatous disease)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000475"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001596--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001596"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily v member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000095--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000095"><rdfs:label xml:lang="en">calcium channel subunit alpha-2/delta family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000094"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001202--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001202"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily KQT member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001201"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001067--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001067"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> Inward rectifier potassium channel 13</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001066"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001406--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001406"><rdfs:label xml:lang="en">P21817</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001434--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001434"><rdfs:label xml:lang="en">sodium channel; nonvoltage-gated 1; beta (Liddle syndrome)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001428"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001084--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001084"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->inward rectifier potassium channel 18</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001043"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000501--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000501"><rdfs:label xml:lang="en">P59646</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000971--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000971"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000521--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000521"><rdfs:label xml:lang="en">P58549</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000586--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000586"><rdfs:label xml:lang="en">P78334</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001106--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001106"><rdfs:label xml:lang="en">P48051</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001382--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001382"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> P2X receptor> P2X purinoceptor 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001381"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001051--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001051"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->atp-sensitive inward rectifier potassium channel 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000973--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000973"><rdfs:label xml:lang="en">1.A.1.9.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000972"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001121--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001121"><rdfs:label xml:lang="en">Q9NPA1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000166--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000166"><rdfs:label xml:lang="en">Q8WXS5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001676--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001676"><rdfs:label xml:lang="en">Q9H313</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001696--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001696"><rdfs:label xml:lang="en">Q8NHX9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000647--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000647"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, AMPA 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000646"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001681--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001681"><rdfs:label xml:lang="en">Q9BSA4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001373--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001373"><rdfs:label xml:lang="en">P2X receptor family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001372"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000116--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000116"><rdfs:label xml:lang="en">protein->ion channel->calcium channel beta subunit family->voltage-dependent l-type calcium channel subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000115"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001412--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001412"><rdfs:label xml:lang="en">ryanodine receptor 2 (cardiac)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001411"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000083--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000083"><rdfs:label xml:lang="en">bestrophin 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000082"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001351--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001351"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily h member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000912--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000912"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Polycystic kidney disease 2-like 1 protein</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000911"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000179--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000179"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent L-type calcium channel subunit alpha-1C</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000178"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000632--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000632"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit theta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000631"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001607--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001607"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily V, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001606"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000637--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000637"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> AMPA receptor> Glutamate receptor 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000636"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001706--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001706"><rdfs:label xml:lang="en">A6NN92</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000051--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000051"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->acid-sensing ion channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000035"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000463--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000463"><rdfs:label xml:lang="en">cyclic nucleotide gated channel beta 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000462"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000243--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000243"><rdfs:label xml:lang="en">cation channel, sperm associated 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000242"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000084--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000084"><rdfs:label xml:lang="en">protein->ion channel->anion channel->anion channel-forming bestrophin (bestrophin) family->bestrophin 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000083"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000329--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000329"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->intracellular chloride channel (clic) family->Chloride intracellular channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000328"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000176--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000176"><rdfs:label xml:lang="en">Q01668</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000193--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000193"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, N type, alpha 1B subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000192"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000209--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000209"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel alpha-1 subunit family->CACNA1G subfamily->voltage-dependent T-type calcium channel subunit alpha-1g</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000208"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001239--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001239"><rdfs:label xml:lang="en">potassium voltage-gated channel; shaker-related subfamily; member 1 (episodic ataxia with myokymia)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001238"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000686--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000686"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, kainate 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001046--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001046"><rdfs:label xml:lang="en">P78508</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001206--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001206"><rdfs:label xml:lang="en">Q14721</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001096--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001096"><rdfs:label xml:lang="en">P48050</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000316--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000316"><rdfs:label xml:lang="en">P51800</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000440--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000440"><rdfs:label xml:lang="en">cyclic nucleotide-gated cation channel (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000439"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001537--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001537"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily C; member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001536"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000981--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000981"><rdfs:label xml:lang="en">Q9Y257</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000486--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000486"><rdfs:label xml:lang="en">Q5R3K3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000672--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000672"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, kainate 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000671"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001131--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001131"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->calcium-activated potassium channel subunit alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001536--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001536"><rdfs:label xml:lang="en">Q13507</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001251--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001251"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily a member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001596--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001596"><rdfs:label xml:lang="en">Q9Y5S1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000161--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000161"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-6 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000321--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000321"><rdfs:label xml:lang="en">P51801</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000267--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000267"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Chloride channel> Epithelial chloride channel> Calcium-activated chloride channel regulator 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000266"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000119--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000119"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->the ca(2+) channel auxiliary subunit types 1-4 (cca-) family->voltage-dependent l-type calcium channel subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000118"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000657--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000657"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, delta 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000656"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001344--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001344"><rdfs:label xml:lang="en">potassium voltage-gated channel; subfamily H (eag-related); member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001343"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001623--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001623"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily V; member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001622"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000746--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000746"><rdfs:label xml:lang="en">Q96D96</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000131--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000131"><rdfs:label xml:lang="en">protein->ion channel->calcium channel beta subunit family->voltage-dependent l-type calcium channel subunit beta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000115"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001391--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001391"><rdfs:label xml:lang="en">protein->ion channel->p2x receptor family->p2x purinoceptor 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001612--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001612"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily V member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001611"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000292--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000292"><rdfs:label xml:lang="en">CLCN3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000291"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001001--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001001"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium channel subfamily t member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000976--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000976"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001246--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001246"><rdfs:label xml:lang="en">P22001</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001766--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001766"><rdfs:label xml:lang="en">P35212</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001714"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001796--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001796"><rdfs:label xml:lang="en">P55087</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001714"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000998--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000998"><rdfs:label xml:lang="en">potassium channel family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000997"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000787--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000787"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> IP3 receptor> Inositol 1,4,5-trisphosphate receptor type 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000786"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000152--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000152"><rdfs:label xml:lang="en">CACNG5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000151"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000302--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000302"><rdfs:label xml:lang="en">CLCN5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000301"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000387--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000387"><rdfs:label xml:lang="en">CHRNA6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000386"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000058--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000058"><rdfs:label xml:lang="en">anoctamin 1, calcium activated chloride channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000057"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000241--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000241"><rdfs:label xml:lang="en">CatSper and Two-Pore channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000240"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000298--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000298"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->h(+)/cl(-) exchange transporter 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000561--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000561"><rdfs:label xml:lang="en">Q16445</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001583--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001583"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily M; member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001582"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001401--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001401"><rdfs:label xml:lang="en">protein->ion channel->p2x receptor family->p2x purinoceptor 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000716--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000716"><rdfs:label xml:lang="en">O60391</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000468--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000468"><rdfs:label xml:lang="en">cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000467"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000018--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000018"><rdfs:label xml:lang="en">5-hydroxytryptamine (serotonin) receptor 3C, ionotropic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000017"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000536--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000536"><rdfs:label xml:lang="en">P14867</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001408--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001408"><rdfs:label xml:lang="en">purinergic receptor P2X; ligand-gated ion channel; 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001407"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001316--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001316"><rdfs:label xml:lang="en">Q9UJ96</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000099--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000099"><rdfs:label xml:lang="en">Calcium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000862"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000081--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000081"><rdfs:label xml:lang="en">protein->ion channel->bestrophin family->bestrophin-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000075"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000388--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000388"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit alpha-5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000831--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000831"><rdfs:label xml:lang="en">Q9GZU1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000562--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000562"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, alpha 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000561"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000896--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000896"><rdfs:label xml:lang="en">Q7Z443</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000286--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000286"><rdfs:label xml:lang="en">P51788</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000337--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000337"><rdfs:label xml:lang="en">CLIC3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000336"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000667--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000667"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, kainate 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000666"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000001--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000001"><rdfs:label xml:lang="en">UniprotID</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000000"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001203--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001203"><rdfs:label xml:lang="en">1.A.1.15.4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001202"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001457--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001457"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type II, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001456"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000369--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000369"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Neuronal acetylcholine receptor subunit alpha-10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000368"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000697--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000697"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, N-methyl D-aspartate 2B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000696"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000117--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000117"><rdfs:label xml:lang="en">CACNB2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000116"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001201--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001201"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily kqt member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000607--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000607"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, pi</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000606"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001027--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001027"><rdfs:label xml:lang="en">potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001026"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000096--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000096"><rdfs:label xml:lang="en">Q9NY47</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000095"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000079--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000079"><rdfs:label xml:lang="en">protein->ion channel->anion channel->anion channel-forming bestrophin (bestrophin) family->bestrophin 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000078"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000582--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000582"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, delta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000581"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000378--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000378"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001623--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001623"><rdfs:label xml:lang="en">TMC family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001622"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001164--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001164"><rdfs:label xml:lang="en">protein->ion channel->potassium channel kcne family->potassium voltage-gated channel subfamily e member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001163"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000052--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000052"><rdfs:label xml:lang="en">ASIC5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000051"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000947--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000947"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 16</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000946"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000864--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000864"><rdfs:label xml:lang="en">Connexins and Pannexins</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000863"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001052--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001052"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 11</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001051"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000776--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000776"><rdfs:label xml:lang="en">Q14571</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001481--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001481"><rdfs:label xml:lang="en">Q8IWT1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000907--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000907"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Polycystin-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000906"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000361--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000361"><rdfs:label xml:lang="en">Q9GZZ6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001137--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001137"><rdfs:label xml:lang="en">potassium large conductance calcium-activated channel, subfamily M, beta member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001136"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001197--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001197"><rdfs:label xml:lang="en">potassium voltage-gated channel, KQT-like subfamily, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001196"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001069--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001069"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel; subfamily J; member 13</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001048"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000637--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000637"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, AMPA 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000636"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001220--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001220"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Voltage-gated potassium channel beta-subunit family> Voltage-gated potassium channel subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001219"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001352--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001352"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily H (eag-related), member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001351"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000474--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000474"><rdfs:label xml:lang="en">protein->ion channel->proton channel->voltage-gated->phagocyte (gp91(phox)) nadph oxidase family->Cytochrome b-245 heavy chain</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000473"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000919--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000919"><rdfs:label xml:lang="en">protein->ion channel->polycystin family->polycystic kidney disease and receptor for egg jelly-related protein</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000893"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000652--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000652"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> AMPA receptor> Glutamate receptor 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000651"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000529--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000529"><rdfs:label xml:lang="en">protein->ion channel->golgi ph regulator ->golgi ph regulator a</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000528"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000737--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000737"><rdfs:label xml:lang="en">glycine receptor, alpha 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000736"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000347--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000347"><rdfs:label xml:lang="en">CLIC5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000346"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000501--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000501"><rdfs:label xml:lang="en">protein->ion channel->fxyd family->fxyd domain-containing ion transport regulator 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000495"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001174--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001174"><rdfs:label xml:lang="en">protein->ion channel->potassium channel kcne family->potassium voltage-gated channel subfamily e member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001163"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001621--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001621"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily v member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001316--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001316"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily g member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000376--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000376"><rdfs:label xml:lang="en">P43681</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001372--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001372"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily H member 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001371"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000148--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000148"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; gamma subunit 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000147"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000152--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000152"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit gamma family> Voltage-dependent calcium channel gamma-4 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000151"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001801--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001801"><rdfs:label xml:lang="en">P57773</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001714"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000666--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000666"><rdfs:label xml:lang="en">Q13002</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001491--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001491"><rdfs:label xml:lang="en">Q14524</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000611--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000611"><rdfs:label xml:lang="en">P24046</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001045--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001045"><rdfs:label xml:lang="en">Calcium; Potassium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001044"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000194--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000194"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel alpha-1 subunit family->CACNA1B subfamily->voltage-dependent N-type calcium channel subunit alpha-1b</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000193"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000031--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000031"><rdfs:label xml:lang="en">P78348</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000541--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000541"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001426--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001426"><rdfs:label xml:lang="en">P51168</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000728--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000728"><rdfs:label xml:lang="en">glycine receptor; alpha 1 (startle disease/hyperekplexia; stiff man syndrome)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000727"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001372--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001372"><rdfs:label xml:lang="en">purinergic receptor P2X, ligand-gated ion channel, 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001371"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001662--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001662"><rdfs:label xml:lang="en">transmembrane protein 37</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001661"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000832--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000832"><rdfs:label xml:lang="en">mucolipin 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000831"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000400--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000400"><rdfs:label xml:lang="en">cholinergic receptor; nicotinic; alpha polypeptide 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000399"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001678--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001678"><rdfs:label xml:lang="en">tweety family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001677"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001651--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001651"><rdfs:label xml:lang="en">Q7Z402</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000173--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000173"><rdfs:label xml:lang="en">1.C.12.1.3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000172"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000631--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000631"><rdfs:label xml:lang="en">P42261</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000404--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000404"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->Acetylcholine receptor subunit beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000403"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000060--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000060"><rdfs:label xml:lang="en">anoctamin family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000059"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000382--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000382"><rdfs:label xml:lang="en">CHRNA5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000381"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001272--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001272"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily A member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001271"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000606--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000606"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit gamma-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001477--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001477"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type IV, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001476"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001512--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001512"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 11 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001511"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000467--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000467"><rdfs:label xml:lang="en">CFTR</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000466"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000616--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000616"><rdfs:label xml:lang="en">P28476</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001462--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001462"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type II, beta subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001461"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000013--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000013"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->5-hydroxytryptamine receptor 3a</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001192--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001192"><rdfs:label xml:lang="en">potassium voltage-gated channel, KQT-like subfamily, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001191"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001556--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001556"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->short transient receptor potential channel 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000399--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000399"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily->Alpha-9/CHRNA9 sub-subfamily->Neuronal acetylcholine receptor subunit alpha-9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000398"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000704--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000704"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, nmda 2c</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000633"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000113--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000113"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, beta 1 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000112"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001492--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001492"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type V, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001491"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001472--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001472"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 3 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001471"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000489--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000489"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->FAM26F</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000488"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001108--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001108"><rdfs:label xml:lang="en">1.A.2.1.3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001107"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000426--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000426"><rdfs:label xml:lang="en">Q04844</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001617--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001617"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily V, member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001616"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000062--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000062"><rdfs:label xml:lang="en">ANO2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000061"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001680--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001680"><rdfs:label xml:lang="en">tweety homolog 1 (Drosophila)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001679"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001152--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001152"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily S member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001151"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001321--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001321"><rdfs:label xml:lang="en">Q8TAE7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001494--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001494"><rdfs:label xml:lang="en">sodium channel; voltage-gated; type IX; alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001453"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001516--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001516"><rdfs:label xml:lang="en">Q9H2B4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000040"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000286--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000286"><rdfs:label xml:lang="en">ClC family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000285"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001617--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001617"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily V member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001616"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000882--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000882"><rdfs:label xml:lang="en">piezo-type mechanosensitive ion channel component 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000881"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000262--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000262"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Chloride channel> Epithelial chloride channel> Calcium-activated chloride channel regulator 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000261"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001674--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001674"><rdfs:label xml:lang="en">protein->ion channel->tmem38 family->trimeric intracellular cation channel type b</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001668"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001036--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001036"><rdfs:label xml:lang="en">O15554</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000661--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000661"><rdfs:label xml:lang="en">P39086</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001346--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001346"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily h member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001696--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001696"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->two pore calcium channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001577--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001577"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily M, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001576"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000261--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000261"><rdfs:label xml:lang="en">Q9UQC9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000260"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000285--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000285"><rdfs:label xml:lang="en">chloride channel (TC 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000284"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000867--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000867"><rdfs:label xml:lang="en">pannexin 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000866"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000088--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000088"><rdfs:label xml:lang="en">bestrophin 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000087"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000245--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000245"><rdfs:label xml:lang="en">cation channel; sperm associated 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000244"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000507--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000507"><rdfs:label xml:lang="en">FXYD domain containing ion transport regulator 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000506"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000524--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000524"><rdfs:label xml:lang="en">protein->ion channel->fxyd family->fxyd domain-containing ion transport regulator 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000495"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000482--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000482"><rdfs:label xml:lang="en">FAM26E</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000481"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000981--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000981"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000782--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000782"><rdfs:label xml:lang="en">inositol 1,4,5-trisphosphate receptor, type 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000781"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001301--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001301"><rdfs:label xml:lang="en">Q03721</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000224--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000224"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent T-type calcium channel subunit alpha-1I</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000223"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000693--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000693"><rdfs:label xml:lang="en">glutamate receptor; ionotropic; N-methyl D-aspartate 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000692"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000749--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000749"><rdfs:label xml:lang="en">Voltage-gated proton channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000748"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001860--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001860"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily M member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001859"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000219--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000219"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->voltage-dependent T-type calcium channel subunit alpha-1i</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000218"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000408--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000408"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, beta 2 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000407"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000986--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000986"><rdfs:label xml:lang="en">Q9Y2U2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000692--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000692"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, N-methyl D-aspartate 2A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000691"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001222--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001222"><rdfs:label xml:lang="en">potassium voltage-gated channel; shaker-related subfamily; beta member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001221"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000906--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000906"><rdfs:label xml:lang="en">Q9P0L9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001606--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001606"><rdfs:label xml:lang="en">Q9HBA0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000799--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000799"><rdfs:label xml:lang="en">protein->ion channel->recoverin family->calsenilin</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000788"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001187--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001187"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily KQT member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001186"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000153--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000153"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, gamma subunit 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000152"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000312--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000312"><rdfs:label xml:lang="en">CLCN7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000311"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000384--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000384"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily-> Alpha-5/CHRNA5 sub-subfamily->Neuronal acetylcholine receptor subunit alpha-5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000383"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000093--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000093"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, alpha 2/delta subunit 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000092"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000442--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000442"><rdfs:label xml:lang="en">CNGA2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000441"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000592--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000592"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit epsilon</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000591"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000214--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000214"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent T-type calcium channel subunit alpha-1G</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000213"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001131--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001131"><rdfs:label xml:lang="en">Q16558</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001014--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001014"><rdfs:label xml:lang="en">Voltage-gated potassium channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000998"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000324--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000324"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->chloride channel family->CLCNKB subfamily->Chloride channel protein ClC-Kb</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000323"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001219--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001219"><rdfs:label xml:lang="en">protein->ion channel->shaker potassium channel beta subunit family->voltage-gated potassium channel subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001218"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001397--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001397"><rdfs:label xml:lang="en">purinergic receptor P2X, ligand-gated ion channel, 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001396"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001466--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001466"><rdfs:label xml:lang="en">Q9NY46</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001511--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001511"><rdfs:label xml:lang="en">Q8IZF0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001306--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001306"><rdfs:label xml:lang="en">Q9H3M0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000966--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000966"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000026--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000026"><rdfs:label xml:lang="en">A5X5Y0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000539--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000539"><rdfs:label xml:lang="en">GABA<sub>A</sub> receptors</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000010"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000736--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000736"><rdfs:label xml:lang="en">Q5JXX5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000454--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000454"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->cyclic nucleotide-gated cation channel family->CNGA4 subfamily->Cyclic nucleotide-gated cation channel alpha-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000453"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000254--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000254"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->Cation channel sperm-associated protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000253"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000696--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000696"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, nmda 2a</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001519--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001519"><rdfs:label xml:lang="en">protein->ion channel->slc26a/sulp transporter ->sulfate anion transporter 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001518"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000062--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000062"><rdfs:label xml:lang="en">other_ic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000467"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001125--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001125"><rdfs:label xml:lang="en">8.A.14.1.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001124"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000952--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000952"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 17</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000951"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001442--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001442"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Epithelial sodium channel> Amiloride-sensitive sodium channel subunit gamma</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001441"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001021--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001021"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily v member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000801--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000801"><rdfs:label xml:lang="en">Q6PIL6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000458--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000458"><rdfs:label xml:lang="en">cyclic nucleotide gated channel beta 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000457"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000207--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000207"><rdfs:label xml:lang="en">CACNA1G</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000206"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001026--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001026"><rdfs:label xml:lang="en">protein->ion channel->potassium channel kcnn family->small conductance calcium-activated potassium channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001707--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001707"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Zinc-activated channel> Zinc-activated ligand-gated ion channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001706"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000577--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000577"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, beta 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000576"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001007--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001007"><rdfs:label xml:lang="en">potassium channel, subfamily U, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001006"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000391--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000391"><rdfs:label xml:lang="en">P36544</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001296--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001296"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily c member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000099--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000099"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->ca(2+) channel auxiliary subunit 2 types 1-4 (cca-2) family->voltage-dependent calcium channel subunit alpha-2/delta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000098"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000851--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000851"><rdfs:label xml:lang="en">Q96PH1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000850"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001875--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001875"><rdfs:label xml:lang="en">Ion</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001874"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001499--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001499"><rdfs:label xml:lang="en">sodium channel; voltage-gated; type V; alpha (long QT syndrome 3)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001453"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001561--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001561"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->short transient receptor potential channel 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000487--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000487"><rdfs:label xml:lang="en">Protein FAM26F</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000486"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000517--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000517"><rdfs:label xml:lang="en">FXYD domain containing ion transport regulator 6 pseudogene 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000516"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000044--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000044"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Acid-sensing ion channel> Acid-sensing ion channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000043"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001202--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001202"><rdfs:label xml:lang="en">potassium voltage-gated channel, KQT-like subfamily, member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001201"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000141--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000141"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-2 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000651--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000651"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001836--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001836"><rdfs:label xml:lang="en">Q92482</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000326--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000326"><rdfs:label xml:lang="en">O00299</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000634--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000634"><rdfs:label xml:lang="en">Ionotropic glutamate receptors</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000633"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001671--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001671"><rdfs:label xml:lang="en">Q9NVV0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000087--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000087"><rdfs:label xml:lang="en">BEST4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000086"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000860--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000860"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Miscellaneous ion channel> Ca2+ release-activated Ca2+ channel family> Calcium release-activated calcium channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000859"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000876--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000876"><rdfs:label xml:lang="en">protein->ion channel->pannexin family->pannexin-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000122--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000122"><rdfs:label xml:lang="en">CACNB3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000121"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000209--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000209"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent R-type calcium channel subunit alpha-1E</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000208"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001287--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001287"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shaw-related subfamily, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001286"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000048--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000048"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->acid-sensing ion channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001343--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001343"><rdfs:label xml:lang="en">1.A.1.5.2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001342"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000542--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000542"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, alpha 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000541"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001689--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001689"><rdfs:label xml:lang="en">protein->ion channel->tweety family->protein tweety homolog 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001678"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001121--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001121"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->g protein-activated inward rectifier potassium channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001011--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001011"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium channel subfamily u member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000028--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000028"><rdfs:label xml:lang="en">5-hydroxytryptamine (serotonin) receptor 3E, ionotropic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000027"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001194--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001194"><rdfs:label xml:lang="en">potassium voltage-gated channel; KQT-like subfamily; member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001193"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000020--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000020"><rdfs:label xml:lang="en">Cation</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000902"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000293--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000293"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->chloride channel protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000847--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000847"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Mucolipin-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000846"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001784--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001784"><rdfs:label xml:lang="en">aquaporin 2 (collecting duct)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000438--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000438"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->acetylcholine receptor subunit gamma</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001023--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001023"><rdfs:label xml:lang="en">potassium channel KCNN family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001022"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001608--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001608"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily V; member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001607"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001146--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001146"><rdfs:label xml:lang="en">Q96KK3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000248--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000248"><rdfs:label xml:lang="en">protein->ion channel->cation channel sperm-associated ->cation channel sperm-associated protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001122--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001122"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> G protein-activated inward rectifier potassium channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001121"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000098--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000098"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, alpha 2/delta subunit 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000097"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000722--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000722"><rdfs:label xml:lang="en">glycine receptor, alpha 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000721"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001492--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001492"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 9 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001491"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000172--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000172"><rdfs:label xml:lang="en">CACNA1C</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000171"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000369--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000369"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily-> Alpha-2/CHRNA2 sub-subfamily->Neuronal acetylcholine receptor subunit alpha-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000368"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000034--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000034"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> 5HT3 receptor> 5-hydroxytryptamine receptor 3E</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000033"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001756--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001756"><rdfs:label xml:lang="en">P29972</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000317--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000317"><rdfs:label xml:lang="en">CLCNKA</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000316"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000837--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000837"><rdfs:label xml:lang="en">mucolipin 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000836"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000014--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000014"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> 5HT3 receptor> 5-hydroxytryptamine receptor 3A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000013"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000046--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000046"><rdfs:label xml:lang="en">Q96FT7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001214--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001214"><rdfs:label xml:lang="en">potassium voltage-gated channel; Shab-related subfamily; member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001153"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001427--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001427"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Epithelial sodium channel> Amiloride-sensitive sodium channel subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001426"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000419--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000419"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor beta subunit> Neuronal acetylcholine receptor subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000418"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000227--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000227"><rdfs:label xml:lang="en">CALHM2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000226"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000412--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000412"><rdfs:label xml:lang="en">CHRNB3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000411"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000872--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000872"><rdfs:label xml:lang="en">pannexin 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000871"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001444--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001444"><rdfs:label xml:lang="en">sodium channel; nonvoltage-gated 1; gamma</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001428"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000056--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000056"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->acid-sensing ion channel 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000035"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000447--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000447"><rdfs:label xml:lang="en">TCDB says voltage gated (http://ebi2.uniprot.org/uniprot/P29973)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000662--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000662"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, kainate 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000661"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001062--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001062"><rdfs:label xml:lang="en">1.A.2.1.2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001061"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000177--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000177"><rdfs:label xml:lang="en">CACNA1D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000176"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000576--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000576"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000822--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000822"><rdfs:label xml:lang="en">leucine rich repeat containing 55</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000821"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000486--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000486"><rdfs:label xml:lang="en">protein->ion channel->fam26 family->protein fam26e</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000225"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001639--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001639"><rdfs:label xml:lang="en">protein->ion channel->tmc family->transmembrane channel-like protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001623"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000138--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000138"><rdfs:label xml:lang="en">8.A.16.1.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000137"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000577--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000577"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000576"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001487--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001487"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type IX, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001486"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000726--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000726"><rdfs:label xml:lang="en">P23416</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000020--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000020"><rdfs:label xml:lang="en">Cation</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000832"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000691--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000691"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, nmda 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000757--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000757"><rdfs:label xml:lang="en">hyperpolarization activated cyclic nucleotide-gated potassium channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000756"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001091--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001091"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->inward rectifier potassium channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000612--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000612"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, rho 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000611"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001177--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001177"><rdfs:label xml:lang="en">potassium voltage-gated channel, Isk-related family, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001176"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000901--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000901"><rdfs:label xml:lang="en">Q13563</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000816--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000816"><rdfs:label xml:lang="en">Q8N7C0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000157--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000157"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit gamma family> Voltage-dependent calcium channel gamma-5 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000156"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000196--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000196"><rdfs:label xml:lang="en">O00555</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000907--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000907"><rdfs:label xml:lang="en">polycystic kidney disease 2-like 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000906"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001142--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001142"><rdfs:label xml:lang="en">potassium large conductance calcium-activated channel, subfamily M, beta member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001141"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000144--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000144"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel auxiliary subunit 1-8 (cca) family->Voltage-dependent calcium channel gamma-3 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000143"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000484--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000484"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->Protein FAM26E</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000483"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000692--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000692"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> NMDA receptor> Glutamate receptor ionotropic, NMDA 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000691"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000035--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000035"><rdfs:label xml:lang="en">amiloride-sensitive sodium channel (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000034"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001217--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001217"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily B member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001216"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001432--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001432"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Epithelial sodium channel> Amiloride-sensitive sodium channel subunit beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001431"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001357--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001357"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily H member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001356"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000966--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000966"><rdfs:label xml:lang="en">O14649</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000403--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000403"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit alpha-9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000029--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000029"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> 5HT3 receptor> 5-hydroxytryptamine receptor 3D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000028"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000313--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000313"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->chloride transport protein 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000466--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000466"><rdfs:label xml:lang="en">P13569</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001122--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001122"><rdfs:label xml:lang="en">potassium large conductance calcium-activated channel, subfamily M beta member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001121"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001666--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001666"><rdfs:label xml:lang="en">Q9H6F2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000997--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000997"><rdfs:label xml:lang="en">potassium channel, subfamily T, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000996"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000366--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000366"><rdfs:label xml:lang="en">Q15822</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000641--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000641"><rdfs:label xml:lang="en">P42263</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000737--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000737"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Glycine receptor> Glycine receptor subunit alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000736"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000444--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000444"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Cyclic nucleotide-regulated channel> cGMP-gated cation channel alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000443"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000707--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000707"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, N-methyl D-aspartate 2D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000706"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001307--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001307"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily F, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001306"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000284--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000284"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->the chloride carrier/channel (clc) family->Chloride channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000283"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000188--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000188"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent l-type calcium channel subunit alpha-1f</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001453--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001453"><rdfs:label xml:lang="en">sodium channel auxiliary subunit SCN1B (TC 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001452"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001527--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001527"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily A, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001526"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000208--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000208"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent r-type calcium channel subunit alpha-1e</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001151--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001151"><rdfs:label xml:lang="en">Q9ULS6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001729--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001729"><rdfs:label xml:lang="en">aquaporin 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001221--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001221"><rdfs:label xml:lang="en">Q13303</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001507--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001507"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 10 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001506"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001412--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001412"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ryanodine receptor> Ryanodine receptor 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001411"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000876--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000876"><rdfs:label xml:lang="en">Q92508</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000176--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000176"><rdfs:label xml:lang="en">Voltage-gated calcium channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000175"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001424--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001424"><rdfs:label xml:lang="en">Epithelial sodium channels (ENaC)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000035"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001558--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001558"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily C; member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001557"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001063--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001063"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel; subfamily J; member 12</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001649--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001649"><rdfs:label xml:lang="en">protein->ion channel->tmc family->transmembrane channel-like protein 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001623"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001496--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001496"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 5 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001629--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001629"><rdfs:label xml:lang="en">protein->ion channel->tmc family->transmembrane channel-like protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001623"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001321--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001321"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily g member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000218--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000218"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, T type, alpha 1I subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000217"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000967--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000967"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Two-pore domain potassium channel> Potassium channel subfamily K member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000966"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001566--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001566"><rdfs:label xml:lang="en">O94759</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000433--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000433"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, gamma (muscle)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000432"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000039--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000039"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->amiloride-sensitive sodium channel family->ASIC2 subfamily->acid-sensing ion channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000038"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000157--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000157"><rdfs:label xml:lang="en">CACNG6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000156"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000298--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000298"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000297"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000941--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000941"><rdfs:label xml:lang="en">Q9H427</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001586--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001586"><rdfs:label xml:lang="en">Q7Z2W7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000383--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000383"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 5 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000382"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000313--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000313"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000312"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001497--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001497"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 5 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001496"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000272--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000272"><rdfs:label xml:lang="en">CLCA4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000271"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000429--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000429"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor delta subunit> Acetylcholine receptor subunit delta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000428"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001406--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001406"><rdfs:label xml:lang="en">protein->ion channel->p2x receptor family->p2x purinoceptor 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001532--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001532"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily C, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001531"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000175--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000175"><rdfs:label xml:lang="en">calcium channel alpha-1 subunit (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000174"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001043--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001043"><rdfs:label xml:lang="en">1.A.1.16.2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001042"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000109--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000109"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->ca(2+) channel auxiliary subunit 2 types 1-4 (cca-2) family->voltage-dependent calcium channel subunit alpha-2/delta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000108"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000449--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000449"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Cyclic nucleotide-regulated channel> Cyclic nucleotide-gated olfactory channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000448"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001602--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001602"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily V member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001601"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001222--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001222"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, beta member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001221"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001428--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001428"><rdfs:label xml:lang="en">1.A.6.1.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001427"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001187--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001187"><rdfs:label xml:lang="en">potassium voltage-gated channel, KQT-like subfamily, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001186"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000003--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000003"><rdfs:label xml:lang="en">name_TCRD</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000002"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000602--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000602"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, gamma 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000601"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000374--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000374"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Neuronal acetylcholine receptor subunit alpha-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000373"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001541--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001541"><rdfs:label xml:lang="en">Q9UBN4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000772--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000772"><rdfs:label xml:lang="en">inositol 1,4,5-trisphosphate receptor, type 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000771"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001377--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001377"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> P2X receptor> P2X purinoceptor 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001376"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000753--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000753"><rdfs:label xml:lang="en">potassium channel HCN family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000752"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000211--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000211"><rdfs:label xml:lang="en">O95180</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000916--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000916"><rdfs:label xml:lang="en">protein->ion channel->polycystin family->polycystic kidney disease 2-like 2 protein</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001861--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001861"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily M; member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001860"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001659--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001659"><rdfs:label xml:lang="en">protein->ion channel->tmc family->transmembrane channel-like protein 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001623"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000223--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000223"><rdfs:label xml:lang="en">calcium homeostasis modulator 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000222"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000931--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000931"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001016--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001016"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily v member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000431--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000431"><rdfs:label xml:lang="en">P07510</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001387--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001387"><rdfs:label xml:lang="en">purinergic receptor P2X, ligand-gated ion channel, 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001386"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001601--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001601"><rdfs:label xml:lang="en">Q8NET8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001193--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001193"><rdfs:label xml:lang="en">1.A.1.15.2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001192"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000012--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000012"><rdfs:label xml:lang="en">Channel Activity</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000011"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000169--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000169"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel auxiliary subunit 1-8 (cca) family->Voltage-dependent calcium channel gamma-8 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000168"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000266--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000266"><rdfs:label xml:lang="en">protein->ion channel->clcr family->calcium-activated chloride channel regulator 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000260"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001431--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001431"><rdfs:label xml:lang="en">P51172</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000747--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000747"><rdfs:label xml:lang="en">hydrogen voltage-gated channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000746"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000268--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000268"><rdfs:label xml:lang="en">chloride channel accessory 3, pseudogene</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000267"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001401--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001401"><rdfs:label xml:lang="en">Q99572</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001407--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001407"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> P2X receptor> P2X purinoceptor 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001406"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000777--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000777"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> IP3 receptor> Inositol 1,4,5-trisphosphate receptor type 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000776"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001452--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001452"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type I, beta subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001451"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001526--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001526"><rdfs:label xml:lang="en">O75762</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000220--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000220"><rdfs:label xml:lang="en">1.A.1.11.3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000219"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000409--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000409"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor beta subunit> Acetylcholine receptor subunit beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000408"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001132--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001132"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Calcium-activated potassium channel> Calcium-activated potassium channel subunit alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001131"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000991--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000991"><rdfs:label xml:lang="en">Q9NPC2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001576--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001576"><rdfs:label xml:lang="en">Q8TD43</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001875--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001875"><rdfs:label xml:lang="en">Ion</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000512"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001441--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001441"><rdfs:label xml:lang="en">Q9UQD0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001816--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001816"><rdfs:label xml:lang="en">Q5T442</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001815"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001062--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001062"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 13</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001061"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000852--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000852"><rdfs:label xml:lang="en">NADPH oxidase, EF-hand calcium binding domain 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000851"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001422--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001422"><rdfs:label xml:lang="en">sodium channel, non-voltage-gated 1 alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001421"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001071--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001071"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->atp-sensitive inward rectifier potassium channel 14</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000251--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000251"><rdfs:label xml:lang="en">Q7RTX7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000020--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000020"><rdfs:label xml:lang="en">Cation</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000019"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000456--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000456"><rdfs:label xml:lang="en">Q14028</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001049--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001049"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel; subfamily J; member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001048"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001491--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001491"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 9 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001759--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001759"><rdfs:label xml:lang="en">aquaporin 1 (channel-forming integral protein; 28kDa)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001691--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001691"><rdfs:label xml:lang="en">Q9ULQ1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001147--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001147"><rdfs:label xml:lang="en">potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001146"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001731--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001731"><rdfs:label xml:lang="en">O95377</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001714"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000021--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000021"><rdfs:label xml:lang="en">Q70Z44</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000681--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000681"><rdfs:label xml:lang="en">Q16478</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000406--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000406"><rdfs:label xml:lang="en">P17787</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001006--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001006"><rdfs:label xml:lang="en">A8MYU2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001107--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001107"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> G protein-activated inward rectifier potassium channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001106"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001396--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001396"><rdfs:label xml:lang="en">O15547</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000372--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000372"><rdfs:label xml:lang="en">CHRNA3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000371"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000106--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000106"><rdfs:label xml:lang="en">Q7Z3S7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001791--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001791"><rdfs:label xml:lang="en">P55064</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000027--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000027"><rdfs:label xml:lang="en">HTR3E</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000026"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001456--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001456"><rdfs:label xml:lang="en">Q99250</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000748--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000748"><rdfs:label xml:lang="en">hydrogen channel family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000747"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001217--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001217"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, beta member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001216"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000226--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000226"><rdfs:label xml:lang="en">protein->ion channel->fam26 family->calcium homeostasis modulator protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000225"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000362--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000362"><rdfs:label xml:lang="en">CHRNA10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000361"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000591--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000591"><rdfs:label xml:lang="en">Q8N1C3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000183--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000183"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, L type, alpha 1F subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000182"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001236--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001236"><rdfs:label xml:lang="en">Q16322</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001557--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001557"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily C, member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001556"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000229--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000229"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium homeostasis modulator ca(2+) channel (calhm-c) family->Calcium homeostasis modulator protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000228"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000899--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000899"><rdfs:label xml:lang="en">protein->ion channel->polycystin family->polycystic kidney disease protein 1-like 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000893"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000597--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000597"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit gamma-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000596"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000111--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000111"><rdfs:label xml:lang="en">Q02641</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001411--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001411"><rdfs:label xml:lang="en">Q92736</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001500--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001500"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 7 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001499"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001582--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001582"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily M member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001581"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001116--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001116"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->atp-sensitive inward rectifier potassium channel 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000208--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000208"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, T type, alpha 1G subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000207"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001041--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001041"><rdfs:label xml:lang="en">protein->ion channel->potassium channel kcnn family->intermediate conductance calcium-activated potassium channel protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000306--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000306"><rdfs:label xml:lang="en">P51797</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001622--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001622"><rdfs:label xml:lang="en">transmembrane channel-like 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001621"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001247--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001247"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily A member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001246"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000057--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000057"><rdfs:label xml:lang="en">ANO1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000056"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001581--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001581"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily m member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001191--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001191"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily kqt member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001238--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001238"><rdfs:label xml:lang="en">1.A.1.2.2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001237"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001875--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001875"><rdfs:label xml:lang="en">Ion</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000024"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000219--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000219"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent T-type calcium channel subunit alpha-1H</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000218"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001297--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001297"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shaw-related subfamily, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001296"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000045--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000045"><rdfs:label xml:lang="en">Sodium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000044"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000114--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000114"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel beta subunit family->voltage-dependent l-type calcium channel subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000113"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000681--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000681"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, kainate 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000139--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000139"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel auxiliary subunit 1-8 (cca) family->Voltage-dependent calcium channel gamma-2 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000138"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000383--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000383"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit alpha-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000263--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000263"><rdfs:label xml:lang="en">chloride channel accessory 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000262"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000144--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000144"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; gamma subunit 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000138"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000451--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000451"><rdfs:label xml:lang="en">Q8IV77</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000450"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000691--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000691"><rdfs:label xml:lang="en">Q12879</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001247--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001247"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001246"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000136--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000136"><rdfs:label xml:lang="en">Q9Y698</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001381--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001381"><rdfs:label xml:lang="en">protein->ion channel->p2x receptor family->p2x purinoceptor 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000386--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000386"><rdfs:label xml:lang="en">Q15825</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000495--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000495"><rdfs:label xml:lang="en">FXYD family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000494"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000889--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000889"><rdfs:label xml:lang="en">protein->ion channel->mal family->plasmolipin</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000888"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000557--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000557"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, alpha 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000556"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001051--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001051"><rdfs:label xml:lang="en">Q14654</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001111--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001111"><rdfs:label xml:lang="en">Q15842</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001137--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001137"><rdfs:label xml:lang="en">potassium large conductance calcium-activated channel; subfamily M; beta member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001125"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000931--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000931"><rdfs:label xml:lang="en">Q9HB15</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000393--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000393"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 7 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000392"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000076--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000076"><rdfs:label xml:lang="en">protein->ion channel->bestrophin family->bestrophin-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000075"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001407--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001407"><rdfs:label xml:lang="en">ryanodine receptor 1 (skeletal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001406"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000434--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000434"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->Acetylcholine receptor subunit gamma</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000433"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001347--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001347"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily H member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001346"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001196--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001196"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily kqt member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001356--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001356"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily h member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001342--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001342"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily H member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001341"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000551--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000551"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000289--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000289"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->chloride channel family->ClC-2/CLCN2 subfamily->Chloride channel protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000288"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000443--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000443"><rdfs:label xml:lang="en">protein->ion channel->cyclic nucleotide-gated cation channel ->cgmp-gated cation channel alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001875--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001875"><rdfs:label xml:lang="en">Ion</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000617--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000617"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, rho 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000616"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000853--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000853"><rdfs:label xml:lang="en">Proteins> Transporter> Transmembrane 1-electron transfer carriers> NADPH oxidase 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000852"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000622--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000622"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, rho 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000621"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000483--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000483"><rdfs:label xml:lang="en">family with sequence similarity 26, member E</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000482"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001198--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001198"><rdfs:label xml:lang="en">1.A.1.15.3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001197"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001536--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001536"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->short transient receptor potential channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001436--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001436"><rdfs:label xml:lang="en">P51170</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001462--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001462"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 2 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001461"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001851--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001851"><rdfs:label xml:lang="en">Q96PS8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001092--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001092"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> Inward rectifier potassium channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001091"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000069--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000069"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->the calcium-dependent chloride channel (ca-clc) family->Anoctamin-6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000068"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001421--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001421"><rdfs:label xml:lang="en">protein->ion channel->ryanodine receptor ->ryanodine receptor 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001126--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001126"><rdfs:label xml:lang="en">potassium large conductance calcium-activated channel; subfamily M beta member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001125"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001342--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001342"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily H (eag-related), member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001341"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000266--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000266"><rdfs:label xml:lang="en">Q9Y6N3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000469--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000469"><rdfs:label xml:lang="en">protein->ion channel->anion channel->the atp-binding cassette (abc) superfamily->Cystic fibrosis transmembrane conductance regulator</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000468"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000171--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000171"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-8 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000581--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000581"><rdfs:label xml:lang="en">O14764</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001486--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001486"><rdfs:label xml:lang="en">sodium channel; voltage-gated; type IV; beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001465"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000351--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000351"><rdfs:label xml:lang="en">Q96NY7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000068--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000068"><rdfs:label xml:lang="en">anoctamin 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000411--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000411"><rdfs:label xml:lang="en">Q05901</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000263--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000263"><rdfs:label xml:lang="en">Calcium; Chloride</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000262"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000364--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000364"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily->Alpha-10/CHRNA10 sub-subfamily->Neuronal acetylcholine receptor subunit alpha-10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000363"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000992--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000992"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000991"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000289--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000289"><rdfs:label xml:lang="en">chloride channel 1; skeletal muscle (Thomsen disease; autosomal dominant)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000288"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000136--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000136"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-1 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000228--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000228"><rdfs:label xml:lang="en">calcium homeostasis modulator 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000227"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000776--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000776"><rdfs:label xml:lang="en">protein->ion channel->insp3 receptor family->inositol 1,4,5-trisphosphate receptor type 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001156--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001156"><rdfs:label xml:lang="en">Q9BQ31</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000833--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000833"><rdfs:label xml:lang="en">transient receptor (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000832"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001116--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001116"><rdfs:label xml:lang="en">Q92806</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000015--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000015"><rdfs:label xml:lang="en">5-hydroxytryptamine (serotonin) receptor 3A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000014"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000721--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000721"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, nmda 3b</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000049--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000049"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Acid-sensing ion channel> Acid-sensing ion channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000048"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000237--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000237"><rdfs:label xml:lang="en">CATSPER1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000236"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000294--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000294"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Chloride channel> ClC chloride channel> Chloride channel protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000293"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000351--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000351"><rdfs:label xml:lang="en">protein->ion channel->chloride channel clic family->chloride intracellular channel protein 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000330"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001572--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001572"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily M member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001571"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000242--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000242"><rdfs:label xml:lang="en">CATSPER2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000241"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000547--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000547"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, alpha 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000546"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001771--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001771"><rdfs:label xml:lang="en">P36382</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001211--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001211"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily b member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001461--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001461"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 2 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000309--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000309"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->chloride channel family->ClC-6/CLCN6 subfamily->Chloride transport protein 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000308"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000877--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000877"><rdfs:label xml:lang="en">piezo-type mechanosensitive ion channel component 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000876"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000013--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000013"><rdfs:label xml:lang="en">5-hydroxytryptamine (serotonin) receptor 3B, ionotropic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000373--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000373"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 3 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000372"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000747--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000747"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Glycine receptor> Glycine receptor subunit beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000746"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001799--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001799"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Aquaporin> Water-specific aquaporin> Aquaporin-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001451--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001451"><rdfs:label xml:lang="en">Q07699</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000294--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000294"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->chloride channel family->ClC-3/CLCN3 subfamily->H(+)/Cl(-) exchange transporter 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000293"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000478--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000478"><rdfs:label xml:lang="en">family with sequence similarity 26, member D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000477"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001442--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001442"><rdfs:label xml:lang="en">sodium channel, voltage gated, type VIII, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001441"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001557--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001557"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Short transient receptor potential channel 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001556"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001486--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001486"><rdfs:label xml:lang="en">Q15858</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001408--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001408"><rdfs:label xml:lang="en">ryanodine receptor (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001407"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000742--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000742"><rdfs:label xml:lang="en">glycine receptor, beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000741"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001292--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001292"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily C member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001291"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000961--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000961"><rdfs:label xml:lang="en">O95069</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001066--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001066"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->inward rectifier potassium channel 13</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001056--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001056"><rdfs:label xml:lang="en">Q14500</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000301--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000301"><rdfs:label xml:lang="en">P51795</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000352--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000352"><rdfs:label xml:lang="en">CLIC6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000351"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000967--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000967"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000966"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001396--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001396"><rdfs:label xml:lang="en">protein->ion channel->p2x receptor family->p2x purinoceptor 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000153--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000153"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; gamma subunit 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000152"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000356--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000356"><rdfs:label xml:lang="en">protein->ion channel->chloride channel clic family->chloride intracellular channel protein 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000330"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001585--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001585"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily M member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000727--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000727"><rdfs:label xml:lang="en">glycine receptor, alpha 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000726"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000005--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000005"><rdfs:label xml:lang="en">FamilyAnnotation_TCRD</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000004"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001541--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001541"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->short transient receptor potential channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001021--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001021"><rdfs:label xml:lang="en">Q92952</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000012--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000012"><rdfs:label xml:lang="en">lgic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000011"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001082--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001082"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 18</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001081"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001367--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001367"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily H member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001366"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001697--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001697"><rdfs:label xml:lang="en">two pore segment channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001696"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001664--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001664"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-like subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000009--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000009"><rdfs:label xml:lang="en">ChEMBL_Class_Path</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000008"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000282--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000282"><rdfs:label xml:lang="en">CLCN1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000281"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000611--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000611"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit pi</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000067--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000067"><rdfs:label xml:lang="en">Chloride</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000353"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000982--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000982"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000981"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000346--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000346"><rdfs:label xml:lang="en">Q9NZA1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000202--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000202"><rdfs:label xml:lang="en">CACNA1E</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000201"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001157--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001157"><rdfs:label xml:lang="en">potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001156"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000188--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000188"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, L type, alpha 1S subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000187"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001317--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001317"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily G member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001316"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000417--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000417"><rdfs:label xml:lang="en">CHRNB4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000416"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001246--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001246"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily a member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001101--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001101"><rdfs:label xml:lang="en">P48544</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000856--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000856"><rdfs:label xml:lang="en">Q96D31</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000850"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000019--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000019"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->5-hydroxytryptamine receptor subfamily->HTR3C sub-subfamily->5-hydroxytryptamine receptor 3c</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000018"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001677--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001677"><rdfs:label xml:lang="en">tweety family member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001676"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001472--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001472"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type III, beta subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001471"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001811--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001811"><rdfs:label xml:lang="en">Q13520</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000291--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000291"><rdfs:label xml:lang="en">P51790</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001191--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001191"><rdfs:label xml:lang="en">O43525</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000008--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000008"><rdfs:label xml:lang="en">5-hydroxytryptamine (serotonin) receptor 3A, ionotropic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000007"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000226--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000226"><rdfs:label xml:lang="en">Q9HA72</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000471--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000471"><rdfs:label xml:lang="en">P04839</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000173--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000173"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, L type, alpha 1C subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000172"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001474--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001474"><rdfs:label xml:lang="en">protein->ion channel->sodium channel auxiliary subunit scn3b ->sodium channel subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001473"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000834--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000834"><rdfs:label xml:lang="en">Transient Receptor Potential channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000833"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001518--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001518"><rdfs:label xml:lang="en">voltage gated channel like 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001517"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001800--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001800"><rdfs:label xml:lang="en">aquaporin 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001799"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000465--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000465"><rdfs:label xml:lang="en">TCDB says voltage gated (http://ebi2.uniprot.org/uniprot/Q14028)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000902--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000902"><rdfs:label xml:lang="en">polycystic kidney disease 2 (autosomal dominant)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000901"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000293--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000293"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000292"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000280--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000280"><rdfs:label xml:lang="en">chloride channel MCLC family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000279"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000503--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000503"><rdfs:label xml:lang="en">FXYD domain containing ion transport regulator 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000502"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001701--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001701"><rdfs:label xml:lang="en">Q401N2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000181--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000181"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; L type; alpha 1C subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000180"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001229--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001229"><rdfs:label xml:lang="en">protein->ion channel->shaker potassium channel beta subunit family->voltage-gated potassium channel subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001218"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001056--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001056"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->atp-sensitive inward rectifier potassium channel 11</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001076--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001076"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->atp-sensitive inward rectifier potassium channel 15</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000736--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000736"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->glycine receptor subunit alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001831--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001831"><rdfs:label xml:lang="en">Q8NFK1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000330--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000330"><rdfs:label xml:lang="en">chloride channel CLIC family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000329"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001471--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001471"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 3 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001875--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001875"><rdfs:label xml:lang="en">Ion</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000507"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000468--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000468"><rdfs:label xml:lang="en">protein->ion channel->cyclic nucleotide-gated cation channel ->cyclic nucleotide-gated cation channel beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001052--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001052"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> ATP-sensitive inward rectifier potassium channel 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001051"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001751--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001751"><rdfs:label xml:lang="en">P29033</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001871--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001871"><rdfs:label xml:lang="en">Q9Y6H8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000038--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000038"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->acid-sensing ion channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001186--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001186"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily kqt member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001706--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001706"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->zinc-activated ligand-gated ion channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001531--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001531"><rdfs:label xml:lang="en">P48995</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000226--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000226"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; alpha 1I subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000220"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001473--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001473"><rdfs:label xml:lang="en">sodium channel auxiliary subunit SCN3B (TC 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001472"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001367--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001367"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily H (eag-related), member 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001366"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001117--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001117"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> ATP-sensitive inward rectifier potassium channel 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001116"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001429--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001429"><rdfs:label xml:lang="en">sodium channel; nonvoltage-gated 1 alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001428"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001362--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001362"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily H (eag-related), member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001361"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001781--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001781"><rdfs:label xml:lang="en">P41181</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001331--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001331"><rdfs:label xml:lang="en">O95259</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000498--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000498"><rdfs:label xml:lang="en">FXYD domain containing ion transport regulator 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000497"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000413--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000413"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000986--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000986"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000067--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000067"><rdfs:label xml:lang="en">Chloride</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000343"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000566--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000566"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit alpha-6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000198--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000198"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent n-type calcium channel subunit alpha-1b</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001327--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001327"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily G member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001326"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001042--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001042"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001041"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000022--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000022"><rdfs:label xml:lang="en">HTR3D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000021"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000180--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000180"><rdfs:label xml:lang="en">1.A.1.11.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000179"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000181--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000181"><rdfs:label xml:lang="en">O60840</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001511--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001511"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 11 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001646--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001646"><rdfs:label xml:lang="en">Q7Z403</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000763--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000763"><rdfs:label xml:lang="en">Sodium; Potassium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000757"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000762--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000762"><rdfs:label xml:lang="en">hyperpolarization activated cyclic nucleotide-gated potassium channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000761"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000178--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000178"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent l-type calcium channel subunit alpha-1c</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000225--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000225"><rdfs:label xml:lang="en">FAM26 family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000224"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000249--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000249"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->Cation channel sperm-associated protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000248"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000075--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000075"><rdfs:label xml:lang="en">bestrophin family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000074"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000633--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000633"><rdfs:label xml:lang="en">glutamate-gated ion channel (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000632"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000821--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000821"><rdfs:label xml:lang="en">Q6ZSA7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000850--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000850"><rdfs:label xml:lang="en">Hydrogen</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000847"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001371--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001371"><rdfs:label xml:lang="en">P51575</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000461--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000461"><rdfs:label xml:lang="en">Q9NQW8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000460"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000146--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000146"><rdfs:label xml:lang="en">Q9UBN1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000911--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000911"><rdfs:label xml:lang="en">Q9NZM6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000758"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000231--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000231"><rdfs:label xml:lang="en">Q86XJ0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001226--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001226"><rdfs:label xml:lang="en">O43448</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001647--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001647"><rdfs:label xml:lang="en">transmembrane channel-like 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001646"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001072--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001072"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 15</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001071"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000184--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000184"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent L-type calcium channel subunit alpha-1D</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000183"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000189--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000189"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent L-type calcium channel subunit alpha-1F</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000188"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000927--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000927"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000926"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001612--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001612"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily V, member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001611"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001126--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001126"><rdfs:label xml:lang="en">Q12791</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000328--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000328"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->chloride channel protein clc-kb</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000811--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000811"><rdfs:label xml:lang="en">Q5VT99</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000829--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000829"><rdfs:label xml:lang="en">protein->ion channel->mcu family->calcium uniporter protein, mitochondrial</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000828"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000409--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000409"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->Neuronal acetylcholine receptor subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000408"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000222--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000222"><rdfs:label xml:lang="en">CALHM1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000221"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001161--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001161"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily s member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000448--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000448"><rdfs:label xml:lang="en">cyclic nucleotide gated channel alpha 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000447"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000379--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000379"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->Acetylcholine receptor subfamily->Alpha-4/CHRNA4 sub-subfamily->Neuronal acetylcholine receptor subunit alpha-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000378"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000081--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000081"><rdfs:label xml:lang="en">Q8N1M1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001814--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001814"><rdfs:label xml:lang="en">aquaporin 6; kidney specific</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000276--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000276"><rdfs:label xml:lang="en">Q96S66</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000506--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000506"><rdfs:label xml:lang="en">protein->ion channel->fxyd family->fxyd domain-containing ion transport regulator 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000495"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000972--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000972"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000971"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000429--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000429"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family->Acetylcholine receptor subunit epsilon</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000428"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000191--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000191"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; alpha 1F subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000180"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000596--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000596"><rdfs:label xml:lang="en">P18507</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000475--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000475"><rdfs:label xml:lang="en">Proteins> Transporter> Transmembrane 1-electron transfer carriers> Cytochrome b-245 heavy chain</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000474"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000551--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000551"><rdfs:label xml:lang="en">P48169</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000886--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000886"><rdfs:label xml:lang="en">Q9Y342</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000702--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000702"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> NMDA receptor> Glutamate receptor ionotropic, NMDA 2B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000701"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000092--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000092"><rdfs:label xml:lang="en">CACNA2D1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000091"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001533--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001533"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily A; member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001532"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000019--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000019"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> 5HT3 receptor> 5-hydroxytryptamine receptor 3B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000018"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000398--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000398"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit alpha-7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000858--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000858"><rdfs:label xml:lang="en">Orai family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000857"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000047--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000047"><rdfs:label xml:lang="en">ASIC4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000046"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001176--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001176"><rdfs:label xml:lang="en">Q8WWG9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000269--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000269"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->epithelial chloride channel (e-clc) family->Calcium-activated chloride channel regulator family member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000268"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000834--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000834"><rdfs:label xml:lang="en">Transient Receptor Potential channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000893"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001341--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001341"><rdfs:label xml:lang="en">Q9ULD8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001483--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001483"><rdfs:label xml:lang="en">sodium channel auxiliary subunit SCN4B (TC 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001482"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000696--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000696"><rdfs:label xml:lang="en">Q13224</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001231--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001231"><rdfs:label xml:lang="en">Q09470</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000473--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000473"><rdfs:label xml:lang="en">protein->ion channel->abc transporter superfamily->cystic fibrosis transmembrane conductance regulator</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000156--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000156"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-5 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000423--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000423"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, delta (muscle)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000422"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000056--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000056"><rdfs:label xml:lang="en">Q5XXA6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000363--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000363"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->acetylcholine receptor subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000672--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000672"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> Kainate receptor> Glutamate receptor ionotropic, kainate 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000671"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000162--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000162"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit gamma family> Voltage-dependent calcium channel gamma-6 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000161"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001416--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001416"><rdfs:label xml:lang="en">Q15413</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000121--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000121"><rdfs:label xml:lang="en">P54284</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000716--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000716"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, nmda 3a</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000863--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000863"><rdfs:label xml:lang="en">pannexin family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000862"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001641--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001641"><rdfs:label xml:lang="en">Q6UXY8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000241--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000241"><rdfs:label xml:lang="en">Q96P56</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000711--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000711"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, nmda 2d</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001347--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001347"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily H (eag-related), member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001346"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000972--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000972"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Two-pore domain potassium channel> Potassium channel subfamily K member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000971"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001096--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001096"><rdfs:label xml:lang="en">protein->ion channel->inward rectifier-type potassium channel ->g protein-activated inward rectifier potassium channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001551--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001551"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->short transient receptor potential channel 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001506--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001506"><rdfs:label xml:lang="en">Q9UI33</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001661--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001661"><rdfs:label xml:lang="en">Q8WXS4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000996--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000996"><rdfs:label xml:lang="en">Q5JUK3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001861--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001861"><rdfs:label xml:lang="en">Q9NTQ9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000082--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000082"><rdfs:label xml:lang="en">vitelliform macular dystrophy 2-like 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000081"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001237--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001237"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily A member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001236"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001741--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001741"><rdfs:label xml:lang="en">P08034</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000756--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000756"><rdfs:label xml:lang="en">protein->ion channel->potassium channel hcn family->potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001012--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001012"><rdfs:label xml:lang="en">potassium channel, subfamily V, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001011"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000164--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000164"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel auxiliary subunit 1-8 (cca) family->Voltage-dependent calcium channel gamma-7 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000163"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000721--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000721"><rdfs:label xml:lang="en">P23415</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000731--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000731"><rdfs:label xml:lang="en">O75311</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001201--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001201"><rdfs:label xml:lang="en">Q9NR82</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000277--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000277"><rdfs:label xml:lang="en">CLCC1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000276"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000177--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000177"><rdfs:label xml:lang="en">vgic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000176"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000836--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000836"><rdfs:label xml:lang="en">Q8IZK6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001591--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001591"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily m member 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001446--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001446"><rdfs:label xml:lang="en">P35498</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000732--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000732"><rdfs:label xml:lang="en">glycine receptor, alpha 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000731"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001189--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001189"><rdfs:label xml:lang="en">potassium voltage-gated channel; KQT-like subfamily; member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001188"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001044--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001044"><rdfs:label xml:lang="en">Inwardly rectifying potassium channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001043"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000094--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000094"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel subunit alpha-2/delta family->voltage-dependent calcium channel subunit alpha-2/delta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000093"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000766--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000766"><rdfs:label xml:lang="en">Q9Y3Q4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000758"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001326--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001326"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily g member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000104--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000104"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->ca(2+) channel auxiliary subunit 2 types 1-4 (cca-2) family->voltage-dependent calcium channel subunit alpha-2/delta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000103"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000142--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000142"><rdfs:label xml:lang="en">CACNG3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000141"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000887--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000887"><rdfs:label xml:lang="en">plasmolipin</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000886"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001592--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001592"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily M member 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001591"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000193--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000193"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent l-type calcium channel subunit alpha-1s</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000217--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000217"><rdfs:label xml:lang="en">CACNA1I</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000216"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000951--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000951"><rdfs:label xml:lang="en">Q96T54</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001846--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001846"><rdfs:label xml:lang="en">Q96KN9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001047--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001047"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001046"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000587--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000587"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit delta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000586"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000448--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000448"><rdfs:label xml:lang="en">protein->ion channel->cyclic nucleotide-gated cation channel ->cyclic nucleotide-gated olfactory channel</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000879--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000879"><rdfs:label xml:lang="en">protein->ion channel->piezo family->piezo-type mechanosensitive ion channel component 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000878"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000373--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000373"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit alpha-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000423--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000423"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->neuronal acetylcholine receptor subunit beta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000218--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000218"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent t-type calcium channel subunit alpha-1h</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000794--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000794"><rdfs:label xml:lang="en">protein->ion channel->recoverin family->kv channel-interacting protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000788"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000161--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000161"><rdfs:label xml:lang="en">P62955</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000548--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000548"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor; alpha 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000547"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001547--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001547"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily C, member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001546"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001037--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001037"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Calcium-activated potassium channel> Small conductance calcium-activated potassium channel protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001036"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001123--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001123"><rdfs:label xml:lang="en">KCNMB (TC 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001122"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000149--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000149"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel auxiliary subunit 1-8 (cca) family->Voltage-dependent calcium channel gamma-4 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000148"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001031--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001031"><rdfs:label xml:lang="en">protein->ion channel->potassium channel kcnn family->small conductance calcium-activated potassium channel protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000601--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000601"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit gamma-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000273--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000273"><rdfs:label xml:lang="en">chloride channel accessory 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000272"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000962--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000962"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Two-pore domain potassium channel> Potassium channel subfamily K member 18</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000961"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000817--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000817"><rdfs:label xml:lang="en">leucine rich repeat containing 52</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000816"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001506--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001506"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 10 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000789--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000789"><rdfs:label xml:lang="en">protein->ion channel->recoverin family->kv channel-interacting protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000788"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000112--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000112"><rdfs:label xml:lang="en">CACNB1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000111"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001621--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001621"><rdfs:label xml:lang="en">Q8TDI8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000546--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000546"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit alpha-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000866--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000866"><rdfs:label xml:lang="en">protein->ion channel->pannexin family->pannexin-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000128--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000128"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; beta 3 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000127"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001667--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001667"><rdfs:label xml:lang="en">transmembrane protein 38A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001666"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000182--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000182"><rdfs:label xml:lang="en">CACNA1F</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000181"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000141--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000141"><rdfs:label xml:lang="en">O60359</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000942--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000942"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 15</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000941"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000363--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000363"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 10 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000362"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000781--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000781"><rdfs:label xml:lang="en">protein->ion channel->insp3 receptor family->inositol 1,4,5-trisphosphate receptor type 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000304--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000304"><rdfs:label xml:lang="en">chloride channel 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000303"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001117--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001117"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001116"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001112--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001112"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001111"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000186--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000186"><rdfs:label xml:lang="en">Q13698</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000962--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000962"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000961"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001066--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001066"><rdfs:label xml:lang="en">Q9UNX9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000132--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000132"><rdfs:label xml:lang="en">CACNG1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000131"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000115--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000115"><rdfs:label xml:lang="en">calcium channel beta subunit family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000114"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001037--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001037"><rdfs:label xml:lang="en">potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001036"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001381--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001381"><rdfs:label xml:lang="en">P56373</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001476--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001476"><rdfs:label xml:lang="en">P35499</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000045"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000724--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000724"><rdfs:label xml:lang="en">Glycine receptors</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000010"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000446--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000446"><rdfs:label xml:lang="en">Q16281</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001276--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001276"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily d member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000341--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000341"><rdfs:label xml:lang="en">protein->ion channel->chloride channel clic family->chloride intracellular channel protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000330"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001416--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001416"><rdfs:label xml:lang="en">protein->ion channel->ryanodine receptor ->ryanodine receptor 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000204--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000204"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel alpha-1 subunit family->CACNA1E subfamily->voltage-dependent R-type calcium channel subunit alpha-1e</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000203"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001322--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001322"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily G, member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001321"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001454--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001454"><rdfs:label xml:lang="en">sodium channel; voltage-gated; type I; alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001453"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001392--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001392"><rdfs:label xml:lang="en">purinergic receptor P2X, ligand-gated ion channel, 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001391"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000511--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000511"><rdfs:label xml:lang="en">Q9H0Q3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001518--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001518"><rdfs:label xml:lang="en">SLC26A/SulP transporter (TC 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001517"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001452--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001452"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated sodium channel> Sodium channel protein type 1 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001451"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001266--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001266"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily a member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001002--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001002"><rdfs:label xml:lang="en">potassium channel, subfamily T, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001001"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000516--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000516"><rdfs:label xml:lang="en">P58550</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000043--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000043"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->acid-sensing ion channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000063--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000063"><rdfs:label xml:lang="en">protein->ion channel->anoctamin family->anoctamin-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000974--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000974"><rdfs:label xml:lang="en">potassium channel; subfamily K; member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000973"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001276--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001276"><rdfs:label xml:lang="en">Q9NZV8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000146--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000146"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-3 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000666--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000666"><rdfs:label xml:lang="en">protein->ion channel->glutamate-gated ion channel ->glutamate receptor ionotropic, kainate 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001296--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001296"><rdfs:label xml:lang="en">Q14003</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000806--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000806"><rdfs:label xml:lang="en">Q2I0M4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001091--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001091"><rdfs:label xml:lang="en">P48549</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001112--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001112"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Inwardly rectifying potassium channel> G protein-activated inward rectifier potassium channel 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001111"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001139--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001139"><rdfs:label xml:lang="en">protein->ion channel->kcnmb ->calcium-activated potassium channel subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001123"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001356--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001356"><rdfs:label xml:lang="en">Q9H252</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000097--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000097"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit alpha2delta family> Voltage-dependent calcium channel subunit alpha-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000096"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001036--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001036"><rdfs:label xml:lang="en">protein->ion channel->potassium channel kcnn family->small conductance calcium-activated potassium channel protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000203--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000203"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, R type, alpha 1E subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000202"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001216--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001216"><rdfs:label xml:lang="en">Q14722</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001001--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001001"><rdfs:label xml:lang="en">Q6UVM3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000288--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000288"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->chloride channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000888--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000888"><rdfs:label xml:lang="en">MAL family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000887"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000977--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000977"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000976"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001346--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001346"><rdfs:label xml:lang="en">Q9UQ05</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000946--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000946"><rdfs:label xml:lang="en">Q96T55</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001526--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001526"><rdfs:label xml:lang="en">solute carrier family 26; member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001525"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001597--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001597"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily V member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001596"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001196--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001196"><rdfs:label xml:lang="en">P56696</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000741--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000741"><rdfs:label xml:lang="en">P48167</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000807--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000807"><rdfs:label xml:lang="en">leucine rich repeat containing 26</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000806"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000206--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000206"><rdfs:label xml:lang="en">O43497</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000936--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000936"><rdfs:label xml:lang="en">Q9HB14</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000475--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000475"><rdfs:label xml:lang="en">cystic fibrosis transmembrane conductance regulator; ATP-binding cassette (sub-family C; member 7)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000474"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001153--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001153"><rdfs:label xml:lang="en">1.A.1.2.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001152"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001682--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001682"><rdfs:label xml:lang="en">tweety family member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001681"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001517--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001517"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Miscellaneous ion channel> Sodium leak channel, non-selective> Sodium leak channel non-selective protein</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001516"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001011--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001011"><rdfs:label xml:lang="en">Q6PIU1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001686--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001686"><rdfs:label xml:lang="en">Q9C0H2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000024--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000024"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> 5HT3 receptor> 5-hydroxytryptamine receptor 3C</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000023"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001532--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001532"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily A member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001531"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000441--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000441"><rdfs:label xml:lang="en">Q16280</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000440"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001134--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001134"><rdfs:label xml:lang="en">protein->ion channel->kcnmb ->calcium-activated potassium channel subunit beta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001123"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001156--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001156"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily s member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000748--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000748"><rdfs:label xml:lang="en">glycine receptor; beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000747"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000746--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000746"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->glycine receptor subunit beta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001712--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001712"><rdfs:label xml:lang="en">Aquaporins</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001711"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001581--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001581"><rdfs:label xml:lang="en">Q96QT4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000073--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000073"><rdfs:label xml:lang="en">bestrophin 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000072"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000174--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000174"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->voltage-dependent L-type calcium channel subunit alpha-1c</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000173"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000656--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000656"><rdfs:label xml:lang="en">O43424</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000258--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000258"><rdfs:label xml:lang="en">chloride channel accessory 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000257"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000871--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000871"><rdfs:label xml:lang="en">Q96QZ0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000303--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000303"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->h(+)/cl(-) exchange transporter 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000096--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000096"><rdfs:label xml:lang="en">protein->ion channel->calcium channel subunit alpha-2/delta family->voltage-dependent calcium channel subunit alpha-2/delta-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000095"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000439--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000439"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->cyclic nucleotide-gated cation channel family>cGMP-gated cation channel alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000438"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001386--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001386"><rdfs:label xml:lang="en">Q99571</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000262--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000262"><rdfs:label xml:lang="en">CLCA2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000261"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001616--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001616"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily v member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000234--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000234"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium homeostasis modulator ca(2+) channel (calhm-c) family->Calcium homeostasis modulator protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000233"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001776--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001776"><rdfs:label xml:lang="en">P36383</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001167--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001167"><rdfs:label xml:lang="en">potassium voltage-gated channel, Isk-related family, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001166"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000897--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000897"><rdfs:label xml:lang="en">polycystic kidney disease 1-like 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000896"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001322--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001322"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily G member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001321"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001227--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001227"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, beta member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001226"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001266--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001266"><rdfs:label xml:lang="en">Q96RP8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000123--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000123"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; beta 2 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000122"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001216--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001216"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily b member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000256--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000256"><rdfs:label xml:lang="en">A8K7I4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000937--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000937"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 13</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000936"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000926--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000926"><rdfs:label xml:lang="en">P57789</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001077--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001077"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 16</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001076"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000283--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000283"><rdfs:label xml:lang="en">chloride channel, voltage-sensitive 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000282"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000626--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000626"><rdfs:label xml:lang="en">Q9UN88</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000676--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000676"><rdfs:label xml:lang="en">Q16099</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001033--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001033"><rdfs:label xml:lang="en">1.A.1.16.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001032"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000502--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000502"><rdfs:label xml:lang="en">FXYD4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000501"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000706--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000706"><rdfs:label xml:lang="en">glutamate receptor; ionotropic; N-methyl D-aspartate 2C</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000705"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001507--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001507"><rdfs:label xml:lang="en">sodium channel, voltage-gated, type XI, alpha subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001506"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000576--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000576"><rdfs:label xml:lang="en">P28472</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001362--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001362"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily H member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001361"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000014--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000014"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated-> 5-hydroxytryptamine receptor subfamily->HTR3B sub-subfamily->5-hydroxytryptamine receptor 3b</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000013"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000891--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000891"><rdfs:label xml:lang="en">Q7Z442</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000154--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000154"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel auxiliary subunit 1-8 (cca) family->Voltage-dependent calcium channel gamma-5 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000153"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000717--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000717"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, N-methyl-D-aspartate 3B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000716"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001464--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001464"><rdfs:label xml:lang="en">protein->ion channel->sodium channel auxiliary subunit scn2b ->sodium channel subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001463"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001552--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001552"><rdfs:label xml:lang="en">transient receptor potential cation channel, subfamily C, member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001551"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000617--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000617"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit rho-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000616"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000528--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000528"><rdfs:label xml:lang="en">Golgi pH regulator (TC 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000527"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001061--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001061"><rdfs:label xml:lang="en">O60928</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000917--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000917"><rdfs:label xml:lang="en">polycystin (PKD) family receptor for egg jelly</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000916"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000064--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000064"><rdfs:label xml:lang="en">Proteins> Ion channel> Other ion channel> Chloride channel> Calcium-activated chloride channel> Anoctamin-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000063"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000071--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000071"><rdfs:label xml:lang="en">protein->ion channel->anoctamin family->anoctamin-6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000060"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000296--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000296"><rdfs:label xml:lang="en">P51793</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001736--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001736"><rdfs:label xml:lang="en">O95452</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000862--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000862"><rdfs:label xml:lang="en">pannexin 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000861"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000278--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000278"><rdfs:label xml:lang="en">chloride channel CLIC-like 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000277"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000356--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000356"><rdfs:label xml:lang="en">P02708</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001267--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001267"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001266"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000677--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000677"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> Kainate receptor> Glutamate receptor ionotropic, kainate 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000676"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000458--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000458"><rdfs:label xml:lang="en">protein->ion channel->cyclic nucleotide-gated cation channel ->cyclic nucleotide-gated cation channel alpha-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001422--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001422"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ryanodine receptor> Ryanodine receptor 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001421"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001141--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001141"><rdfs:label xml:lang="en">potassium large conductance calcium-activated channel; subfamily M; beta member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001125"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000368--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000368"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, alpha 2 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000367"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000189--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000189"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->calcium channel alpha-1 subunit family->CACNA1S subfamily->voltage-dependent L-type calcium channel subunit alpha-1s</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000188"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000438--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000438"><rdfs:label xml:lang="en">cyclic nucleotide gated channel alpha 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000437"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001169--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001169"><rdfs:label xml:lang="en">protein->ion channel->potassium channel kcne family->potassium voltage-gated channel subfamily e member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001163"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000066--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000066"><rdfs:label xml:lang="en">protein->ion channel->anoctamin family->anoctamin-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000060"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001124--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001124"><rdfs:label xml:lang="en">protein->ion channel->kcnmb ->calcium-activated potassium channel subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001123"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000066--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000066"><rdfs:label xml:lang="en">Q4KMQ2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000065"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000078--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000078"><rdfs:label xml:lang="en">bestrophin 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000077"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001271--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001271"><rdfs:label xml:lang="en">Q9NSA2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000007--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000007"><rdfs:label xml:lang="en">HTR3A</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000006"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000433--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000433"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->acetylcholine receptor subunit epsilon</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000107--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000107"><rdfs:label xml:lang="en">CACNA2D4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000106"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000552--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000552"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, alpha 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000551"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001786--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001786"><rdfs:label xml:lang="en">P48165</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001714"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001157--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001157"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily S member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001156"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001165--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001165"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Slow voltage-gated potassium channel accessory protein family> Potassium voltage-gated channel subfamily E member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001164"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001336--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001336"><rdfs:label xml:lang="en">Q12809</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001690--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001690"><rdfs:label xml:lang="en">tweety homolog 3 (Drosophila)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001689"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000264--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000264"><rdfs:label xml:lang="en">protein->ion channel->anion channel->ligand-gated->epithelial chloride channel (e-clc) family->Calcium-activated chloride channel regulator 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000263"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000332--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000332"><rdfs:label xml:lang="en">CLIC2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000331"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000906--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000906"><rdfs:label xml:lang="en">protein->ion channel->polycystin family->polycystin-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001517--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001517"><rdfs:label xml:lang="en">solute carrier family 26 (anion exchanger), member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001516"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000135--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000135"><rdfs:label xml:lang="en">PMP-22/EMP/MP20 family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000134"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000034--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000034"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->amiloride-sensitive sodium channel family->ASIC1 subfamily->acid-sensing ion channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000033"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000128--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000128"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, beta 4 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000127"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001192--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001192"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily KQT member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001191"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001311--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001311"><rdfs:label xml:lang="en">Q9UIX4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000418--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000418"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, beta 4 (neuronal)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000417"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000454--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000454"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Cyclic nucleotide-regulated channel> Cyclic nucleotide-gated cation channel alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000453"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001361--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001361"><rdfs:label xml:lang="en">Q9NS40</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000999--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000999"><rdfs:label xml:lang="en">Calcium-activated potassium channels</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000998"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000988--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000988"><rdfs:label xml:lang="en">potassium channel; subfamily K; member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000987"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000752--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000752"><rdfs:label xml:lang="en">hyperpolarization activated cyclic nucleotide-gated potassium channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000751"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000397--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000397"><rdfs:label xml:lang="en">CHRNA9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000396"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001556--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001556"><rdfs:label xml:lang="en">Q9HCX4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001821--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001821"><rdfs:label xml:lang="en">Q6PEY0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000061--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000061"><rdfs:label xml:lang="en">Q9NQ90</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001499--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001499"><rdfs:label xml:lang="en">protein->ion channel->sodium channel ->sodium channel protein type 7 subunit alpha</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001443"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000133--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000133"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; beta 4 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000132"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000782--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000782"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> IP3 receptor> Inositol 1,4,5-trisphosphate receptor type 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000781"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001132--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001132"><rdfs:label xml:lang="en">potassium large conductance calcium-activated channel, subfamily M, beta member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001131"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000470--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000470"><rdfs:label xml:lang="en">ABC transporter superfamily</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000469"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000957--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000957"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 18</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000956"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000039--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000039"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Acid-sensing ion channel> Acid-sensing ion channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000038"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001044--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001044"><rdfs:label xml:lang="en">potassium intermediate/small conductance calcium-activated channel; subfamily N; member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001043"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000354--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000354"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->intracellular chloride channel (clic) family->Chloride intracellular channel protein 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000353"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001361--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001361"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily h member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000677--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000677"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, kainate 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000676"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000099--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000099"><rdfs:label xml:lang="en">Calcium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001412"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000239--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000239"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->Cation channel sperm-associated protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000238"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000453--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000453"><rdfs:label xml:lang="en">cyclic nucleotide gated channel alpha 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000452"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001224--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001224"><rdfs:label xml:lang="en">protein->ion channel->shaker potassium channel beta subunit family->voltage-gated potassium channel subunit beta-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001218"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001277--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001277"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily D member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001276"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000597--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000597"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, gamma 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000596"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000040--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000040"><rdfs:label xml:lang="en">Calcium; Sodium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000039"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000357--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000357"><rdfs:label xml:lang="en">CHRNA1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000356"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001301--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001301"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily c member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001218--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001218"><rdfs:label xml:lang="en">shaker potassium channel beta subunit family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001217"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000308--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000308"><rdfs:label xml:lang="en">protein->ion channel->chloride channel ->h(+)/cl(-) exchange transporter 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001668--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001668"><rdfs:label xml:lang="en">TMEM38 family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001667"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000174--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000174"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; gamma subunit 8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000173"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000562--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000562"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit alpha-5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000561"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000732--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000732"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Glycine receptor> Glycine receptor subunit alpha-2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000731"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001754--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001754"><rdfs:label xml:lang="en">gap junction protein; beta 2; 26kDa (connexin 26)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000017--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000017"><rdfs:label xml:lang="en">HTR3C</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000126--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000126"><rdfs:label xml:lang="en">protein->ion channel->calcium channel beta subunit family->voltage-dependent l-type calcium channel subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000115"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000756--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000756"><rdfs:label xml:lang="en">Q9UL51</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000755"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000082--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000082"><rdfs:label xml:lang="en">BEST3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000081"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001874--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001874"><rdfs:label xml:lang="en">gap junction protein; alpha 3; 46kDa (connexin 46)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000062"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000036--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000036"><rdfs:label xml:lang="en">Q16515</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000035"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000147--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000147"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit gamma family> Voltage-dependent calcium channel gamma-3 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000146"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000124--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000124"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->ca(2+) channel auxiliary subunit types 1-4 (cca-) family->voltage-dependent l-type calcium channel subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000123"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000687--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000687"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> Kainate receptor> Glutamate receptor ionotropic, kainate 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000686"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000198--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000198"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, P/Q type, alpha 1A subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000197"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000804--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000804"><rdfs:label xml:lang="en">protein->ion channel->recoverin family->kv channel-interacting protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000788"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000997--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000997"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Two-pore domain potassium channel> Potassium channel subfamily K member 9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000996"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001576--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001576"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily m member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001286--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001286"><rdfs:label xml:lang="en">P48547</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001136--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001136"><rdfs:label xml:lang="en">Q9Y691</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000828--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000828"><rdfs:label xml:lang="en">MCU family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000827"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000334--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000334"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->intracellular chloride channel (clic) family->Chloride intracellular channel protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000333"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000449--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000449"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->cyclic nucleotide-gated cation channel family->Cyclic nucleotide-gated cation channel alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000448"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000859--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000859"><rdfs:label xml:lang="en">protein->ion channel->orai family->calcium release-activated calcium channel protein 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000858"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001642--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001642"><rdfs:label xml:lang="en">transmembrane channel-like 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001641"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000428--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000428"><rdfs:label xml:lang="en">cholinergic receptor, nicotinic, epsilon (muscle)</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000427"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000522--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000522"><rdfs:label xml:lang="en">FXYD domain containing ion transport regulator 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000521"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001241--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001241"><rdfs:label xml:lang="en">P16389</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001553--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001553"><rdfs:label xml:lang="en">transient receptor potential cation channel; subfamily C; member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001552"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000203--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000203"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent p/q-type calcium channel subunit alpha-1a</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001376--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001376"><rdfs:label xml:lang="en">Q9UBL9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000578--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000578"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor; beta 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000577"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000987--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000987"><rdfs:label xml:lang="en">1.A.1.8.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000986"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000567--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000567"><rdfs:label xml:lang="en">gamma-aminobutyric acid (GABA) A receptor, beta 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000566"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000129--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000129"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->ca(2+) channel auxiliary subunit types 1-4 (cca-) family->voltage-dependent l-type calcium channel subunit beta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000128"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000166--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000166"><rdfs:label xml:lang="en">protein->ion channel->pmp-22/emp/mp20 family->voltage-dependent calcium channel gamma-7 subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000135"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000199--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000199"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Voltage-gated calcium channel> Voltage-dependent N-type calcium channel subunit alpha-1B</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000198"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001017--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001017"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily V member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000304--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000304"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->chloride channel family->ClC-5/CLCN5 subfamily->H(+)/Cl(-) exchange transporter 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000303"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001826--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001826"><rdfs:label xml:lang="en">Q8N144</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000642--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000642"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> AMPA receptor> Glutamate receptor 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000641"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000766--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000766"><rdfs:label xml:lang="en">protein->ion channel->potassium channel hcn family->potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000008--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000008"><rdfs:label xml:lang="en">DTO_Class_Path</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000007"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000367--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000367"><rdfs:label xml:lang="en">CHRNA2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000366"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001312--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001312"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily F member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001311"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001607--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001607"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily V member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001606"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001087--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001087"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001086"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000232--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000232"><rdfs:label xml:lang="en">CALHM3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000231"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000407--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000407"><rdfs:label xml:lang="en">CHRNB2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000406"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001687--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001687"><rdfs:label xml:lang="en">tweety family member 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001686"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000344--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000344"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->intracellular chloride channel (clic) family->Chloride intracellular channel protein 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000343"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000319--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000319"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->chloride channel family->CLCNKA subfamily->Chloride channel protein ClC-Ka</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000318"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000072--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000072"><rdfs:label xml:lang="en">BEST1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000071"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000987--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000987"><rdfs:label xml:lang="en">potassium channel, subfamily K, member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000986"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001076--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001076"><rdfs:label xml:lang="en">Q9NPI9</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000379--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000379"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Neuronal acetylcholine receptor subunit alpha-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000378"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000751--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000751"><rdfs:label xml:lang="en">protein->ion channel->hydrogen channel family->voltage-gated hydrogen channel 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001241--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001241"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily a member 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001207--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001207"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily KQT member 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001206"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001272--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001272"><rdfs:label xml:lang="en">potassium voltage-gated channel, Shal-related subfamily, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001271"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001081--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001081"><rdfs:label xml:lang="en">B7U540</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000271--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000271"><rdfs:label xml:lang="en">Q14CN2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000263"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001637--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001637"><rdfs:label xml:lang="en">transmembrane channel-like 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001636"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000926--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000926"><rdfs:label xml:lang="en">protein->ion channel->two pore domain potassium channel ->potassium channel subfamily k member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000029--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000029"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->5-hydroxytryptamine receptor subfamily->HTR3E sub-subfamily->5-hydroxytryptamine receptor 3e</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000028"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000299--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000299"><rdfs:label xml:lang="en">protein->ion channel->anion channel->voltage-gated->chloride carrier/channel (clc) family->H(+)/Cl(-) exchange transporter 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000298"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000436--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000436"><rdfs:label xml:lang="en">P29973</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000652--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000652"><rdfs:label xml:lang="en">glutamate receptor, ionotropic, delta 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000651"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000253--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000253"><rdfs:label xml:lang="en">protein->ion channel->cation channel sperm-associated ->cation channel sperm-associated protein 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000464--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000464"><rdfs:label xml:lang="en">protein->ion channel->cation channel->ligand-gated->cyclic nucleotide-gated cation channel family->CNGB3 subfamily->Cyclic nucleotide-gated cation channel beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000463"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000091--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000091"><rdfs:label xml:lang="en">protein->ion channel->bestrophin family->bestrophin-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000075"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001237--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001237"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, member 10</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001236"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001281--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001281"><rdfs:label xml:lang="en">Q9UK17</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000428--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000428"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->acetylcholine receptor subunit delta</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001171--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001171"><rdfs:label xml:lang="en">Q9Y6H6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001179--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001179"><rdfs:label xml:lang="en">protein->ion channel->potassium channel kcne family->potassium voltage-gated channel subfamily e member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001163"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001402--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001402"><rdfs:label xml:lang="en">purinergic receptor P2X, ligand-gated ion channel, 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001401"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000884--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000884"><rdfs:label xml:lang="en">protein->ion channel->piezo family->piezo-type mechanosensitive ion channel component 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000878"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001432--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001432"><rdfs:label xml:lang="en">sodium channel, non-voltage-gated 1, delta subunit</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001431"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000473--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000473"><rdfs:label xml:lang="en">cytochrome b-245, beta polypeptide</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000472"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000733--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000733"><rdfs:label xml:lang="en">glycine receptor; alpha 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000732"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000348--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000348"><rdfs:label xml:lang="en">chloride intracellular channel 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000347"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000099--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000099"><rdfs:label xml:lang="en">Calcium</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001407"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000601--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000601"><rdfs:label xml:lang="en">Q99928</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001622--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001622"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Transient receptor potential channel> Transient receptor potential cation channel subfamily V member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001621"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001332--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001332"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily H (eag-related), member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001331"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000389--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000389"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Neuronal acetylcholine receptor subunit alpha-5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000388"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000812--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000812"><rdfs:label xml:lang="en">leucine rich repeat containing 38</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000811"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001716--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001716"><rdfs:label xml:lang="en">O43315</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001715"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000581--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000581"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000223--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000223"><rdfs:label xml:lang="en">protein->ion channel->calcium channel alpha-1 subunit ->voltage-dependent t-type calcium channel subunit alpha-1i</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000331--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000331"><rdfs:label xml:lang="en">O15247</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001513--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001513"><rdfs:label xml:lang="en">cation-nonselective channel family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001512"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000591--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000591"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit epsilon</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000132--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000132"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit beta family> Voltage-dependent L-type calcium channel subunit beta-4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000131"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000561--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000561"><rdfs:label xml:lang="en">protein->ion channel->ligand-gated ion channel ->gamma-aminobutyric acid receptor subunit alpha-5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000421--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000421"><rdfs:label xml:lang="en">Q07001</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001337--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001337"><rdfs:label xml:lang="en">potassium voltage-gated channel, subfamily H (eag-related), member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001336"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001097--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001097"><rdfs:label xml:lang="en">potassium inwardly-rectifying channel, subfamily J, member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001096"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000651--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000651"><rdfs:label xml:lang="en">Q9ULK0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000025"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001679--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001679"><rdfs:label xml:lang="en">protein->ion channel->tweety family->protein tweety homolog 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001678"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001281--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001281"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily d member 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001441--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001441"><rdfs:label xml:lang="en">protein->ion channel->amiloride-sensitive sodium channel ->amiloride-sensitive sodium channel subunit gamma</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000012"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001271--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001271"><rdfs:label xml:lang="en">protein->ion channel->potassium channel family->potassium voltage-gated channel subfamily a member 7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000647--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000647"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Ionotropic glutamate receptor> AMPA receptor> Glutamate receptor 3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000646"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000336--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000336"><rdfs:label xml:lang="en">protein->ion channel->chloride channel clic family->chloride intracellular channel protein 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000330"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001016--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001016"><rdfs:label xml:lang="en">Q8TDN2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001262--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001262"><rdfs:label xml:lang="en">potassium voltage-gated channel, shaker-related subfamily, member 6</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001261"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000137--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000137"><rdfs:label xml:lang="en">CACNG2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000136"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000138--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000138"><rdfs:label xml:lang="en">calcium channel, voltage-dependent, gamma subunit 2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000137"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000381--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000381"><rdfs:label xml:lang="en">P30532</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000020"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000530--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000530"><rdfs:label xml:lang="en">Anion</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000529"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000267--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000267"><rdfs:label xml:lang="en">CLCA3P</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000266"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000878--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000878"><rdfs:label xml:lang="en">PIEZO family</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000877"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000139--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000139"><rdfs:label xml:lang="en">calcium channel; voltage-dependent; gamma subunit 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000138"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001048--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001048"><rdfs:label xml:lang="en">1.A.2.1.1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001047"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000127--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000127"><rdfs:label xml:lang="en">Proteins> Auxiliary transport protein> Calcium channel auxiliary subunit beta family> Voltage-dependent L-type calcium channel subunit beta-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000126"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000971--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000971"><rdfs:label xml:lang="en">Q9NYG8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000016"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000184--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000184"><rdfs:label xml:lang="en">protein->ion channel->cation channel->voltage-gated->voltage-dependent L-type calcium channel subunit alpha-1f</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000183"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001162--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001162"><rdfs:label xml:lang="en">potassium voltage-gated channel, Isk-related family, member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001161"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000016--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000016"><rdfs:label xml:lang="en">Q8WXA8</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000015"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000916--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000916"><rdfs:label xml:lang="en">Q9NTG1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000011--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000011"><rdfs:label xml:lang="en">TCDB Name</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000010"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000854--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000854"><rdfs:label xml:lang="en">NADPH oxidase; EF hand calcium-binding domain 5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000853"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001307--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001307"><rdfs:label xml:lang="en">Proteins> Ion channel> Voltage-gated ion channel> Potassium channels> Voltage-gated potassium channel> Potassium voltage-gated channel subfamily C member 4</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001306"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000086--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000086"><rdfs:label xml:lang="en">Q8NFU0</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000067"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000841--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000841"><rdfs:label xml:lang="en">Q8TDD5</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000099"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000004--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000004"><rdfs:label xml:lang="en">DTO_Classification_New</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000003"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000727--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000727"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Glycine receptor> Glycine receptor subunit alpha-1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000726"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000062--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000062"><rdfs:label xml:lang="en">other_ic</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000061"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001841--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001841"><rdfs:label xml:lang="en">Q969M2</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410001714"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000399--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000399"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> Nicotinic acetylcholine receptor> Nicotinic acetylcholine receptor alpha subunit> Neuronal acetylcholine receptor subunit alpha-7</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000398"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410001566--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410001566"><rdfs:label xml:lang="en">protein->ion channel->transient receptor ->transient receptor potential cation channel subfamily m member 1</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000177"/></owl:Class>
<!-- http://www.drugtargetontology.org/dto#DTO_00410000607--> <owl:Class rdf:about="http://www.drugtargetontology.org/dto#DTO_00410000607"><rdfs:label xml:lang="en">Proteins> Ion channel> Ligand-gated ion channel> GABA-A receptor> Gamma-aminobutyric acid receptor subunit gamma-3</rdfs:label><rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto#DTO_00410000606"/></owl:Class>



    <!-- http://www.drugtargetontology.org/dto#DTO_00118729 -->

    <owl:Class rdf:about="&dto;DTO_00118729">
        <rdfs:label>chloride channel mclc family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118730 -->

    <owl:Class rdf:about="&dto;DTO_00118730">
        <rdfs:label>chloride channel </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118731 -->

    <owl:Class rdf:about="&dto;DTO_00118731">
        <rdfs:label>chloride channel clic family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118732 -->

    <owl:Class rdf:about="&dto;DTO_00118732">
        <rdfs:label>cyclic nucleotide-gated cation channel </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118733 -->

    <owl:Class rdf:about="&dto;DTO_00118733">
        <rdfs:label>orai family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118734 -->

    <owl:Class rdf:about="&dto;DTO_00118734">
        <rdfs:label>recoverin family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118735 -->

    <owl:Class rdf:about="&dto;DTO_00118735">
        <rdfs:label>cation channel sperm-associated </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118736 -->

    <owl:Class rdf:about="&dto;DTO_00118736">
        <rdfs:label>fxyd family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118737 -->

    <owl:Class rdf:about="&dto;DTO_00118737">
        <rdfs:label>golgi ph regulator </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118738 -->

    <owl:Class rdf:about="&dto;DTO_00118738">
        <rdfs:label>glutamate-gated ion channel </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118739 -->

    <owl:Class rdf:about="&dto;DTO_00118739">
        <rdfs:label>potassium channel hcn family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118740 -->

    <owl:Class rdf:about="&dto;DTO_00118740">
        <rdfs:label>hydrogen channel family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118741 -->

    <owl:Class rdf:about="&dto;DTO_00118741">
        <rdfs:label>inward rectifier-type potassium channel </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118742 -->

    <owl:Class rdf:about="&dto;DTO_00118742">
        <rdfs:label>insp3 receptor family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118743 -->

    <owl:Class rdf:about="&dto;DTO_00118743">
        <rdfs:label>potassium channel family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118744 -->

    <owl:Class rdf:about="&dto;DTO_00118744">
        <rdfs:label>shaker potassium channel beta subunit family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118745 -->

    <owl:Class rdf:about="&dto;DTO_00118745">
        <rdfs:label>kcnmb </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118746 -->

    <owl:Class rdf:about="&dto;DTO_00118746">
        <rdfs:label>potassium channel kcne family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118747 -->

    <owl:Class rdf:about="&dto;DTO_00118747">
        <rdfs:label>two pore domain potassium channel </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118748 -->

    <owl:Class rdf:about="&dto;DTO_00118748">
        <rdfs:label>potassium channel kcnn family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118749 -->

    <owl:Class rdf:about="&dto;DTO_00118749">
        <rdfs:label>transient receptor </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118750 -->

    <owl:Class rdf:about="&dto;DTO_00118750">
        <rdfs:label>mcu family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118751 -->

    <owl:Class rdf:about="&dto;DTO_00118751">
        <rdfs:label>cation-nonselective channel family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118752 -->

    <owl:Class rdf:about="&dto;DTO_00118752">
        <rdfs:label>p2x receptor family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118753 -->

    <owl:Class rdf:about="&dto;DTO_00118753">
        <rdfs:label>pannexin family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118754 -->

    <owl:Class rdf:about="&dto;DTO_00118754">
        <rdfs:label>piezo family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118755 -->

    <owl:Class rdf:about="&dto;DTO_00118755">
        <rdfs:label>polycystin family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118756 -->

    <owl:Class rdf:about="&dto;DTO_00118756">
        <rdfs:label>mal family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118757 -->

    <owl:Class rdf:about="&dto;DTO_00118757">
        <rdfs:label>ryanodine receptor </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118758 -->

    <owl:Class rdf:about="&dto;DTO_00118758">
        <rdfs:label>slc26a/sulp transporter </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118759 -->

    <owl:Class rdf:about="&dto;DTO_00118759">
        <rdfs:label>sodium channel </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118760 -->

    <owl:Class rdf:about="&dto;DTO_00118760">
        <rdfs:label>sodium channel auxiliary subunit scn1b </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118761 -->

    <owl:Class rdf:about="&dto;DTO_00118761">
        <rdfs:label>sodium channel auxiliary subunit scn2b </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118762 -->

    <owl:Class rdf:about="&dto;DTO_00118762">
        <rdfs:label>sodium channel auxiliary subunit scn3b </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118763 -->

    <owl:Class rdf:about="&dto;DTO_00118763">
        <rdfs:label>sodium channel auxiliary subunit scn4b </rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118764 -->

    <owl:Class rdf:about="&dto;DTO_00118764">
        <rdfs:label>tmem38 family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118765 -->

    <owl:Class rdf:about="&dto;DTO_00118765">
        <rdfs:label>tmc family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118766 -->

    <owl:Class rdf:about="&dto;DTO_00118766">
        <rdfs:label>tweety family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00103000"/>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118767 -->

    <owl:Class rdf:about="&dto;DTO_00118767">
        <rdfs:label>5-hydroxytryptamine receptor 3a</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <geneSynonyms>5HT3R</geneSynonyms>
        <uniprot_xref>P46098</uniprot_xref>
        <geneSynonyms>HTR3</geneSynonyms>
        <symbol>HTR3A</symbol>
        <definition>A protein that is a translation product of the human HTR3A gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118768 -->

    <owl:Class rdf:about="&dto;DTO_00118768">
        <rdfs:label>5-hydroxytryptamine receptor 3b</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>O95264</uniprot_xref>
        <symbol>HTR3B</symbol>
        <definition>A protein that is a translation product of the human HTR3B gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118769 -->

    <owl:Class rdf:about="&dto;DTO_00118769">
        <rdfs:label>5-hydroxytryptamine receptor 3c</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>Q8WXA8</uniprot_xref>
        <symbol>HTR3C</symbol>
        <definition>A protein that is a translation product of the human HTR3C gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118770 -->

    <owl:Class rdf:about="&dto;DTO_00118770">
        <rdfs:label>5-hydroxytryptamine receptor 3d</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>Q70Z44</uniprot_xref>
        <definition>A protein that is a translation product of the human HTR3D gene or a 1:1 ortholog thereof. </definition>
        <symbol>HTR3D</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118771 -->

    <owl:Class rdf:about="&dto;DTO_00118771">
        <rdfs:label>5-hydroxytryptamine receptor 3e</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>HTR3E</symbol>
        <definition>A protein that is a translation product of the human HTR3E gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>A5X5Y0</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118772 -->

    <owl:Class rdf:about="&dto;DTO_00118772">
        <rdfs:label>neuronal acetylcholine receptor subunit alpha-10</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>Q9GZZ6</uniprot_xref>
        <geneSynonyms>NACHRA10</geneSynonyms>
        <symbol>CHRNA10</symbol>
        <definition>A protein that is a translation product of the human CHRNA10 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118773 -->

    <owl:Class rdf:about="&dto;DTO_00118773">
        <rdfs:label>neuronal acetylcholine receptor subunit alpha-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human CHRNA2 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q15822</uniprot_xref>
        <symbol>CHRNA2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118774 -->

    <owl:Class rdf:about="&dto;DTO_00118774">
        <rdfs:label>neuronal acetylcholine receptor subunit alpha-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>P32297</uniprot_xref>
        <definition>A protein that is a translation product of the human CHRNA3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CHRNA3</symbol>
        <geneSynonyms>NACHRA3</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118775 -->

    <owl:Class rdf:about="&dto;DTO_00118775">
        <rdfs:label>neuronal acetylcholine receptor subunit alpha-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>CHRNA4</symbol>
        <geneSynonyms>NACRA4</geneSynonyms>
        <uniprot_xref>P43681</uniprot_xref>
        <definition>A protein that is a translation product of the human CHRNA4 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118776 -->

    <owl:Class rdf:about="&dto;DTO_00118776">
        <rdfs:label>neuronal acetylcholine receptor subunit alpha-5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human CHRNA5 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P30532</uniprot_xref>
        <geneSynonyms>NACHRA5</geneSynonyms>
        <symbol>CHRNA5</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118777 -->

    <owl:Class rdf:about="&dto;DTO_00118777">
        <rdfs:label>neuronal acetylcholine receptor subunit alpha-6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human CHRNA6 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q15825</uniprot_xref>
        <symbol>CHRNA6</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118778 -->

    <owl:Class rdf:about="&dto;DTO_00118778">
        <rdfs:label>neuronal acetylcholine receptor subunit alpha-7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <geneSynonyms>NACHRA7</geneSynonyms>
        <uniprot_xref>P36544</uniprot_xref>
        <symbol>CHRNA7</symbol>
        <definition>A protein that is a translation product of the human CHRNA7 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118779 -->

    <owl:Class rdf:about="&dto;DTO_00118779">
        <rdfs:label>neuronal acetylcholine receptor subunit alpha-9</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>Q9UGM1</uniprot_xref>
        <geneSynonyms>NACHRA9</geneSynonyms>
        <symbol>CHRNA9</symbol>
        <definition>A protein that is a translation product of the human CHRNA9 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118780 -->

    <owl:Class rdf:about="&dto;DTO_00118780">
        <rdfs:label>acetylcholine receptor subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>P02708</uniprot_xref>
        <geneSynonyms>ACHRA</geneSynonyms>
        <definition>A protein that is a translation product of the human CHRNA1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>CHNRA</geneSynonyms>
        <symbol>CHRNA1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118781 -->

    <owl:Class rdf:about="&dto;DTO_00118781">
        <rdfs:label>neuronal acetylcholine receptor subunit beta-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>CHRNB2</symbol>
        <uniprot_xref>P17787</uniprot_xref>
        <definition>A protein that is a translation product of the human CHRNB2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118782 -->

    <owl:Class rdf:about="&dto;DTO_00118782">
        <rdfs:label>neuronal acetylcholine receptor subunit beta-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human CHRNB3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CHRNB3</symbol>
        <uniprot_xref>Q05901</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118783 -->

    <owl:Class rdf:about="&dto;DTO_00118783">
        <rdfs:label>neuronal acetylcholine receptor subunit beta-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>P30926</uniprot_xref>
        <definition>A protein that is a translation product of the human CHRNB4 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CHRNB4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118784 -->

    <owl:Class rdf:about="&dto;DTO_00118784">
        <rdfs:label>acetylcholine receptor subunit beta</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>P11230</uniprot_xref>
        <geneSynonyms>CHRNB</geneSynonyms>
        <definition>A protein that is a translation product of the human CHRNB1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>ACHRB</geneSynonyms>
        <symbol>CHRNB1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118785 -->

    <owl:Class rdf:about="&dto;DTO_00118785">
        <rdfs:label>acetylcholine receptor subunit delta</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>Q07001</uniprot_xref>
        <symbol>CHRND</symbol>
        <geneSynonyms>ACHRD</geneSynonyms>
        <definition>A protein that is a translation product of the human CHRND gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118786 -->

    <owl:Class rdf:about="&dto;DTO_00118786">
        <rdfs:label>acetylcholine receptor subunit epsilon</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human CHRNE gene or a 1:1 ortholog thereof. </definition>
        <symbol>CHRNE</symbol>
        <geneSynonyms>ACHRE</geneSynonyms>
        <uniprot_xref>Q04844</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118787 -->

    <owl:Class rdf:about="&dto;DTO_00118787">
        <rdfs:label>acetylcholine receptor subunit gamma</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>P07510</uniprot_xref>
        <geneSynonyms>ACHRG</geneSynonyms>
        <symbol>CHRNG</symbol>
        <definition>A protein that is a translation product of the human CHRNG gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118788 -->

    <owl:Class rdf:about="&dto;DTO_00118788">
        <rdfs:label>anoctamin-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118719"/>
        <geneSynonyms>ORAOV2</geneSynonyms>
        <symbol>ANO1</symbol>
        <geneSynonyms>TAOS2</geneSynonyms>
        <definition>A protein that is a translation product of the human ANO1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>TMEM16A</geneSynonyms>
        <geneSynonyms>DOG1</geneSynonyms>
        <uniprot_xref>Q5XXA6</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118789 -->

    <owl:Class rdf:about="&dto;DTO_00118789">
        <rdfs:label>anoctamin-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118719"/>
        <uniprot_xref>Q9NQ90</uniprot_xref>
        <definition>A protein that is a translation product of the human ANO2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>TMEM16B</geneSynonyms>
        <symbol>ANO2</symbol>
        <geneSynonyms>C12orf3</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118790 -->

    <owl:Class rdf:about="&dto;DTO_00118790">
        <rdfs:label>anoctamin-6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118719"/>
        <definition>A protein that is a translation product of the human ANO6 gene or a 1:1 ortholog thereof. </definition>
        <symbol>ANO6</symbol>
        <uniprot_xref>Q4KMQ2</uniprot_xref>
        <geneSynonyms>TMEM16F</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118791 -->

    <owl:Class rdf:about="&dto;DTO_00118791">
        <rdfs:label>acid-sensing ion channel 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <uniprot_xref>P78348</uniprot_xref>
        <symbol>ASIC1</symbol>
        <definition>A protein that is a translation product of the human ASIC1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>ACCN2</geneSynonyms>
        <geneSynonyms>BNAC2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118792 -->

    <owl:Class rdf:about="&dto;DTO_00118792">
        <rdfs:label>acid-sensing ion channel 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <definition>A protein that is a translation product of the human ASIC2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>BNAC1</geneSynonyms>
        <geneSynonyms>MDEG</geneSynonyms>
        <geneSynonyms>ACCN</geneSynonyms>
        <symbol>ASIC2</symbol>
        <geneSynonyms>ACCN1</geneSynonyms>
        <uniprot_xref>Q16515</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118793 -->

    <owl:Class rdf:about="&dto;DTO_00118793">
        <rdfs:label>acid-sensing ion channel 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <geneSynonyms>SLNAC1</geneSynonyms>
        <definition>A protein that is a translation product of the human ASIC3 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>TNAC1</geneSynonyms>
        <symbol>ASIC3</symbol>
        <geneSynonyms>ACCN3</geneSynonyms>
        <uniprot_xref>Q9UHC3</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118794 -->

    <owl:Class rdf:about="&dto;DTO_00118794">
        <rdfs:label>acid-sensing ion channel 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <definition>A protein that is a translation product of the human ASIC4 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>ACCN4</geneSynonyms>
        <uniprot_xref>Q96FT7</uniprot_xref>
        <symbol>ASIC4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118795 -->

    <owl:Class rdf:about="&dto;DTO_00118795">
        <rdfs:label>acid-sensing ion channel 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <uniprot_xref>Q9NY37</uniprot_xref>
        <symbol>ASIC5</symbol>
        <definition>A protein that is a translation product of the human ASIC5 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>ACCN5</geneSynonyms>
        <geneSynonyms>HINAC</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118796 -->

    <owl:Class rdf:about="&dto;DTO_00118796">
        <rdfs:label>bestrophin-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118721"/>
        <symbol>BEST1</symbol>
        <uniprot_xref>O76090</uniprot_xref>
        <definition>A protein that is a translation product of the human BEST1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>VMD2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118797 -->

    <owl:Class rdf:about="&dto;DTO_00118797">
        <rdfs:label>bestrophin-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118721"/>
        <definition>A protein that is a translation product of the human BEST2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>BEST2</symbol>
        <geneSynonyms>VMD2L1</geneSynonyms>
        <uniprot_xref>Q8NFU1</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118798 -->

    <owl:Class rdf:about="&dto;DTO_00118798">
        <rdfs:label>bestrophin-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118721"/>
        <definition>A protein that is a translation product of the human BEST3 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>VMD2L3</geneSynonyms>
        <symbol>BEST3</symbol>
        <uniprot_xref>Q8N1M1</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118799 -->

    <owl:Class rdf:about="&dto;DTO_00118799">
        <rdfs:label>bestrophin-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118721"/>
        <uniprot_xref>Q8NFU0</uniprot_xref>
        <symbol>BEST4</symbol>
        <definition>A protein that is a translation product of the human BEST4 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>VMD2L2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118800 -->

    <owl:Class rdf:about="&dto;DTO_00118800">
        <rdfs:label>voltage-dependent calcium channel subunit alpha-2/delta-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118722"/>
        <geneSynonyms>MHS3</geneSynonyms>
        <uniprot_xref>P54289</uniprot_xref>
        <geneSynonyms>CCHL2A</geneSynonyms>
        <definition>A protein that is a translation product of the human CACNA2D1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>CACNL2A</geneSynonyms>
        <symbol>CACNA2D1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118801 -->

    <owl:Class rdf:about="&dto;DTO_00118801">
        <rdfs:label>voltage-dependent calcium channel subunit alpha-2/delta-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118722"/>
        <definition>A protein that is a translation product of the human CACNA2D2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CACNA2D2</symbol>
        <uniprot_xref>Q9NY47</uniprot_xref>
        <geneSynonyms>KIAA0558</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118802 -->

    <owl:Class rdf:about="&dto;DTO_00118802">
        <rdfs:label>voltage-dependent calcium channel subunit alpha-2/delta-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118722"/>
        <symbol>CACNA2D3</symbol>
        <uniprot_xref>Q8IZS8</uniprot_xref>
        <definition>A protein that is a translation product of the human CACNA2D3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118803 -->

    <owl:Class rdf:about="&dto;DTO_00118803">
        <rdfs:label>voltage-dependent calcium channel subunit alpha-2/delta-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118722"/>
        <definition>A protein that is a translation product of the human CACNA2D4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q7Z3S7</uniprot_xref>
        <symbol>CACNA2D4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118804 -->

    <owl:Class rdf:about="&dto;DTO_00118804">
        <rdfs:label>voltage-dependent p/q-type calcium channel subunit alpha-1a</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <uniprot_xref>O00555</uniprot_xref>
        <symbol>CACNA1A</symbol>
        <geneSynonyms>CACNL1A4</geneSynonyms>
        <geneSynonyms>CACN3</geneSynonyms>
        <geneSynonyms>CACH4</geneSynonyms>
        <definition>A voltage-gated calcium channel subunit alpha that is a translation product of the human CACNA1A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118805 -->

    <owl:Class rdf:about="&dto;DTO_00118805">
        <rdfs:label>voltage-dependent n-type calcium channel subunit alpha-1b</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <geneSynonyms>CACNL1A5</geneSynonyms>
        <symbol>CACNA1B</symbol>
        <uniprot_xref>Q00975</uniprot_xref>
        <geneSynonyms>CACH5</geneSynonyms>
        <definition>A voltage-gated calcium channel subunit alpha that is a translation product of the human CACNA1B gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118806 -->

    <owl:Class rdf:about="&dto;DTO_00118806">
        <rdfs:label>voltage-dependent l-type calcium channel subunit alpha-1c</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <geneSynonyms>CCHL1A1</geneSynonyms>
        <definition>A voltage-gated calcium channel subunit alpha that is a translation product of the human CACNA1C gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>CACH2</geneSynonyms>
        <geneSynonyms>CACN2</geneSynonyms>
        <uniprot_xref>Q13936</uniprot_xref>
        <geneSynonyms>CACNL1A1</geneSynonyms>
        <symbol>CACNA1C</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118807 -->

    <owl:Class rdf:about="&dto;DTO_00118807">
        <rdfs:label>voltage-dependent l-type calcium channel subunit alpha-1d</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <symbol>CACNA1D</symbol>
        <geneSynonyms>CACH3</geneSynonyms>
        <geneSynonyms>CACN4</geneSynonyms>
        <uniprot_xref>Q01668</uniprot_xref>
        <geneSynonyms>CACNL1A2</geneSynonyms>
        <definition>A voltage-gated calcium channel subunit alpha that is a translation product of the human CACNA1D gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>CCHL1A2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118808 -->

    <owl:Class rdf:about="&dto;DTO_00118808">
        <rdfs:label>voltage-dependent r-type calcium channel subunit alpha-1e</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <uniprot_xref>Q15878</uniprot_xref>
        <symbol>CACNA1E</symbol>
        <geneSynonyms>CACH6</geneSynonyms>
        <geneSynonyms>CACNL1A6</geneSynonyms>
        <definition>A voltage-gated calcium channel subunit alpha that is a translation product of the human CACNA1E gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118809 -->

    <owl:Class rdf:about="&dto;DTO_00118809">
        <rdfs:label>voltage-dependent l-type calcium channel subunit alpha-1f</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <uniprot_xref>O60840</uniprot_xref>
        <definition>A voltage-gated calcium channel subunit alpha that is a translation product of the human CACNA1F gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>CACNAF1</geneSynonyms>
        <symbol>CACNA1F</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118810 -->

    <owl:Class rdf:about="&dto;DTO_00118810">
        <rdfs:label>voltage-dependent t-type calcium channel subunit alpha-1g</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <definition>A protein that is a translation product of the human CACNA1G gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>O43497</uniprot_xref>
        <symbol>CACNA1G</symbol>
        <geneSynonyms>KIAA1123</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118811 -->

    <owl:Class rdf:about="&dto;DTO_00118811">
        <rdfs:label>voltage-dependent t-type calcium channel subunit alpha-1h</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <definition>A protein that is a translation product of the human CACNA1H gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>O95180</uniprot_xref>
        <symbol>CACNA1H</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118812 -->

    <owl:Class rdf:about="&dto;DTO_00118812">
        <rdfs:label>voltage-dependent t-type calcium channel subunit alpha-1i</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <uniprot_xref>Q9P0X4</uniprot_xref>
        <definition>A protein that is a translation product of the human CACNA1I gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>CACNA1I</symbol>
        <geneSynonyms>KIAA1120</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118813 -->

    <owl:Class rdf:about="&dto;DTO_00118813">
        <rdfs:label>voltage-dependent l-type calcium channel subunit alpha-1s</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <geneSynonyms>CACH1</geneSynonyms>
        <uniprot_xref>Q13698</uniprot_xref>
        <geneSynonyms>CACN1</geneSynonyms>
        <symbol>CACNA1S</symbol>
        <definition>A voltage-gated calcium channel subunit alpha that is a translation product of the human CACNA1S gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>CACNL1A3</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118814 -->

    <owl:Class rdf:about="&dto;DTO_00118814">
        <rdfs:label>voltage-dependent l-type calcium channel subunit beta-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118724"/>
        <symbol>CACNB1</symbol>
        <geneSynonyms>CACNLB1</geneSynonyms>
        <uniprot_xref>Q02641</uniprot_xref>
        <definition>A protein that is a translation product of the human CACNB1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118815 -->

    <owl:Class rdf:about="&dto;DTO_00118815">
        <rdfs:label>voltage-dependent l-type calcium channel subunit beta-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118724"/>
        <uniprot_xref>Q08289</uniprot_xref>
        <geneSynonyms>CACNLB2</geneSynonyms>
        <symbol>CACNB2</symbol>
        <definition>A protein that is a translation product of the human CACNB2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>MYSB</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118816 -->

    <owl:Class rdf:about="&dto;DTO_00118816">
        <rdfs:label>voltage-dependent l-type calcium channel subunit beta-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118724"/>
        <geneSynonyms>CACNLB3</geneSynonyms>
        <uniprot_xref>P54284</uniprot_xref>
        <symbol>CACNB3</symbol>
        <definition>A protein that is a translation product of the human CACNB3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118817 -->

    <owl:Class rdf:about="&dto;DTO_00118817">
        <rdfs:label>voltage-dependent l-type calcium channel subunit beta-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118724"/>
        <symbol>CACNB4</symbol>
        <definition>A protein that is a translation product of the human CACNB4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>O00305</uniprot_xref>
        <geneSynonyms>CACNLB4</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118818 -->

    <owl:Class rdf:about="&dto;DTO_00118818">
        <rdfs:label>calcium homeostasis modulator protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118725"/>
        <geneSynonyms>FAM26C</geneSynonyms>
        <uniprot_xref>Q8IU99</uniprot_xref>
        <definition>A protein that is a translation product of the human CALHM1 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CALHM1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118819 -->

    <owl:Class rdf:about="&dto;DTO_00118819">
        <rdfs:label>calcium homeostasis modulator protein 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118725"/>
        <definition>A protein that is a translation product of the human CALHM2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>FAM26B</geneSynonyms>
        <uniprot_xref>Q9HA72</uniprot_xref>
        <symbol>CALHM2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118820 -->

    <owl:Class rdf:about="&dto;DTO_00118820">
        <rdfs:label>calcium homeostasis modulator protein 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118725"/>
        <symbol>CALHM3</symbol>
        <definition>A protein that is a translation product of the human CALHM3 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q86XJ0</uniprot_xref>
        <geneSynonyms>FAM26A</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118821 -->

    <owl:Class rdf:about="&dto;DTO_00118821">
        <rdfs:label>voltage-dependent calcium channel gamma-1 subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <uniprot_xref>Q06432</uniprot_xref>
        <symbol>CACNG1</symbol>
        <definition>A protein that is a translation product of the human CACNG1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>CACNLG</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118822 -->

    <owl:Class rdf:about="&dto;DTO_00118822">
        <rdfs:label>voltage-dependent calcium channel gamma-2 subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <symbol>CACNG2</symbol>
        <uniprot_xref>Q9Y698</uniprot_xref>
        <definition>A protein that is a translation product of the human CACNG2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118823 -->

    <owl:Class rdf:about="&dto;DTO_00118823">
        <rdfs:label>voltage-dependent calcium channel gamma-3 subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <symbol>CACNG3</symbol>
        <definition>A protein that is a translation product of the human CACNG3 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>O60359</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118824 -->

    <owl:Class rdf:about="&dto;DTO_00118824">
        <rdfs:label>voltage-dependent calcium channel gamma-4 subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <uniprot_xref>Q9UBN1</uniprot_xref>
        <definition>A protein that is a translation product of the human CACNG4 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CACNG4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118825 -->

    <owl:Class rdf:about="&dto;DTO_00118825">
        <rdfs:label>voltage-dependent calcium channel gamma-5 subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <definition>A protein that is a translation product of the human CACNG5 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9UF02</uniprot_xref>
        <symbol>CACNG5</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118826 -->

    <owl:Class rdf:about="&dto;DTO_00118826">
        <rdfs:label>voltage-dependent calcium channel gamma-6 subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <symbol>CACNG6</symbol>
        <definition>A protein that is a translation product of the human CACNG6 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9BXT2</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118827 -->

    <owl:Class rdf:about="&dto;DTO_00118827">
        <rdfs:label>voltage-dependent calcium channel gamma-7 subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <definition>A protein that is a translation product of the human CACNG7 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P62955</uniprot_xref>
        <symbol>CACNG7</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118828 -->

    <owl:Class rdf:about="&dto;DTO_00118828">
        <rdfs:label>voltage-dependent calcium channel gamma-8 subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <geneSynonyms>CACNG6</geneSynonyms>
        <uniprot_xref>Q8WXS5</uniprot_xref>
        <definition>A protein that is a translation product of the human CACNG8 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CACNG8</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118829 -->

    <owl:Class rdf:about="&dto;DTO_00118829">
        <rdfs:label>voltage-dependent calcium channel gamma-like subunit</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118726"/>
        <symbol>TMEM37</symbol>
        <definition>A protein that is a translation product of the human TMEM37 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q8WXS4</uniprot_xref>
        <geneSynonyms>PR</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118830 -->

    <owl:Class rdf:about="&dto;DTO_00118830">
        <rdfs:label>cystic fibrosis transmembrane conductance regulator</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118727"/>
        <definition>A protein that is a translation product of the human CFTR gene or a 1:1 ortholog thereof. Involved in the transport of chloride ions. The characteristic domain composition of the functional isoform consists of two modules of a membrane-spanning domain (ABC transporter transmembrane region) followed by a nucleotide-binding domain (ABC transporter domains), separated by an intracellular regulatory domain (R-domain). It also contains a C-terminal PDZ-binding region. The R-domain is an inhibitory domain of CFTR,and phosphorylation of the R-domain removes this inhibition, allowing activation of chloride flux. [PMID:9922375, PRO:CNA] </definition>
        <geneSynonyms>ABCC7</geneSynonyms>
        <uniprot_xref>P13569</uniprot_xref>
        <symbol>CFTR</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118831 -->

    <owl:Class rdf:about="&dto;DTO_00118831">
        <rdfs:label>calcium-activated chloride channel regulator 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118728"/>
        <definition>A protein that is a translation product of the human CLCA1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>CACC1</geneSynonyms>
        <uniprot_xref>A8K7I4</uniprot_xref>
        <symbol>CLCA1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118832 -->

    <owl:Class rdf:about="&dto;DTO_00118832">
        <rdfs:label>calcium-activated chloride channel regulator 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118728"/>
        <uniprot_xref>Q9UQC9</uniprot_xref>
        <geneSynonyms>CACC3</geneSynonyms>
        <symbol>CLCA2</symbol>
        <definition>A protein that is a translation product of the human CLCA2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118833 -->

    <owl:Class rdf:about="&dto;DTO_00118833">
        <rdfs:label>calcium-activated chloride channel regulator family member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118728"/>
        <uniprot_xref>Q9Y6N3</uniprot_xref>
        <definition>A protein that is a translation product of the human CLCA3P gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>CLCA3</geneSynonyms>
        <symbol>CLCA3P</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118834 -->

    <owl:Class rdf:about="&dto;DTO_00118834">
        <rdfs:label>calcium-activated chloride channel regulator 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118728"/>
        <uniprot_xref>Q14CN2</uniprot_xref>
        <geneSynonyms>CaCC2</geneSynonyms>
        <symbol>CLCA4</symbol>
        <definition>A protein that is a translation product of the human CLCA4 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118835 -->

    <owl:Class rdf:about="&dto;DTO_00118835">
        <rdfs:label>chloride channel clic-like protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118729"/>
        <symbol>CLCC1</symbol>
        <uniprot_xref>Q96S66</uniprot_xref>
        <geneSynonyms>KIAA0761</geneSynonyms>
        <geneSynonyms>MCLC</geneSynonyms>
        <definition>A protein that is a translation product of the human CLCC1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118836 -->

    <owl:Class rdf:about="&dto;DTO_00118836">
        <rdfs:label>chloride channel protein clc-ka</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <symbol>CLCNKA</symbol>
        <definition>A protein that is a translation product of the human CLCNKA gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P51800</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118837 -->

    <owl:Class rdf:about="&dto;DTO_00118837">
        <rdfs:label>chloride channel protein clc-kb</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <symbol>CLCNKB</symbol>
        <uniprot_xref>P51801</uniprot_xref>
        <definition>A protein that is a translation product of the human CLCNKB gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118838 -->

    <owl:Class rdf:about="&dto;DTO_00118838">
        <rdfs:label>chloride channel protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <definition>A protein that is a translation product of the human CLCN1 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CLCN1</symbol>
        <uniprot_xref>P35523</uniprot_xref>
        <geneSynonyms>CLC1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118839 -->

    <owl:Class rdf:about="&dto;DTO_00118839">
        <rdfs:label>chloride channel protein 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <uniprot_xref>P51788</uniprot_xref>
        <definition>A protein that is a translation product of the human CLCN2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CLCN2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118840 -->

    <owl:Class rdf:about="&dto;DTO_00118840">
        <rdfs:label>h(+)/cl(-) exchange transporter 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <symbol>CLCN3</symbol>
        <uniprot_xref>P51790</uniprot_xref>
        <definition>A protein that is a translation product of the human CLCN3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118841 -->

    <owl:Class rdf:about="&dto;DTO_00118841">
        <rdfs:label>h(+)/cl(-) exchange transporter 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <uniprot_xref>P51793</uniprot_xref>
        <definition>A protein that is a translation product of the human CLCN4 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CLCN4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118842 -->

    <owl:Class rdf:about="&dto;DTO_00118842">
        <rdfs:label>h(+)/cl(-) exchange transporter 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <definition>A protein that is a translation product of the human CLCN5 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CLCN5</symbol>
        <uniprot_xref>P51795</uniprot_xref>
        <geneSynonyms>CLCK2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118843 -->

    <owl:Class rdf:about="&dto;DTO_00118843">
        <rdfs:label>chloride transport protein 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <geneSynonyms>KIAA0046</geneSynonyms>
        <symbol>CLCN6</symbol>
        <uniprot_xref>P51797</uniprot_xref>
        <definition>A protein that is a translation product of the human CLCN6 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118844 -->

    <owl:Class rdf:about="&dto;DTO_00118844">
        <rdfs:label>h(+)/cl(-) exchange transporter 7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118730"/>
        <symbol>CLCN7</symbol>
        <definition>A protein that is a translation product of the human CLCN7 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P51798</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118845 -->

    <owl:Class rdf:about="&dto;DTO_00118845">
        <rdfs:label>chloride intracellular channel protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118731"/>
        <geneSynonyms>G6</geneSynonyms>
        <definition>A protein that is a translation product of the human CLIC1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>O00299</uniprot_xref>
        <geneSynonyms>NCC27</geneSynonyms>
        <symbol>CLIC1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118846 -->

    <owl:Class rdf:about="&dto;DTO_00118846">
        <rdfs:label>chloride intracellular channel protein 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118731"/>
        <symbol>CLIC2</symbol>
        <definition>A protein that is a translation product of the human CLIC2 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>O15247</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118847 -->

    <owl:Class rdf:about="&dto;DTO_00118847">
        <rdfs:label>chloride intracellular channel protein 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118731"/>
        <definition>A protein that is a translation product of the human CLIC3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CLIC3</symbol>
        <uniprot_xref>O95833</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118848 -->

    <owl:Class rdf:about="&dto;DTO_00118848">
        <rdfs:label>chloride intracellular channel protein 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118731"/>
        <symbol>CLIC4</symbol>
        <uniprot_xref>Q9Y696</uniprot_xref>
        <definition>A protein that is a translation product of the human CLIC4 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118849 -->

    <owl:Class rdf:about="&dto;DTO_00118849">
        <rdfs:label>chloride intracellular channel protein 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118731"/>
        <symbol>CLIC5</symbol>
        <definition>A protein that is a translation product of the human CLIC5 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9NZA1</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118850 -->

    <owl:Class rdf:about="&dto;DTO_00118850">
        <rdfs:label>chloride intracellular channel protein 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118731"/>
        <definition>A protein that is a translation product of the human CLIC6 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q96NY7</uniprot_xref>
        <symbol>CLIC6</symbol>
        <geneSynonyms>CLIC1L</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118851 -->

    <owl:Class rdf:about="&dto;DTO_00118851">
        <rdfs:label>cgmp-gated cation channel alpha-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118732"/>
        <definition>A cyclic nucleotide-gated channel alpha subunit that is a translation product of the human CNGA1 gene or a 1:1 ortholog thereof. In the retina, these proteins can be activated by cyclic GMP which leads to an opening of the cation channel and thereby causing a depolarization of rod photoreceptors. [PRO:CNA] </definition>
        <geneSynonyms>CNCG1</geneSynonyms>
        <geneSynonyms>CNCG</geneSynonyms>
        <symbol>CNGA1</symbol>
        <uniprot_xref>P29973</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118852 -->

    <owl:Class rdf:about="&dto;DTO_00118852">
        <rdfs:label>cyclic nucleotide-gated olfactory channel</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118732"/>
        <symbol>CNGA2</symbol>
        <geneSynonyms>CNCA</geneSynonyms>
        <uniprot_xref>Q16280</uniprot_xref>
        <definition>A cyclic nucleotide-gated channel alpha subunit that is a translation product of the human CNGA2 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <geneSynonyms>CNCG2</geneSynonyms>
        <geneSynonyms>CNCA1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118853 -->

    <owl:Class rdf:about="&dto;DTO_00118853">
        <rdfs:label>cyclic nucleotide-gated cation channel alpha-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118732"/>
        <geneSynonyms>CNCG3</geneSynonyms>
        <uniprot_xref>Q16281</uniprot_xref>
        <symbol>CNGA3</symbol>
        <definition>A cyclic nucleotide-gated channel alpha subunit that is a translation product of the human CNGA3 gene or a 1:1 ortholog thereof. These proteins are the alpha subunits of the cone cyclic nucleotide-gated cation channel. This channel generates the light-evoked electrical responses of cone photoreceptors. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118854 -->

    <owl:Class rdf:about="&dto;DTO_00118854">
        <rdfs:label>cyclic nucleotide-gated cation channel alpha-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118732"/>
        <uniprot_xref>Q8IV77</uniprot_xref>
        <definition>A cyclic nucleotide-gated channel alpha subunit that is a translation product of the human CNGA4 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CNGA4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118855 -->

    <owl:Class rdf:about="&dto;DTO_00118855">
        <rdfs:label>cyclic nucleotide-gated cation channel beta-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118732"/>
        <uniprot_xref>Q14028</uniprot_xref>
        <geneSynonyms>CNCG3L</geneSynonyms>
        <geneSynonyms>RCNC2</geneSynonyms>
        <definition>A cyclic nucleotide-gated channel beta subunit that is a translation product of the human CNGB1 gene or a 1:1 ortholog thereof. </definition>
        <symbol>CNGB1</symbol>
        <geneSynonyms>CNCG4</geneSynonyms>
        <geneSynonyms>CNCG2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118856 -->

    <owl:Class rdf:about="&dto;DTO_00118856">
        <rdfs:label>cyclic nucleotide-gated cation channel beta-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118732"/>
        <uniprot_xref>Q9NQW8</uniprot_xref>
        <symbol>CNGB3</symbol>
        <definition>A cyclic nucleotide-gated channel beta subunit that is a translation product of the human CNGB3 gene or a 1:1 ortholog thereof. Many members of this class are subunits of the cone cyclic nucleotide-gated cation channel, which generates the light-evoked electrical responses of cone photoreceptors. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118857 -->

    <owl:Class rdf:about="&dto;DTO_00118857">
        <rdfs:label>calcium release-activated calcium channel protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118733"/>
        <uniprot_xref>Q96D31</uniprot_xref>
        <symbol>ORAI1</symbol>
        <definition>A protein that is a translation product of the human ORAI1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>CRACM1</geneSynonyms>
        <geneSynonyms>TMEM142A</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118858 -->

    <owl:Class rdf:about="&dto;DTO_00118858">
        <rdfs:label>calsenilin</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118734"/>
        <symbol>KCNIP3</symbol>
        <uniprot_xref>Q9Y2W7</uniprot_xref>
        <geneSynonyms>DREAM</geneSynonyms>
        <geneSynonyms>KCHIP3</geneSynonyms>
        <geneSynonyms>CSEN</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNIP3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118859 -->

    <owl:Class rdf:about="&dto;DTO_00118859">
        <rdfs:label>cation channel sperm-associated protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118735"/>
        <uniprot_xref>Q8NEC5</uniprot_xref>
        <symbol>CATSPER1</symbol>
        <definition>A protein that is a translation product of the human CATSPER1 gene or a 1:1 ortholog thereof. In mammals, four CatSper ion channel subunit genes (CatSpers 1-4) are required for sperm cell hyperactivation and male fertility. The four proteins assemble (presumably as a tetramer) to form a sperm-specific, alkalinization-activated Ca(2+)-selective channel. CatSper channels seem to require auxiliary subunits, such as CatSperB (</definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118860 -->

    <owl:Class rdf:about="&dto;DTO_00118860">
        <rdfs:label>cation channel sperm-associated protein 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118735"/>
        <definition>A protein that is a translation product of the human CATSPER2 gene or a 1:1 ortholog thereof. In mammals, four CatSper ion channel subunit genes (CatSpers 1-4) are required for sperm cell hyperactivation and male fertility. The four proteins assemble (presumably as a tetramer) to form a sperm-specific, alkalinization-activated Ca(2+)-selective channel. CatSper channels seem to require auxiliary subunits, such as CatSperB (</definition>
        <symbol>CATSPER2</symbol>
        <uniprot_xref>Q96P56</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118861 -->

    <owl:Class rdf:about="&dto;DTO_00118861">
        <rdfs:label>cation channel sperm-associated protein 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118735"/>
        <symbol>CATSPER3</symbol>
        <uniprot_xref>Q86XQ3</uniprot_xref>
        <definition>A protein that is a translation product of the human CATSPER3 gene or a 1:1 ortholog thereof. In mammals, four CatSper ion channel subunit genes (CatSpers 1-4) are required for sperm cell hyperactivation and male fertility. The four proteins assemble (presumably as a tetramer) to form a sperm-specific, alkalinization-activated Ca(2+)-selective channel. CatSper channels seem to require auxiliary subunits, such as CatSperB (</definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118862 -->

    <owl:Class rdf:about="&dto;DTO_00118862">
        <rdfs:label>cation channel sperm-associated protein 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118735"/>
        <symbol>CATSPER4</symbol>
        <definition>A protein that is a translation product of the human CATSPER4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q7RTX7</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118863 -->

    <owl:Class rdf:about="&dto;DTO_00118863">
        <rdfs:label>protein fam26d</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118725"/>
        <uniprot_xref>Q5JW98</uniprot_xref>
        <symbol>FAM26D</symbol>
        <geneSynonyms>C6orf78</geneSynonyms>
        <definition>A protein that is a translation product of the human FAM26D gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118864 -->

    <owl:Class rdf:about="&dto;DTO_00118864">
        <rdfs:label>protein fam26e</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118725"/>
        <definition>A protein that is a translation product of the human FAM26E gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q8N5C1</uniprot_xref>
        <symbol>FAM26E</symbol>
        <geneSynonyms>C6orf188</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118865 -->

    <owl:Class rdf:about="&dto;DTO_00118865">
        <rdfs:label>protein fam26f</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118725"/>
        <uniprot_xref>Q5R3K3</uniprot_xref>
        <definition>A protein that is a translation product of the human FAM26F gene or a 1:1 ortholog thereof. </definition>
        <symbol>FAM26F</symbol>
        <geneSynonyms>C6orf187</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118866 -->

    <owl:Class rdf:about="&dto;DTO_00118866">
        <rdfs:label>fxyd domain-containing ion transport regulator 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118736"/>
        <geneSynonyms>PLML</geneSynonyms>
        <geneSynonyms>MAT8</geneSynonyms>
        <definition>A protein that is a translation product of the human FXYD3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>FXYD3</symbol>
        <uniprot_xref>Q14802</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118867 -->

    <owl:Class rdf:about="&dto;DTO_00118867">
        <rdfs:label>fxyd domain-containing ion transport regulator 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118736"/>
        <symbol>FXYD4</symbol>
        <definition>A protein that is a translation product of the human FXYD4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P59646</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118868 -->

    <owl:Class rdf:about="&dto;DTO_00118868">
        <rdfs:label>fxyd domain-containing ion transport regulator 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118736"/>
        <definition>A protein that is a translation product of the human FXYD5 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q96DB9</uniprot_xref>
        <geneSynonyms>DYSAD</geneSynonyms>
        <geneSynonyms>IWU1</geneSynonyms>
        <symbol>FXYD5</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118869 -->

    <owl:Class rdf:about="&dto;DTO_00118869">
        <rdfs:label>fxyd domain-containing ion transport regulator 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118736"/>
        <definition>A protein that is a translation product of the human FXYD6 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9H0Q3</uniprot_xref>
        <symbol>FXYD6</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118870 -->

    <owl:Class rdf:about="&dto;DTO_00118870">
        <rdfs:label>fxyd domain-containing ion transport regulator 7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118736"/>
        <definition>A protein that is a translation product of the human FXYD7 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P58549</uniprot_xref>
        <symbol>FXYD7</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118871 -->

    <owl:Class rdf:about="&dto;DTO_00118871">
        <rdfs:label>putative fxyd domain-containing ion transport regulator 8</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118736"/>
        <symbol>FXYD6P3</symbol>
        <uniprot_xref>P58550</uniprot_xref>
        <definition></definition>
        <geneSynonyms>FXYD8</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118872 -->

    <owl:Class rdf:about="&dto;DTO_00118872">
        <rdfs:label>gamma-aminobutyric acid receptor subunit alpha-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRA1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P14867</uniprot_xref>
        <symbol>GABRA1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118873 -->

    <owl:Class rdf:about="&dto;DTO_00118873">
        <rdfs:label>gamma-aminobutyric acid receptor subunit alpha-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>P47869</uniprot_xref>
        <symbol>GABRA2</symbol>
        <definition>A protein that is a translation product of the human GABRA2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118874 -->

    <owl:Class rdf:about="&dto;DTO_00118874">
        <rdfs:label>gamma-aminobutyric acid receptor subunit alpha-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>GABRA3</symbol>
        <definition>A protein that is a translation product of the human GABRA3 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P34903</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118875 -->

    <owl:Class rdf:about="&dto;DTO_00118875">
        <rdfs:label>gamma-aminobutyric acid receptor subunit alpha-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>GABRA4</symbol>
        <definition>A protein that is a translation product of the human GABRA4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P48169</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118876 -->

    <owl:Class rdf:about="&dto;DTO_00118876">
        <rdfs:label>gamma-aminobutyric acid receptor subunit alpha-5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>GABRA5</symbol>
        <definition>A protein that is a translation product of the human GABRA5 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P31644</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118877 -->

    <owl:Class rdf:about="&dto;DTO_00118877">
        <rdfs:label>gamma-aminobutyric acid receptor subunit alpha-6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>Q16445</uniprot_xref>
        <symbol>GABRA6</symbol>
        <definition>A protein that is a translation product of the human GABRA6 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118878 -->

    <owl:Class rdf:about="&dto;DTO_00118878">
        <rdfs:label>gamma-aminobutyric acid receptor subunit beta-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>P18505</uniprot_xref>
        <definition>A protein that is a translation product of the human GABRB1 gene or a 1:1 ortholog thereof. </definition>
        <symbol>GABRB1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118879 -->

    <owl:Class rdf:about="&dto;DTO_00118879">
        <rdfs:label>gamma-aminobutyric acid receptor subunit beta-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRB2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>GABRB2</symbol>
        <uniprot_xref>P47870</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118880 -->

    <owl:Class rdf:about="&dto;DTO_00118880">
        <rdfs:label>gamma-aminobutyric acid receptor subunit beta-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRB3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>GABRB3</symbol>
        <uniprot_xref>P28472</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118881 -->

    <owl:Class rdf:about="&dto;DTO_00118881">
        <rdfs:label>gamma-aminobutyric acid receptor subunit delta</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRD gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>O14764</uniprot_xref>
        <symbol>GABRD</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118882 -->

    <owl:Class rdf:about="&dto;DTO_00118882">
        <rdfs:label>gamma-aminobutyric acid receptor subunit epsilon</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRE gene or a 1:1 ortholog thereof. </definition>
        <symbol>GABRE</symbol>
        <uniprot_xref>P78334</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118883 -->

    <owl:Class rdf:about="&dto;DTO_00118883">
        <rdfs:label>gamma-aminobutyric acid receptor subunit gamma-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>GABRG1</symbol>
        <definition>A protein that is a translation product of the human GABRG1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q8N1C3</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118884 -->

    <owl:Class rdf:about="&dto;DTO_00118884">
        <rdfs:label>gamma-aminobutyric acid receptor subunit gamma-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRG2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>GABRG2</symbol>
        <uniprot_xref>P18507</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118885 -->

    <owl:Class rdf:about="&dto;DTO_00118885">
        <rdfs:label>gamma-aminobutyric acid receptor subunit gamma-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRG3 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q99928</uniprot_xref>
        <symbol>GABRG3</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118886 -->

    <owl:Class rdf:about="&dto;DTO_00118886">
        <rdfs:label>gamma-aminobutyric acid receptor subunit pi</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>O00591</uniprot_xref>
        <symbol>GABRP</symbol>
        <definition>A protein that is a translation product of the human GABRP gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118887 -->

    <owl:Class rdf:about="&dto;DTO_00118887">
        <rdfs:label>gamma-aminobutyric acid receptor subunit rho-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>GABRR1</symbol>
        <uniprot_xref>P24046</uniprot_xref>
        <definition>A protein that is a translation product of the human GABRR1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118888 -->

    <owl:Class rdf:about="&dto;DTO_00118888">
        <rdfs:label>gamma-aminobutyric acid receptor subunit rho-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRR2 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P28476</uniprot_xref>
        <symbol>GABRR2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118889 -->

    <owl:Class rdf:about="&dto;DTO_00118889">
        <rdfs:label>gamma-aminobutyric acid receptor subunit rho-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GABRR3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>GABRR3</symbol>
        <uniprot_xref>A8MPY1</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118890 -->

    <owl:Class rdf:about="&dto;DTO_00118890">
        <rdfs:label>gamma-aminobutyric acid receptor subunit theta</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>Q9UN88</uniprot_xref>
        <definition>A protein that is a translation product of the human GABRQ gene or a 1:1 ortholog thereof. </definition>
        <symbol>GABRQ</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118891 -->

    <owl:Class rdf:about="&dto;DTO_00118891">
        <rdfs:label>glycine receptor subunit alpha-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>GLRA1</symbol>
        <uniprot_xref>P23415</uniprot_xref>
        <definition>A protein that is a translation product of the human GLRA1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118892 -->

    <owl:Class rdf:about="&dto;DTO_00118892">
        <rdfs:label>glycine receptor subunit alpha-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>GLRA2</symbol>
        <uniprot_xref>P23416</uniprot_xref>
        <definition>A protein that is a translation product of the human GLRA2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118893 -->

    <owl:Class rdf:about="&dto;DTO_00118893">
        <rdfs:label>glycine receptor subunit alpha-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <uniprot_xref>O75311</uniprot_xref>
        <symbol>GLRA3</symbol>
        <definition>A protein that is a translation product of the human GLRA3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118894 -->

    <owl:Class rdf:about="&dto;DTO_00118894">
        <rdfs:label>glycine receptor subunit alpha-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <definition>A protein that is a translation product of the human GLRA4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q5JXX5</uniprot_xref>
        <symbol>GLRA4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118895 -->

    <owl:Class rdf:about="&dto;DTO_00118895">
        <rdfs:label>glycine receptor subunit beta</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <symbol>GLRB</symbol>
        <uniprot_xref>P48167</uniprot_xref>
        <definition>A protein that is a translation product of the human GLRB gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118896 -->

    <owl:Class rdf:about="&dto;DTO_00118896">
        <rdfs:label>golgi ph regulator a</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118737"/>
        <geneSynonyms>GPHRA</geneSynonyms>
        <symbol>GPR89A</symbol>
        <geneSynonyms>SH120</geneSynonyms>
        <geneSynonyms>GPR89</geneSynonyms>
        <uniprot_xref>B7ZAQ6</uniprot_xref>
        <definition>A protein that is a translation product of the human GPR89A gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118897 -->

    <owl:Class rdf:about="&dto;DTO_00118897">
        <rdfs:label>golgi ph regulator b</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118737"/>
        <uniprot_xref>P0CG08</uniprot_xref>
        <geneSynonyms>GPHRB</geneSynonyms>
        <definition>A protein that is a translation product of the human GPR89B gene or a 1:1 ortholog thereof. </definition>
        <symbol>GPR89B</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118898 -->

    <owl:Class rdf:about="&dto;DTO_00118898">
        <rdfs:label>glutamate receptor 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <definition>A protein that is a translation product of the human GRIA1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>GLUH1</geneSynonyms>
        <uniprot_xref>P42261</uniprot_xref>
        <geneSynonyms>GLUR1</geneSynonyms>
        <symbol>GRIA1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118899 -->

    <owl:Class rdf:about="&dto;DTO_00118899">
        <rdfs:label>glutamate receptor 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <uniprot_xref>P42262</uniprot_xref>
        <symbol>GRIA2</symbol>
        <definition>A protein that is a translation product of the human GRIA2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>GLUR2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118900 -->

    <owl:Class rdf:about="&dto;DTO_00118900">
        <rdfs:label>glutamate receptor 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <definition>A protein that is a translation product of the human GRIA3 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>GLUR3</geneSynonyms>
        <geneSynonyms>GLURC</geneSynonyms>
        <symbol>GRIA3</symbol>
        <uniprot_xref>P42263</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118901 -->

    <owl:Class rdf:about="&dto;DTO_00118901">
        <rdfs:label>glutamate receptor 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <geneSynonyms>GLUR4</geneSynonyms>
        <symbol>GRIA4</symbol>
        <definition>A protein that is a translation product of the human GRIA4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P48058</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118902 -->

    <owl:Class rdf:about="&dto;DTO_00118902">
        <rdfs:label>glutamate receptor ionotropic, delta-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <definition>A protein that is a translation product of the human GRID1 gene or a 1:1 ortholog thereof. </definition>
        <symbol>GRID1</symbol>
        <geneSynonyms>KIAA1220</geneSynonyms>
        <uniprot_xref>Q9ULK0</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118903 -->

    <owl:Class rdf:about="&dto;DTO_00118903">
        <rdfs:label>glutamate receptor ionotropic, delta-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <definition>A protein that is a translation product of the human GRID2 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>O43424</uniprot_xref>
        <symbol>GRID2</symbol>
        <geneSynonyms>GLURD2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118904 -->

    <owl:Class rdf:about="&dto;DTO_00118904">
        <rdfs:label>glutamate receptor ionotropic, kainate 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <symbol>GRIK1</symbol>
        <definition>A protein that is a translation product of the human GRIK1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P39086</uniprot_xref>
        <geneSynonyms>GLUR5</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118905 -->

    <owl:Class rdf:about="&dto;DTO_00118905">
        <rdfs:label>glutamate receptor ionotropic, kainate 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <symbol>GRIK2</symbol>
        <definition>A protein that is a translation product of the human GRIK2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>GLUR6</geneSynonyms>
        <uniprot_xref>Q13002</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118906 -->

    <owl:Class rdf:about="&dto;DTO_00118906">
        <rdfs:label>glutamate receptor ionotropic, kainate 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <symbol>GRIK3</symbol>
        <geneSynonyms>GLUR7</geneSynonyms>
        <uniprot_xref>Q13003</uniprot_xref>
        <definition>A protein that is a translation product of the human GRIK3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118907 -->

    <owl:Class rdf:about="&dto;DTO_00118907">
        <rdfs:label>glutamate receptor ionotropic, kainate 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <definition>A protein that is a translation product of the human GRIK4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q16099</uniprot_xref>
        <geneSynonyms>GRIK</geneSynonyms>
        <symbol>GRIK4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118908 -->

    <owl:Class rdf:about="&dto;DTO_00118908">
        <rdfs:label>glutamate receptor ionotropic, kainate 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <symbol>GRIK5</symbol>
        <definition>A protein that is a translation product of the human GRIK5 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>GRIK2</geneSynonyms>
        <uniprot_xref>Q16478</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118909 -->

    <owl:Class rdf:about="&dto;DTO_00118909">
        <rdfs:label>potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118739"/>
        <definition>A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel protein that is a translation product of the human HCN1 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <uniprot_xref>O60741</uniprot_xref>
        <symbol>HCN1</symbol>
        <geneSynonyms>BCNG1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118910 -->

    <owl:Class rdf:about="&dto;DTO_00118910">
        <rdfs:label>potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118739"/>
        <symbol>HCN2</symbol>
        <definition>A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel protein that is a translation product of the human HCN2 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <geneSynonyms>BCNG2</geneSynonyms>
        <uniprot_xref>Q9UL51</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118911 -->

    <owl:Class rdf:about="&dto;DTO_00118911">
        <rdfs:label>potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118739"/>
        <geneSynonyms>KIAA1535</geneSynonyms>
        <uniprot_xref>Q9P1Z3</uniprot_xref>
        <symbol>HCN3</symbol>
        <definition>A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel protein that is a translation product of the human HCN3 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118912 -->

    <owl:Class rdf:about="&dto;DTO_00118912">
        <rdfs:label>potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118739"/>
        <symbol>HCN4</symbol>
        <uniprot_xref>Q9Y3Q4</uniprot_xref>
        <definition>A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel protein that is a translation product of the human HCN4 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118913 -->

    <owl:Class rdf:about="&dto;DTO_00118913">
        <rdfs:label>voltage-gated hydrogen channel 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118740"/>
        <uniprot_xref>Q96D96</uniprot_xref>
        <geneSynonyms>VSOP</geneSynonyms>
        <symbol>HVCN1</symbol>
        <definition>A protein that is a translation product of the human HVCN1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118914 -->

    <owl:Class rdf:about="&dto;DTO_00118914">
        <rdfs:label>atp-sensitive inward rectifier potassium channel 10</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ10 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>P78508</uniprot_xref>
        <symbol>KCNJ10</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118915 -->

    <owl:Class rdf:about="&dto;DTO_00118915">
        <rdfs:label>atp-sensitive inward rectifier potassium channel 11</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ11 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>Q14654</uniprot_xref>
        <symbol>KCNJ11</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118916 -->

    <owl:Class rdf:about="&dto;DTO_00118916">
        <rdfs:label>atp-sensitive inward rectifier potassium channel 12</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <geneSynonyms>KCNJN1</geneSynonyms>
        <uniprot_xref>Q14500</uniprot_xref>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ12 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>IRK2</geneSynonyms>
        <symbol>KCNJ12</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118917 -->

    <owl:Class rdf:about="&dto;DTO_00118917">
        <rdfs:label>inward rectifier potassium channel 13</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ13 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>O60928</uniprot_xref>
        <symbol>KCNJ13</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118918 -->

    <owl:Class rdf:about="&dto;DTO_00118918">
        <rdfs:label>atp-sensitive inward rectifier potassium channel 14</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <geneSynonyms>IRK4</geneSynonyms>
        <uniprot_xref>Q9UNX9</uniprot_xref>
        <symbol>KCNJ14</symbol>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ14 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118919 -->

    <owl:Class rdf:about="&dto;DTO_00118919">
        <rdfs:label>atp-sensitive inward rectifier potassium channel 15</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <uniprot_xref>Q99712</uniprot_xref>
        <symbol>KCNJ15</symbol>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ15 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>KCNJ14</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118920 -->

    <owl:Class rdf:about="&dto;DTO_00118920">
        <rdfs:label>inward rectifier potassium channel 16</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ16 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>Q9NPI9</uniprot_xref>
        <symbol>KCNJ16</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118921 -->

    <owl:Class rdf:about="&dto;DTO_00118921">
        <rdfs:label>inward rectifier potassium channel 18</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <uniprot_xref>B7U540</uniprot_xref>
        <definition>A protein that is a translation product of the human KCNJ18 gene or a 1:1 ortholog thereof. </definition>
        <symbol>KCNJ18</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118922 -->

    <owl:Class rdf:about="&dto;DTO_00118922">
        <rdfs:label>atp-sensitive inward rectifier potassium channel 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <uniprot_xref>P48048</uniprot_xref>
        <geneSynonyms>ROMK1</geneSynonyms>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ1 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>KCNJ1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118923 -->

    <owl:Class rdf:about="&dto;DTO_00118923">
        <rdfs:label>inward rectifier potassium channel 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <uniprot_xref>P63252</uniprot_xref>
        <symbol>KCNJ2</symbol>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ2 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>IRK1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118924 -->

    <owl:Class rdf:about="&dto;DTO_00118924">
        <rdfs:label>g protein-activated inward rectifier potassium channel 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ3 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>P48549</uniprot_xref>
        <symbol>KCNJ3</symbol>
        <geneSynonyms>GIRK1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118925 -->

    <owl:Class rdf:about="&dto;DTO_00118925">
        <rdfs:label>inward rectifier potassium channel 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ4 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>IRK3</geneSynonyms>
        <uniprot_xref>P48050</uniprot_xref>
        <symbol>KCNJ4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118926 -->

    <owl:Class rdf:about="&dto;DTO_00118926">
        <rdfs:label>g protein-activated inward rectifier potassium channel 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <uniprot_xref>P48544</uniprot_xref>
        <symbol>KCNJ5</symbol>
        <geneSynonyms>GIRK4</geneSynonyms>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ5 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118927 -->

    <owl:Class rdf:about="&dto;DTO_00118927">
        <rdfs:label>g protein-activated inward rectifier potassium channel 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <uniprot_xref>P48051</uniprot_xref>
        <geneSynonyms>KATP2</geneSynonyms>
        <geneSynonyms>GIRK2</geneSynonyms>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ6 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>KCNJ6</symbol>
        <geneSynonyms>KCNJ7</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118928 -->

    <owl:Class rdf:about="&dto;DTO_00118928">
        <rdfs:label>atp-sensitive inward rectifier potassium channel 8</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <symbol>KCNJ8</symbol>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ8 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>Q15842</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118929 -->

    <owl:Class rdf:about="&dto;DTO_00118929">
        <rdfs:label>g protein-activated inward rectifier potassium channel 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118741"/>
        <uniprot_xref>Q92806</uniprot_xref>
        <symbol>KCNJ9</symbol>
        <geneSynonyms>GIRK3</geneSynonyms>
        <definition>A G protein-activated inward rectifier potassium channel that is a translation product of the human KCNJ9 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118930 -->

    <owl:Class rdf:about="&dto;DTO_00118930">
        <rdfs:label>inositol 1,4,5-trisphosphate receptor type 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118742"/>
        <symbol>ITPR1</symbol>
        <definition>A protein that is a translation product of the human ITPR1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q14643</uniprot_xref>
        <geneSynonyms>INSP3R1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118931 -->

    <owl:Class rdf:about="&dto;DTO_00118931">
        <rdfs:label>inositol 1,4,5-trisphosphate receptor type 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118742"/>
        <symbol>ITPR2</symbol>
        <uniprot_xref>Q14571</uniprot_xref>
        <definition>A protein that is a translation product of the human ITPR2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118932 -->

    <owl:Class rdf:about="&dto;DTO_00118932">
        <rdfs:label>inositol 1,4,5-trisphosphate receptor type 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118742"/>
        <uniprot_xref>Q14573</uniprot_xref>
        <symbol>ITPR3</symbol>
        <definition>A protein that is a translation product of the human ITPR3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118933 -->

    <owl:Class rdf:about="&dto;DTO_00118933">
        <rdfs:label>potassium voltage-gated channel subfamily a member 10</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNA10 gene or a 1:1 ortholog thereof. It is a subunit of the Kv1.8 channel is a delayed rectifier channel that may be involved in regulating the tone of renal vascular smooth muscle and may also participate in the cardiac action potential. It is regulated by cGMP and postulated to mediate the effects of substances that increase intracellular cGMP. It can coassemble with other Kv1 subunits. [PMID:10836990] </definition>
        <symbol>KCNA10</symbol>
        <uniprot_xref>Q16322</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118934 -->

    <owl:Class rdf:about="&dto;DTO_00118934">
        <rdfs:label>voltage-gated potassium channel subunit beta-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118744"/>
        <definition>A protein that is a translation product of the human KCNAB1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q14722</uniprot_xref>
        <symbol>KCNAB1</symbol>
        <geneSynonyms>KCNA1B</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118935 -->

    <owl:Class rdf:about="&dto;DTO_00118935">
        <rdfs:label>voltage-gated potassium channel subunit beta-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118744"/>
        <geneSynonyms>KCNK2</geneSynonyms>
        <uniprot_xref>Q13303</uniprot_xref>
        <geneSynonyms>KCNA2B</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNAB2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>KCNAB2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118936 -->

    <owl:Class rdf:about="&dto;DTO_00118936">
        <rdfs:label>voltage-gated potassium channel subunit beta-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118744"/>
        <definition>A protein that is a translation product of the human KCNAB3 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>KCNA3B</geneSynonyms>
        <symbol>KCNAB3</symbol>
        <uniprot_xref>O43448</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118937 -->

    <owl:Class rdf:about="&dto;DTO_00118937">
        <rdfs:label>kv channel-interacting protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118734"/>
        <uniprot_xref>Q9NZI2</uniprot_xref>
        <definition>A protein that is a translation product of the human KCNIP1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>KCHIP1</geneSynonyms>
        <symbol>KCNIP1</symbol>
        <geneSynonyms>VABP</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118938 -->

    <owl:Class rdf:about="&dto;DTO_00118938">
        <rdfs:label>kv channel-interacting protein 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118734"/>
        <symbol>KCNIP2</symbol>
        <geneSynonyms>KCHIP2</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNIP2 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9NS61</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118939 -->

    <owl:Class rdf:about="&dto;DTO_00118939">
        <rdfs:label>kv channel-interacting protein 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118734"/>
        <geneSynonyms>KCHIP4</geneSynonyms>
        <geneSynonyms>CALP</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNIP4 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q6PIL6</uniprot_xref>
        <symbol>KCNIP4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118940 -->

    <owl:Class rdf:about="&dto;DTO_00118940">
        <rdfs:label>calcium-activated potassium channel subunit alpha-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A protein that is a translation product of the human KCNMA1 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>KCNMA1</symbol>
        <geneSynonyms>KCNMA</geneSynonyms>
        <geneSynonyms>SLO</geneSynonyms>
        <uniprot_xref>Q12791</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118941 -->

    <owl:Class rdf:about="&dto;DTO_00118941">
        <rdfs:label>calcium-activated potassium channel subunit beta-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118745"/>
        <symbol>KCNMB1</symbol>
        <uniprot_xref>Q16558</uniprot_xref>
        <definition>A protein that is a translation product of the human KCNMB1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118942 -->

    <owl:Class rdf:about="&dto;DTO_00118942">
        <rdfs:label>calcium-activated potassium channel subunit beta-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118745"/>
        <uniprot_xref>Q9Y691</uniprot_xref>
        <definition>A protein that is a translation product of the human KCNMB2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>KCNMB2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118943 -->

    <owl:Class rdf:about="&dto;DTO_00118943">
        <rdfs:label>calcium-activated potassium channel subunit beta-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118745"/>
        <symbol>KCNMB3</symbol>
        <geneSynonyms>KCNMBL</geneSynonyms>
        <uniprot_xref>Q9NPA1</uniprot_xref>
        <geneSynonyms>KCNMB2</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNMB3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118944 -->

    <owl:Class rdf:about="&dto;DTO_00118944">
        <rdfs:label>calcium-activated potassium channel subunit beta-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118745"/>
        <definition>A protein that is a translation product of the human KCNMB4 gene or a 1:1 ortholog thereof. </definition>
        <symbol>KCNMB4</symbol>
        <uniprot_xref>Q86W47</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118945 -->

    <owl:Class rdf:about="&dto;DTO_00118945">
        <rdfs:label>potassium voltage-gated channel subfamily a member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNA1</symbol>
        <uniprot_xref>Q09470</uniprot_xref>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNA1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118946 -->

    <owl:Class rdf:about="&dto;DTO_00118946">
        <rdfs:label>potassium voltage-gated channel subfamily a member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNA2 gene or a 1:1 ortholog thereof. The Kv1.2 channel is involved in maintaining membrane potential, modulating electrical excitability in neurons and muscle. It can coassemble with other Kv1 subunits. [PMID:16382104] </definition>
        <symbol>KCNA2</symbol>
        <uniprot_xref>P16389</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118947 -->

    <owl:Class rdf:about="&dto;DTO_00118947">
        <rdfs:label>potassium voltage-gated channel subfamily a member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNA3</symbol>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNA3 gene or a 1:1 ortholog thereof. The Kv1.3 channel is involved in maintaining membrane potential and calcium signaling in lymphocytes and oligodendrocytes. It can coassemble with other Kv1 subunits. [PRO:CNA] </definition>
        <geneSynonyms>HGK5</geneSynonyms>
        <uniprot_xref>P22001</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118948 -->

    <owl:Class rdf:about="&dto;DTO_00118948">
        <rdfs:label>potassium voltage-gated channel subfamily a member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A protein voltage-gated potassium channel alpha subunit that is a translation product of the human KCNA4 gene or a 1:1 ortholog thereof. The Kv1.4 channel is a fast-inactivating channel involved in neuronal after hypolarization. It can coassemble with other Kv1 subunits. It is closely related to members of the shaker-related voltage-gated potassium channel, but has a unique N-terminal domain, with two tandem inactivation domains (ID1-ID2). ID1 may work as a pore-occluding ball domain, whereas ID2 most likely acts as a docking domain that attaches ID1 to the cytoplasmic face of the channel. [PMID:12590144] </definition>
        <uniprot_xref>P22459</uniprot_xref>
        <geneSynonyms>KCNA4L</geneSynonyms>
        <symbol>KCNA4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118949 -->

    <owl:Class rdf:about="&dto;DTO_00118949">
        <rdfs:label>potassium voltage-gated channel subfamily a member 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>P22460</uniprot_xref>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNA5 gene or a 1:1 ortholog thereof. The voltage-gated potassium channel Kv1.5 mediates the ultrarapid-activating potassium current (IKur) in heart, and also plays a critical role in the regulation of arterial tone. [PMID:10575199, PMID:16772329, PMID:18344374] </definition>
        <symbol>KCNA5</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118950 -->

    <owl:Class rdf:about="&dto;DTO_00118950">
        <rdfs:label>potassium voltage-gated channel subfamily a member 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>P17658</uniprot_xref>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNA6 gene or a 1:1 ortholog thereof. The Kv1.6 channel is Regulator of membrane potential in neurons. The N terminus contains an N terminus inactivation prevention domain. It can coassemble with other Kv1 subunits. [PRO:CNA] </definition>
        <symbol>KCNA6</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118951 -->

    <owl:Class rdf:about="&dto;DTO_00118951">
        <rdfs:label>potassium voltage-gated channel subfamily a member 7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNA7</symbol>
        <uniprot_xref>Q96RP8</uniprot_xref>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNA7 gene or a 1:1 ortholog thereof. The Kv1.7 channel has properties similar to the ultrarapidly activating IKur current in the heart. It can coassemble with other Kv1 subunits. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118952 -->

    <owl:Class rdf:about="&dto;DTO_00118952">
        <rdfs:label>potassium voltage-gated channel subfamily b member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q14721</uniprot_xref>
        <definition>A shab-related voltage-gated potassium channel alpha subunit that is a translation product of the human KCNB1 gene or a 1:1 ortholog thereof. It associates with other subunits to generate a delayed rectifier potassium channel. [PRO:CNA] </definition>
        <symbol>KCNB1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118953 -->

    <owl:Class rdf:about="&dto;DTO_00118953">
        <rdfs:label>potassium voltage-gated channel subfamily b member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A shab-related voltage-gated potassium channel alpha subunit that is a translation product of the human KCNB2 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <uniprot_xref>Q92953</uniprot_xref>
        <symbol>KCNB2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118954 -->

    <owl:Class rdf:about="&dto;DTO_00118954">
        <rdfs:label>potassium voltage-gated channel subfamily c member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>P48547</uniprot_xref>
        <definition>A shaw-related voltage-gated potassium channel alpha subunit that is a translation product of the human KCNC1 gene or a 1:1 ortholog thereof. They contain an ATM motif at the C-terminus, following the S6 segment that allows interaction with axonal targeting machinery when exposed. [PRO:CNA] </definition>
        <symbol>KCNC1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118955 -->

    <owl:Class rdf:about="&dto;DTO_00118955">
        <rdfs:label>potassium voltage-gated channel subfamily c member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q96PR1</uniprot_xref>
        <definition>A shaw-related voltage-gated potassium channel alpha subunit that is a translation product of the human KCNC2 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>KCNC2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118956 -->

    <owl:Class rdf:about="&dto;DTO_00118956">
        <rdfs:label>potassium voltage-gated channel subfamily c member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A shaw-related voltage-gated potassium channel alpha subunit that is a translation product of the human KCNC3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>KCNC3</symbol>
        <uniprot_xref>Q14003</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118957 -->

    <owl:Class rdf:about="&dto;DTO_00118957">
        <rdfs:label>potassium voltage-gated channel subfamily c member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A shaw-related voltage-gated potassium channel alpha subunit that is a translation product of the human KCNC4 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>KCNC4</symbol>
        <uniprot_xref>Q03721</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118958 -->

    <owl:Class rdf:about="&dto;DTO_00118958">
        <rdfs:label>potassium voltage-gated channel subfamily d member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q9NSA2</uniprot_xref>
        <symbol>KCND1</symbol>
        <definition>A shal-related voltage-gated potassium channel that is a translation product of the human KCND1 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118959 -->

    <owl:Class rdf:about="&dto;DTO_00118959">
        <rdfs:label>potassium voltage-gated channel subfamily d member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <geneSynonyms>KIAA1044</geneSynonyms>
        <definition>A shal-related voltage-gated potassium channel that is a translation product of the human KCND2 gene or a 1:1 ortholog thereof. Kv4.2 potassium channels play a critical role in postsynaptic excitability. They are modulated by phosphorylation as well as by association with Kv4 Channel Interacting Proteins (KChIPs). The N terminus contains an ER retention motif RKR that seems to be masked when associated to KChiPs. This masking increases surface expression. [PMID:12829703, PRO:CNA] </definition>
        <uniprot_xref>Q9NZV8</uniprot_xref>
        <symbol>KCND2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118960 -->

    <owl:Class rdf:about="&dto;DTO_00118960">
        <rdfs:label>potassium voltage-gated channel subfamily d member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q9UK17</uniprot_xref>
        <definition>A shal-related voltage-gated potassium channel that is a translation product of the human KCND3 gene or a 1:1 ortholog thereof. These subunits form homotetramers or heterotetramers with KCND1 and/or KCND2. Associates with the regulatory subunits KCNIP1, KCNIP2, KCNIP3 and KCNIP4. [PRO:CNA] </definition>
        <symbol>KCND3</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118961 -->

    <owl:Class rdf:about="&dto;DTO_00118961">
        <rdfs:label>potassium voltage-gated channel subfamily e member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118746"/>
        <definition>A protein that is a translation product of the human KCNE1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P15382</uniprot_xref>
        <symbol>KCNE1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118962 -->

    <owl:Class rdf:about="&dto;DTO_00118962">
        <rdfs:label>potassium voltage-gated channel subfamily e member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118746"/>
        <uniprot_xref>Q9Y6J6</uniprot_xref>
        <definition>A protein that is a translation product of the human KCNE2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>KCNE2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118963 -->

    <owl:Class rdf:about="&dto;DTO_00118963">
        <rdfs:label>potassium voltage-gated channel subfamily e member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118746"/>
        <uniprot_xref>Q9Y6H6</uniprot_xref>
        <symbol>KCNE3</symbol>
        <definition>A protein that is a translation product of the human KCNE3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118964 -->

    <owl:Class rdf:about="&dto;DTO_00118964">
        <rdfs:label>potassium voltage-gated channel subfamily e member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118746"/>
        <uniprot_xref>Q8WWG9</uniprot_xref>
        <symbol>KCNE4</symbol>
        <definition>A protein that is a translation product of the human KCNE4 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118965 -->

    <owl:Class rdf:about="&dto;DTO_00118965">
        <rdfs:label>potassium voltage-gated channel subfamily f member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNF1 gene or a 1:1 ortholog thereof. KCNF1 is a modulator of the shab-related potassium channels (Kv2). Unlike other potassium channel subunits, KCNF1 subunits are not able to form functional channels on their own. [PMID:9696692] </definition>
        <symbol>KCNF1</symbol>
        <uniprot_xref>Q9H3M0</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118966 -->

    <owl:Class rdf:about="&dto;DTO_00118966">
        <rdfs:label>potassium voltage-gated channel subfamily g member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A modulatory voltage-gated potassium channel subunit KCNG that is a translation product of the human KCNG1 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <uniprot_xref>Q9UIX4</uniprot_xref>
        <symbol>KCNG1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118967 -->

    <owl:Class rdf:about="&dto;DTO_00118967">
        <rdfs:label>potassium voltage-gated channel subfamily g member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q9UJ96</uniprot_xref>
        <symbol>KCNG2</symbol>
        <definition>A modulatory voltage-gated potassium channel subunit KCNG that is a translation product of the human KCNG2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>KCNF2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118968 -->

    <owl:Class rdf:about="&dto;DTO_00118968">
        <rdfs:label>potassium voltage-gated channel subfamily g member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNG3</symbol>
        <definition>A modulatory voltage-gated potassium channel subunit KCNG that is a translation product of the human KCNG3 gene or a 1:1 ortholog thereof. It has to be associated with Kv2 subunits (</definition>
        <uniprot_xref>Q8TAE7</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118969 -->

    <owl:Class rdf:about="&dto;DTO_00118969">
        <rdfs:label>potassium voltage-gated channel subfamily g member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q8TDN1</uniprot_xref>
        <symbol>KCNG4</symbol>
        <geneSynonyms>KCNG3</geneSynonyms>
        <definition>A modulatory voltage-gated potassium channel subunit KCNG that is a translation product of the human KCNG4 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118970 -->

    <owl:Class rdf:about="&dto;DTO_00118970">
        <rdfs:label>potassium voltage-gated channel subfamily h member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>O95259</uniprot_xref>
        <definition>A voltage-gated potassium channel Eag alpha subunit that is a translation product of the human KHCN1 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <geneSynonyms>EAG1</geneSynonyms>
        <geneSynonyms>EAG</geneSynonyms>
        <symbol>KCNH1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118971 -->

    <owl:Class rdf:about="&dto;DTO_00118971">
        <rdfs:label>potassium voltage-gated channel subfamily h member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <geneSynonyms>ERG</geneSynonyms>
        <uniprot_xref>Q12809</uniprot_xref>
        <definition>A voltage-gated potassium channel Erg alpha subunit that is a translation product of the human KCNH2 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <geneSynonyms>ERG1</geneSynonyms>
        <symbol>KCNH2</symbol>
        <geneSynonyms>HERG</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118972 -->

    <owl:Class rdf:about="&dto;DTO_00118972">
        <rdfs:label>potassium voltage-gated channel subfamily h member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <geneSynonyms>KIAA1282</geneSynonyms>
        <symbol>KCNH3</symbol>
        <definition>A voltage-gated potassium channel Elk alpha subunit that is a translation product of the human KHCN3 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <uniprot_xref>Q9ULD8</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118973 -->

    <owl:Class rdf:about="&dto;DTO_00118973">
        <rdfs:label>potassium voltage-gated channel subfamily h member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q9UQ05</uniprot_xref>
        <definition>A voltage-gated potassium channel Elk alpha subunit that is a translation product of the human KHCN4 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>KCNH4</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118974 -->

    <owl:Class rdf:about="&dto;DTO_00118974">
        <rdfs:label>potassium voltage-gated channel subfamily h member 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A voltage-gated potassium channel Eag alpha subunit that is a translation product of the human KHCN5 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>KCNH5</symbol>
        <geneSynonyms>EAG2</geneSynonyms>
        <uniprot_xref>Q8NCM2</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118975 -->

    <owl:Class rdf:about="&dto;DTO_00118975">
        <rdfs:label>potassium voltage-gated channel subfamily h member 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q9H252</uniprot_xref>
        <definition>A voltage-gated potassium channel Erg alpha subunit that is a translation product of the human KHCN6 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>KCNH6</symbol>
        <geneSynonyms>ERG2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118976 -->

    <owl:Class rdf:about="&dto;DTO_00118976">
        <rdfs:label>potassium voltage-gated channel subfamily h member 7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A voltage-gated potassium channel Erg alpha subunit that is a translation product of the human KCNH7 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <uniprot_xref>Q9NS40</uniprot_xref>
        <geneSynonyms>ERG3</geneSynonyms>
        <symbol>KCNH7</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118977 -->

    <owl:Class rdf:about="&dto;DTO_00118977">
        <rdfs:label>potassium voltage-gated channel subfamily h member 8</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNH8</symbol>
        <uniprot_xref>Q96L42</uniprot_xref>
        <definition>A voltage-gated potassium channel Elk alpha subunit that is a translation product of the human KCNH8 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118978 -->

    <owl:Class rdf:about="&dto;DTO_00118978">
        <rdfs:label>potassium channel subfamily k member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK1 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>KCNK1</symbol>
        <geneSynonyms>TWIK1</geneSynonyms>
        <geneSynonyms>HOHO1</geneSynonyms>
        <geneSynonyms>KCNO1</geneSynonyms>
        <uniprot_xref>O00180</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118979 -->

    <owl:Class rdf:about="&dto;DTO_00118979">
        <rdfs:label>potassium channel subfamily k member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <geneSynonyms>TREK</geneSynonyms>
        <uniprot_xref>O95069</uniprot_xref>
        <definition>A protein that is a translation product of the human KCNK2 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>TREK1</geneSynonyms>
        <symbol>KCNK2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118980 -->

    <owl:Class rdf:about="&dto;DTO_00118980">
        <rdfs:label>potassium channel subfamily k member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <geneSynonyms>TASK</geneSynonyms>
        <uniprot_xref>O14649</uniprot_xref>
        <geneSynonyms>TASK1</geneSynonyms>
        <symbol>KCNK3</symbol>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK3 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118981 -->

    <owl:Class rdf:about="&dto;DTO_00118981">
        <rdfs:label>potassium channel subfamily k member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <uniprot_xref>Q9NYG8</uniprot_xref>
        <symbol>KCNK4</symbol>
        <geneSynonyms>TRAAK</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNK4 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118982 -->

    <owl:Class rdf:about="&dto;DTO_00118982">
        <rdfs:label>potassium channel subfamily k member 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <symbol>KCNK5</symbol>
        <uniprot_xref>O95279</uniprot_xref>
        <geneSynonyms>TASK2</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNK5 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118983 -->

    <owl:Class rdf:about="&dto;DTO_00118983">
        <rdfs:label>potassium channel subfamily k member 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <geneSynonyms>TWIK2</geneSynonyms>
        <uniprot_xref>Q9Y257</uniprot_xref>
        <symbol>KCNK6</symbol>
        <geneSynonyms>TOSS</geneSynonyms>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK6 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118984 -->

    <owl:Class rdf:about="&dto;DTO_00118984">
        <rdfs:label>potassium channel subfamily k member 7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <uniprot_xref>Q9Y2U2</uniprot_xref>
        <symbol>KCNK7</symbol>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK7 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118985 -->

    <owl:Class rdf:about="&dto;DTO_00118985">
        <rdfs:label>potassium channel subfamily k member 9</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <geneSynonyms>TASK3</geneSynonyms>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK9 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>KCNK9</symbol>
        <uniprot_xref>Q9NPC2</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118986 -->

    <owl:Class rdf:about="&dto;DTO_00118986">
        <rdfs:label>potassium channel subfamily k member 10</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <geneSynonyms>TREK2</geneSynonyms>
        <symbol>KCNK10</symbol>
        <definition>A protein that is a translation product of the human KCNK10 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>P57789</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118987 -->

    <owl:Class rdf:about="&dto;DTO_00118987">
        <rdfs:label>potassium channel subfamily k member 12</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <uniprot_xref>Q9HB15</uniprot_xref>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK12 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>KCNK12</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118988 -->

    <owl:Class rdf:about="&dto;DTO_00118988">
        <rdfs:label>potassium channel subfamily k member 13</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <symbol>KCNK13</symbol>
        <uniprot_xref>Q9HB14</uniprot_xref>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK13 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118989 -->

    <owl:Class rdf:about="&dto;DTO_00118989">
        <rdfs:label>potassium channel subfamily k member 15</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK15 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>KCNK15</symbol>
        <uniprot_xref>Q9H427</uniprot_xref>
        <geneSynonyms>TASK5</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118990 -->

    <owl:Class rdf:about="&dto;DTO_00118990">
        <rdfs:label>potassium channel subfamily k member 16</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <symbol>KCNK16</symbol>
        <uniprot_xref>Q96T55</uniprot_xref>
        <definition>A protein that is a translation product of the human KCNK16 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>TALK1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118991 -->

    <owl:Class rdf:about="&dto;DTO_00118991">
        <rdfs:label>potassium channel subfamily k member 17</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <definition>A potassium channel, TWIK-1-related that is a translation product of the human KCNK17 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>KCNK17</symbol>
        <geneSynonyms>TALK2</geneSynonyms>
        <geneSynonyms>TASK4</geneSynonyms>
        <uniprot_xref>Q96T54</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118992 -->

    <owl:Class rdf:about="&dto;DTO_00118992">
        <rdfs:label>potassium channel subfamily k member 18</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118747"/>
        <symbol>KCNK18</symbol>
        <geneSynonyms>TRIK</geneSynonyms>
        <geneSynonyms>TRESK</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNK18 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q7Z418</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118993 -->

    <owl:Class rdf:about="&dto;DTO_00118993">
        <rdfs:label>small conductance calcium-activated potassium channel protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118748"/>
        <definition>A calcium-activated calmodulin-binding potassium channel alpha subunit that is a translation product of the human KCNN1 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <uniprot_xref>Q92952</uniprot_xref>
        <geneSynonyms>SK</geneSynonyms>
        <symbol>KCNN1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118994 -->

    <owl:Class rdf:about="&dto;DTO_00118994">
        <rdfs:label>small conductance calcium-activated potassium channel protein 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118748"/>
        <symbol>KCNN2</symbol>
        <uniprot_xref>Q9H2S1</uniprot_xref>
        <definition>A calcium-activated calmodulin-binding potassium channel alpha subunit that is a translation product of the human KCNN2 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118995 -->

    <owl:Class rdf:about="&dto;DTO_00118995">
        <rdfs:label>small conductance calcium-activated potassium channel protein 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118748"/>
        <uniprot_xref>Q9UGI6</uniprot_xref>
        <definition>A calcium-activated calmodulin-binding potassium channel alpha subunit that is a translation product of the human KCNN3 gene or a 1:1 ortholog thereof. The KCNN3 gene contains two arrays of CAG trinucleotide repeats, which are highly polymorphic. The SK3 channels are thought to regulate neuronal excitability by contributing to the slow component of synaptic afterhyperpolarization. [PRO:CNA] </definition>
        <geneSynonyms>K3</geneSynonyms>
        <symbol>KCNN3</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118996 -->

    <owl:Class rdf:about="&dto;DTO_00118996">
        <rdfs:label>intermediate conductance calcium-activated potassium channel protein 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118748"/>
        <symbol>KCNN4</symbol>
        <geneSynonyms>SK4</geneSynonyms>
        <geneSynonyms>IK1</geneSynonyms>
        <definition>A calcium-activated calmodulin-binding potassium channel alpha subunit that is a translation product of the human KCNN4 gene or a 1:1 ortholog thereof. It forms a voltage-independent potassium channel that is activated by intracellular calcium. Activation is followed by membrane hyperpolarization which promotes calcium influx. The channel is blocked by clotrimazole and charybdotoxin but is insensitive to apamin. This feature distinguishes the intermediate from the small conductance channels. [PMID:9326665, PMID:9407042] </definition>
        <uniprot_xref>O15554</uniprot_xref>
        <geneSynonyms>IKCA1</geneSynonyms>
        <geneSynonyms>KCA4</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118997 -->

    <owl:Class rdf:about="&dto;DTO_00118997">
        <rdfs:label>potassium voltage-gated channel subfamily kqt member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <geneSynonyms>KCNA8</geneSynonyms>
        <geneSynonyms>KCNA9</geneSynonyms>
        <uniprot_xref>P51787</uniprot_xref>
        <symbol>KCNQ1</symbol>
        <geneSynonyms>KVLQT1</geneSynonyms>
        <definition>A voltage-gated potassium channel subunit KQT that is a translation product of the human KCNQ1 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118998 -->

    <owl:Class rdf:about="&dto;DTO_00118998">
        <rdfs:label>potassium voltage-gated channel subfamily kqt member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A voltage-gated potassium channel subunit KQT that is a translation product of the human KCNQ2 gene or a 1:1 ortholog thereof. Most of the isoforms are generated by splicing that is restricted to a region that encodes the intracellular C-terminal domain of the channel (exons 7-16 in rat). From these, there are two main classes, one containing exon 16 in-frame, and others with an alternative splice junction in exon 14 that results in a frameshift and early termination. In addition, exons 12 and 13 have alternative splice junctions, and exons 8,11, and 15a are subject to splicing. Many members of this class can form heteromeric channels with members of the class KCNQ3 (</definition>
        <uniprot_xref>O43526</uniprot_xref>
        <symbol>KCNQ2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00118999 -->

    <owl:Class rdf:about="&dto;DTO_00118999">
        <rdfs:label>potassium voltage-gated channel subfamily kqt member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <definition>A voltage-gated potassium channel subunit KQT that is a translation product of the human KCNQ3 gene or a 1:1 ortholog thereof. Many members of this class can form heteromeric channels with members of the class KCNQ2 (</definition>
        <uniprot_xref>O43525</uniprot_xref>
        <symbol>KCNQ3</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119000 -->

    <owl:Class rdf:about="&dto;DTO_00119000">
        <rdfs:label>potassium voltage-gated channel subfamily kqt member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNQ4</symbol>
        <uniprot_xref>P56696</uniprot_xref>
        <definition>A voltage-gated potassium channel subunit KQT that is a translation product of the human KCNQ4 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119001 -->

    <owl:Class rdf:about="&dto;DTO_00119001">
        <rdfs:label>potassium voltage-gated channel subfamily kqt member 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNQ5</symbol>
        <definition>A voltage-gated potassium channel subunit KQT that is a translation product of the human KCNQ5 gene or a 1:1 ortholog thereof. It contributes to M-type potassium currents. It is also inhibited by M1 muscarinic receptor activation. [PRO:CNA] </definition>
        <uniprot_xref>Q9NR82</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119002 -->

    <owl:Class rdf:about="&dto;DTO_00119002">
        <rdfs:label>potassium voltage-gated channel subfamily s member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q96KK3</uniprot_xref>
        <definition>A modulatory voltage-gated potassium channel subunit KCNS that is a translation product of the human KCNS1 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>KCNS1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119003 -->

    <owl:Class rdf:about="&dto;DTO_00119003">
        <rdfs:label>potassium voltage-gated channel subfamily s member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q9ULS6</uniprot_xref>
        <geneSynonyms>KIAA1144</geneSynonyms>
        <symbol>KCNS2</symbol>
        <definition>A modulatory voltage-gated potassium channel subunit KCNS that is a translation product of the human KCNS2 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119004 -->

    <owl:Class rdf:about="&dto;DTO_00119004">
        <rdfs:label>potassium voltage-gated channel subfamily s member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q9BQ31</uniprot_xref>
        <definition>A modulatory voltage-gated potassium channel subunit KCNS that is a translation product of the human KCNS3 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>KCNS3</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119005 -->

    <owl:Class rdf:about="&dto;DTO_00119005">
        <rdfs:label>potassium channel subfamily t member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNT1</symbol>
        <uniprot_xref>Q5JUK3</uniprot_xref>
        <definition>A potassium channel subfamily T that is a translation product of the human KCNT1 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>KIAA1422</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119006 -->

    <owl:Class rdf:about="&dto;DTO_00119006">
        <rdfs:label>potassium channel subfamily t member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNT2</symbol>
        <uniprot_xref>Q6UVM3</uniprot_xref>
        <geneSynonyms>SLICK</geneSynonyms>
        <definition>A potassium channel subfamily T that is a translation product of the human KCNT2 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119007 -->

    <owl:Class rdf:about="&dto;DTO_00119007">
        <rdfs:label>potassium channel subfamily u member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <geneSynonyms>KCNMC1</geneSynonyms>
        <symbol>KCNU1</symbol>
        <geneSynonyms>SLO3</geneSynonyms>
        <definition>A protein that is a translation product of the human KCNU1 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>KCNMA3</geneSynonyms>
        <uniprot_xref>A8MYU2</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119008 -->

    <owl:Class rdf:about="&dto;DTO_00119008">
        <rdfs:label>potassium voltage-gated channel subfamily v member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <uniprot_xref>Q6PIU1</uniprot_xref>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNV1 gene or a 1:1 ortholog thereof. It has an atypical S6 segment containing the structural elements that modify inactivation of Kv2 channels. Similarly to KCNF1, KCNV1 and KCNS, KCNV2 subunits are not able to form functional channels on their own. Also in common with these modulatory subunits, it lacks the conserved PxP motif located in the distal part of S6. In this class the motif is PIA. The alteration of the PxP motif seems to be an important determinant of the regulatory function of modulatory subunits. It modulates the activity of KCNB1 and KCNB2 channels by changing kinetics and levels of expression and by shifting the half-inactivation potential to more polarized values. [PMID:16382104] </definition>
        <symbol>KCNV1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119009 -->

    <owl:Class rdf:about="&dto;DTO_00119009">
        <rdfs:label>potassium voltage-gated channel subfamily v member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118743"/>
        <symbol>KCNV2</symbol>
        <uniprot_xref>Q8TDN2</uniprot_xref>
        <definition>A voltage-gated potassium channel alpha subunit that is a translation product of the human KCNV2 gene or a 1:1 ortholog thereof. Similarly to KCNF1, KCNV1 and KCNS, KCNV2 subunits are not able to form functional channels on their own. Also in common with these modulatory subunits, it lacks the conserved PxP motif located in the distal part of S6. In this class the motif is PIS. The alteration of the PxP motif seems to be an important determinant of the regulatory function of modulatory subunits. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119010 -->

    <owl:Class rdf:about="&dto;DTO_00119010">
        <rdfs:label>mucolipin-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <definition>A protein that is a translation product of the human MCOLN1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9GZU1</uniprot_xref>
        <symbol>MCOLN1</symbol>
        <geneSynonyms>ML4</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119011 -->

    <owl:Class rdf:about="&dto;DTO_00119011">
        <rdfs:label>mucolipin-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <symbol>MCOLN2</symbol>
        <uniprot_xref>Q8IZK6</uniprot_xref>
        <definition>A protein that is a translation product of the human MCOLN2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119012 -->

    <owl:Class rdf:about="&dto;DTO_00119012">
        <rdfs:label>mucolipin-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <uniprot_xref>Q8TDD5</uniprot_xref>
        <symbol>MCOLN3</symbol>
        <definition>A protein that is a translation product of the human MCOLN3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119013 -->

    <owl:Class rdf:about="&dto;DTO_00119013">
        <rdfs:label>calcium uniporter protein, mitochondrial</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118750"/>
        <symbol>MCU</symbol>
        <geneSynonyms>CCDC109A</geneSynonyms>
        <uniprot_xref>Q8NE86</uniprot_xref>
        <geneSynonyms>C10orf42</geneSynonyms>
        <definition>A protein that is a translation product of the human MCU gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119014 -->

    <owl:Class rdf:about="&dto;DTO_00119014">
        <rdfs:label>sodium leak channel non-selective protein</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118751"/>
        <definition>A protein that is a translation product of the human NALCN gene or a 1:1 ortholog thereof. The prototype subunit contains four copies of the six transmembrane ion transport protein domain, but the number of copies of this domain varies among splice variants. Responsible for the background sodium ion leak current in neurons and controls neuronal excitability. They are subunits of a voltage-independent, nonselective cation channel. [PMID:17448995, PRO:CNA] </definition>
        <geneSynonyms>VGCNL1</geneSynonyms>
        <uniprot_xref>Q8IZF0</uniprot_xref>
        <symbol>NALCN</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119015 -->

    <owl:Class rdf:about="&dto;DTO_00119015">
        <rdfs:label>glutamate receptor ionotropic, nmda 3a</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <symbol>GRIN3A</symbol>
        <uniprot_xref>Q8TCU5</uniprot_xref>
        <definition>A protein that is a translation product of the human GRIN3A gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>KIAA1973</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119016 -->

    <owl:Class rdf:about="&dto;DTO_00119016">
        <rdfs:label>glutamate receptor ionotropic, nmda 3b</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <uniprot_xref>O60391</uniprot_xref>
        <definition>A protein that is a translation product of the human GRIN3B gene or a 1:1 ortholog thereof. </definition>
        <symbol>GRIN3B</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119017 -->

    <owl:Class rdf:about="&dto;DTO_00119017">
        <rdfs:label>glutamate receptor ionotropic, nmda 2a</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <definition>A protein that is a translation product of the human GRIN2A gene or a 1:1 ortholog thereof. </definition>
        <symbol>GRIN2A</symbol>
        <uniprot_xref>Q12879</uniprot_xref>
        <geneSynonyms>NMDAR2A</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119018 -->

    <owl:Class rdf:about="&dto;DTO_00119018">
        <rdfs:label>glutamate receptor ionotropic, nmda 2b</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <uniprot_xref>Q13224</uniprot_xref>
        <definition>A protein that is a translation product of the human GRIN2B gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>NMDAR2B</geneSynonyms>
        <symbol>GRIN2B</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119019 -->

    <owl:Class rdf:about="&dto;DTO_00119019">
        <rdfs:label>glutamate receptor ionotropic, nmda 2c</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <symbol>GRIN2C</symbol>
        <geneSynonyms>NMDAR2C</geneSynonyms>
        <uniprot_xref>Q14957</uniprot_xref>
        <definition>A protein that is a translation product of the human GRIN2C gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119020 -->

    <owl:Class rdf:about="&dto;DTO_00119020">
        <rdfs:label>glutamate receptor ionotropic, nmda 2d</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <geneSynonyms>GluN2D</geneSynonyms>
        <uniprot_xref>O15399</uniprot_xref>
        <definition>A protein that is a translation product of the human GRIN2D gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>NMDAR2D</geneSynonyms>
        <symbol>GRIN2D</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119021 -->

    <owl:Class rdf:about="&dto;DTO_00119021">
        <rdfs:label>glutamate receptor ionotropic, nmda 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118738"/>
        <geneSynonyms>NMDAR1</geneSynonyms>
        <definition>A protein that is a translation product of the human GRIN1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q05586</uniprot_xref>
        <symbol>GRIN1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119022 -->

    <owl:Class rdf:about="&dto;DTO_00119022">
        <rdfs:label>p2x purinoceptor 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118752"/>
        <geneSynonyms>P2X1</geneSynonyms>
        <uniprot_xref>P51575</uniprot_xref>
        <definition>A protein that is a translation product of the human P2RX1 gene or a 1:1 ortholog thereof. </definition>
        <symbol>P2RX1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119023 -->

    <owl:Class rdf:about="&dto;DTO_00119023">
        <rdfs:label>p2x purinoceptor 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118752"/>
        <symbol>P2RX2</symbol>
        <definition>A protein that is a translation product of the human P2RX2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>P2X2</geneSynonyms>
        <uniprot_xref>Q9UBL9</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119024 -->

    <owl:Class rdf:about="&dto;DTO_00119024">
        <rdfs:label>p2x purinoceptor 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118752"/>
        <definition>A protein that is a translation product of the human P2RX3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>P2RX3</symbol>
        <uniprot_xref>P56373</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119025 -->

    <owl:Class rdf:about="&dto;DTO_00119025">
        <rdfs:label>p2x purinoceptor 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118752"/>
        <uniprot_xref>Q99571</uniprot_xref>
        <symbol>P2RX4</symbol>
        <definition>A protein that is a translation product of the human P2RX4 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119026 -->

    <owl:Class rdf:about="&dto;DTO_00119026">
        <rdfs:label>p2x purinoceptor 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118752"/>
        <geneSynonyms>P2X5</geneSynonyms>
        <symbol>P2RX5</symbol>
        <uniprot_xref>Q93086</uniprot_xref>
        <definition>A protein that is a translation product of the human P2RX5 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119027 -->

    <owl:Class rdf:about="&dto;DTO_00119027">
        <rdfs:label>p2x purinoceptor 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118752"/>
        <definition>A protein that is a translation product of the human P2RX6 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>P2X6</geneSynonyms>
        <uniprot_xref>O15547</uniprot_xref>
        <symbol>P2RX6</symbol>
        <geneSynonyms>P2RXL1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119028 -->

    <owl:Class rdf:about="&dto;DTO_00119028">
        <rdfs:label>p2x purinoceptor 7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118752"/>
        <definition>A protein that is a translation product of the human P2RX7 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q99572</uniprot_xref>
        <symbol>P2RX7</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119029 -->

    <owl:Class rdf:about="&dto;DTO_00119029">
        <rdfs:label>pannexin-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118753"/>
        <uniprot_xref>Q96RD7</uniprot_xref>
        <symbol>PANX1</symbol>
        <geneSynonyms>MRS1</geneSynonyms>
        <definition>A protein that is a translation product of the human PANX1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119030 -->

    <owl:Class rdf:about="&dto;DTO_00119030">
        <rdfs:label>pannexin-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118753"/>
        <definition>A protein that is a translation product of the human PANX2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>PANX2</symbol>
        <uniprot_xref>Q96RD6</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119031 -->

    <owl:Class rdf:about="&dto;DTO_00119031">
        <rdfs:label>pannexin-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118753"/>
        <uniprot_xref>Q96QZ0</uniprot_xref>
        <definition>A protein that is a translation product of the human PANX3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>PANX3</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119032 -->

    <owl:Class rdf:about="&dto;DTO_00119032">
        <rdfs:label>piezo-type mechanosensitive ion channel component 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118754"/>
        <geneSynonyms>FAM38A</geneSynonyms>
        <definition>A protein that is a translation product of the human PIEZO1 gene or a 1:1 ortholog thereof. </definition>
        <symbol>PIEZO1</symbol>
        <uniprot_xref>Q92508</uniprot_xref>
        <geneSynonyms>KIAA0233</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119033 -->

    <owl:Class rdf:about="&dto;DTO_00119033">
        <rdfs:label>piezo-type mechanosensitive ion channel component 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118754"/>
        <definition>A protein that is a translation product of the human PIEZO2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>FAM38B</geneSynonyms>
        <geneSynonyms>C18orf58</geneSynonyms>
        <uniprot_xref>Q9H5I5</uniprot_xref>
        <geneSynonyms>C18orf30</geneSynonyms>
        <symbol>PIEZO2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119034 -->

    <owl:Class rdf:about="&dto;DTO_00119034">
        <rdfs:label>polycystic kidney disease protein 1-like 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118755"/>
        <uniprot_xref>Q7Z442</uniprot_xref>
        <geneSynonyms>KIAA1879</geneSynonyms>
        <definition>A protein that is a translation product of the human PKD1L2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>PKD1L2</symbol>
        <geneSynonyms>PC1L2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119035 -->

    <owl:Class rdf:about="&dto;DTO_00119035">
        <rdfs:label>polycystic kidney disease protein 1-like 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118755"/>
        <symbol>PKD1L3</symbol>
        <definition>A protein that is a translation product of the human PKD1L3 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q7Z443</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119036 -->

    <owl:Class rdf:about="&dto;DTO_00119036">
        <rdfs:label>polycystic kidney disease 2-like 1 protein</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118755"/>
        <symbol>PKD2L1</symbol>
        <geneSynonyms>TRPP3</geneSynonyms>
        <definition>A protein that is a translation product of the human PKD2L1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9P0L9</uniprot_xref>
        <geneSynonyms>PKDL</geneSynonyms>
        <geneSynonyms>PKD2L</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119037 -->

    <owl:Class rdf:about="&dto;DTO_00119037">
        <rdfs:label>polycystic kidney disease 2-like 2 protein</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118755"/>
        <definition>A protein that is a translation product of the human PKD2L2 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9NZM6</uniprot_xref>
        <symbol>PKD2L2</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119038 -->

    <owl:Class rdf:about="&dto;DTO_00119038">
        <rdfs:label>polycystin-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118755"/>
        <uniprot_xref>Q13563</uniprot_xref>
        <symbol>PKD2</symbol>
        <definition>A protein that is a translation product of the human PKD2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119039 -->

    <owl:Class rdf:about="&dto;DTO_00119039">
        <rdfs:label>polycystic kidney disease and receptor for egg jelly-related protein</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118755"/>
        <definition>A protein that is a translation product of the human PKDREJ gene or a 1:1 ortholog thereof. </definition>
        <symbol>PKDREJ</symbol>
        <uniprot_xref>Q9NTG1</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119040 -->

    <owl:Class rdf:about="&dto;DTO_00119040">
        <rdfs:label>plasmolipin</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118756"/>
        <definition>A protein that is a translation product of the human PLLP gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>PMLP</geneSynonyms>
        <geneSynonyms>TM4SF11</geneSynonyms>
        <uniprot_xref>Q9Y342</uniprot_xref>
        <symbol>PLLP</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119041 -->

    <owl:Class rdf:about="&dto;DTO_00119041">
        <rdfs:label>phospholemman</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118736"/>
        <definition>A protein that is a translation product of the human FXYD1 gene or a 1:1 ortholog thereof. </definition>
        <symbol>FXYD1</symbol>
        <uniprot_xref>O00168</uniprot_xref>
        <geneSynonyms>PLM</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119042 -->

    <owl:Class rdf:about="&dto;DTO_00119042">
        <rdfs:label>ryanodine receptor 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118757"/>
        <symbol>RYR1</symbol>
        <geneSynonyms>RYDR</geneSynonyms>
        <uniprot_xref>P21817</uniprot_xref>
        <definition>A protein that is a translation product of the human RYR1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119043 -->

    <owl:Class rdf:about="&dto;DTO_00119043">
        <rdfs:label>ryanodine receptor 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118757"/>
        <symbol>RYR2</symbol>
        <definition>A protein that is a translation product of the human RYR2 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q92736</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119044 -->

    <owl:Class rdf:about="&dto;DTO_00119044">
        <rdfs:label>ryanodine receptor 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118757"/>
        <geneSynonyms>HBRR</geneSynonyms>
        <uniprot_xref>Q15413</uniprot_xref>
        <definition>A protein that is a translation product of the human RYR3 gene or a 1:1 ortholog thereof. </definition>
        <symbol>RYR3</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119045 -->

    <owl:Class rdf:about="&dto;DTO_00119045">
        <rdfs:label>sulfate anion transporter 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118758"/>
        <geneSynonyms>SAT1</geneSynonyms>
        <symbol>SLC26A1</symbol>
        <uniprot_xref>Q9H2B4</uniprot_xref>
        <definition>A protein that is a translation product of the human SLC26A1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119046 -->

    <owl:Class rdf:about="&dto;DTO_00119046">
        <rdfs:label>solute carrier family 26 member 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118758"/>
        <definition>A protein that is a translation product of the human SLC26A6 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9BXS9</uniprot_xref>
        <symbol>SLC26A6</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119047 -->

    <owl:Class rdf:about="&dto;DTO_00119047">
        <rdfs:label>sodium channel protein type 1 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <geneSynonyms>NAC1</geneSynonyms>
        <geneSynonyms>SCN1</geneSynonyms>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN1A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>P35498</uniprot_xref>
        <symbol>SCN1A</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119048 -->

    <owl:Class rdf:about="&dto;DTO_00119048">
        <rdfs:label>sodium channel subunit beta-1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118760"/>
        <uniprot_xref>Q07699</uniprot_xref>
        <definition>A protein that is a translation product of the human SCN1B gene or a 1:1 ortholog thereof. </definition>
        <symbol>SCN1B</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119049 -->

    <owl:Class rdf:about="&dto;DTO_00119049">
        <rdfs:label>sodium channel protein type 2 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <symbol>SCN2A</symbol>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN2A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>NAC2</geneSynonyms>
        <geneSynonyms>SCN2A1</geneSynonyms>
        <uniprot_xref>Q99250</uniprot_xref>
        <geneSynonyms>SCN2A2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119050 -->

    <owl:Class rdf:about="&dto;DTO_00119050">
        <rdfs:label>sodium channel subunit beta-2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118761"/>
        <definition>A protein that is a translation product of the human SCN2B gene or a 1:1 ortholog thereof. </definition>
        <symbol>SCN2B</symbol>
        <uniprot_xref>O60939</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119051 -->

    <owl:Class rdf:about="&dto;DTO_00119051">
        <rdfs:label>sodium channel protein type 3 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <symbol>SCN3A</symbol>
        <geneSynonyms>NAC3</geneSynonyms>
        <geneSynonyms>KIAA1356</geneSynonyms>
        <uniprot_xref>Q9NY46</uniprot_xref>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN3A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119052 -->

    <owl:Class rdf:about="&dto;DTO_00119052">
        <rdfs:label>sodium channel subunit beta-3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118762"/>
        <symbol>SCN3B</symbol>
        <geneSynonyms>KIAA1158</geneSynonyms>
        <uniprot_xref>Q9NY72</uniprot_xref>
        <definition>A protein that is a translation product of the human SCN3B gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119053 -->

    <owl:Class rdf:about="&dto;DTO_00119053">
        <rdfs:label>sodium channel protein type 4 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <uniprot_xref>P35499</uniprot_xref>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN4A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>SCN4A</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119054 -->

    <owl:Class rdf:about="&dto;DTO_00119054">
        <rdfs:label>sodium channel subunit beta-4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118763"/>
        <definition>A protein that is a translation product of the human SCN4B gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q8IWT1</uniprot_xref>
        <symbol>SCN4B</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119055 -->

    <owl:Class rdf:about="&dto;DTO_00119055">
        <rdfs:label>sodium channel protein type 5 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <uniprot_xref>Q14524</uniprot_xref>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN5A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <symbol>SCN5A</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119056 -->

    <owl:Class rdf:about="&dto;DTO_00119056">
        <rdfs:label>sodium channel protein type 7 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <uniprot_xref>Q01118</uniprot_xref>
        <geneSynonyms>SCN6A</geneSynonyms>
        <symbol>SCN7A</symbol>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN7A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119057 -->

    <owl:Class rdf:about="&dto;DTO_00119057">
        <rdfs:label>sodium channel protein type 8 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <symbol>SCN8A</symbol>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN8A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>MED</geneSynonyms>
        <uniprot_xref>Q9UQD0</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119058 -->

    <owl:Class rdf:about="&dto;DTO_00119058">
        <rdfs:label>sodium channel protein type 9 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN9A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>Q15858</uniprot_xref>
        <symbol>SCN9A</symbol>
        <geneSynonyms>NENA</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119059 -->

    <owl:Class rdf:about="&dto;DTO_00119059">
        <rdfs:label>sodium channel protein type 10 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <symbol>SCN10A</symbol>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN10A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <uniprot_xref>Q9Y5Y9</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119060 -->

    <owl:Class rdf:about="&dto;DTO_00119060">
        <rdfs:label>sodium channel protein type 11 subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118759"/>
        <symbol>SCN11A</symbol>
        <geneSynonyms>SCN12A</geneSynonyms>
        <uniprot_xref>Q9UI33</uniprot_xref>
        <definition>A voltage-gated sodium channel subunit alpha that is a translation product of the human SCN11A gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
        <geneSynonyms>SNS2</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119061 -->

    <owl:Class rdf:about="&dto;DTO_00119061">
        <rdfs:label>amiloride-sensitive sodium channel subunit alpha</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <geneSynonyms>SCNN1</geneSynonyms>
        <definition>A protein that is a translation product of the human SCNN1A gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P37088</uniprot_xref>
        <symbol>SCNN1A</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119062 -->

    <owl:Class rdf:about="&dto;DTO_00119062">
        <rdfs:label>amiloride-sensitive sodium channel subunit beta</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <symbol>SCNN1B</symbol>
        <uniprot_xref>P51168</uniprot_xref>
        <definition>A protein that is a translation product of the human SCNN1B gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119063 -->

    <owl:Class rdf:about="&dto;DTO_00119063">
        <rdfs:label>amiloride-sensitive sodium channel subunit delta</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <definition>A protein that is a translation product of the human SCNN1D gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>DNACH</geneSynonyms>
        <symbol>SCNN1D</symbol>
        <uniprot_xref>P51172</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119064 -->

    <owl:Class rdf:about="&dto;DTO_00119064">
        <rdfs:label>amiloride-sensitive sodium channel subunit gamma</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118720"/>
        <definition>A protein that is a translation product of the human SCNN1G gene or a 1:1 ortholog thereof. </definition>
        <symbol>SCNN1G</symbol>
        <uniprot_xref>P51170</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119065 -->

    <owl:Class rdf:about="&dto;DTO_00119065">
        <rdfs:label>trimeric intracellular cation channel type a</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118764"/>
        <symbol>TMEM38A</symbol>
        <uniprot_xref>Q9H6F2</uniprot_xref>
        <definition>A protein that is a translation product of the human TMEM38A gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119066 -->

    <owl:Class rdf:about="&dto;DTO_00119066">
        <rdfs:label>trimeric intracellular cation channel type b</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118764"/>
        <symbol>TMEM38B</symbol>
        <definition>A protein that is a translation product of the human TMEM38B gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>C9orf87</geneSynonyms>
        <uniprot_xref>Q9NVV0</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119067 -->

    <owl:Class rdf:about="&dto;DTO_00119067">
        <rdfs:label>transmembrane channel-like protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118765"/>
        <definition>A protein that is a translation product of the human TMC1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q8TDI8</uniprot_xref>
        <symbol>TMC1</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119068 -->

    <owl:Class rdf:about="&dto;DTO_00119068">
        <rdfs:label>transmembrane channel-like protein 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118765"/>
        <definition>A protein that is a translation product of the human TMC2 gene or a 1:1 ortholog thereof. </definition>
        <symbol>TMC2</symbol>
        <uniprot_xref>Q8TDI7</uniprot_xref>
        <geneSynonyms>C20orf145</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119069 -->

    <owl:Class rdf:about="&dto;DTO_00119069">
        <rdfs:label>transmembrane channel-like protein 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118765"/>
        <symbol>TMC3</symbol>
        <uniprot_xref>Q7Z5M5</uniprot_xref>
        <definition>A protein that is a translation product of the human TMC3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119070 -->

    <owl:Class rdf:about="&dto;DTO_00119070">
        <rdfs:label>transmembrane channel-like protein 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118765"/>
        <uniprot_xref>Q7Z404</uniprot_xref>
        <symbol>TMC4</symbol>
        <definition>A protein that is a translation product of the human TMC4 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119071 -->

    <owl:Class rdf:about="&dto;DTO_00119071">
        <rdfs:label>transmembrane channel-like protein 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118765"/>
        <symbol>TMC5</symbol>
        <uniprot_xref>Q6UXY8</uniprot_xref>
        <definition>A protein that is a translation product of the human TMC5 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119072 -->

    <owl:Class rdf:about="&dto;DTO_00119072">
        <rdfs:label>transmembrane channel-like protein 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118765"/>
        <definition>A protein that is a translation product of the human TMC6 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q7Z403</uniprot_xref>
        <geneSynonyms>EVIN1</geneSynonyms>
        <symbol>TMC6</symbol>
        <geneSynonyms>EVER1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119073 -->

    <owl:Class rdf:about="&dto;DTO_00119073">
        <rdfs:label>transmembrane channel-like protein 7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118765"/>
        <symbol>TMC7</symbol>
        <uniprot_xref>Q7Z402</uniprot_xref>
        <definition>A protein that is a translation product of the human TMC7 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119074 -->

    <owl:Class rdf:about="&dto;DTO_00119074">
        <rdfs:label>transmembrane channel-like protein 8</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118765"/>
        <geneSynonyms>EVIN2</geneSynonyms>
        <geneSynonyms>EVER2</geneSynonyms>
        <symbol>TMC8</symbol>
        <uniprot_xref>Q8IU68</uniprot_xref>
        <definition>A protein that is a translation product of the human TMC8 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119075 -->

    <owl:Class rdf:about="&dto;DTO_00119075">
        <rdfs:label>two pore calcium channel protein 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <definition>A protein that is a translation product of the human TPCN1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9ULQ1</uniprot_xref>
        <geneSynonyms>KIAA1169</geneSynonyms>
        <symbol>TPCN1</symbol>
        <geneSynonyms>TPC1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119076 -->

    <owl:Class rdf:about="&dto;DTO_00119076">
        <rdfs:label>two pore calcium channel protein 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118723"/>
        <uniprot_xref>Q8NHX9</uniprot_xref>
        <geneSynonyms>TPC2</geneSynonyms>
        <symbol>TPCN2</symbol>
        <definition>A protein that is a translation product of the human TPCN2 gene or a 1:1 ortholog thereof. [PRO:WCB] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119077 -->

    <owl:Class rdf:about="&dto;DTO_00119077">
        <rdfs:label>transient receptor potential cation channel subfamily a member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <symbol>TRPA1</symbol>
        <uniprot_xref>O75762</uniprot_xref>
        <definition>A transient receptor potential cation channel TRP that is a translation product of the human TRPA1 gene or a 1:1 ortholog thereof. [PRO:HJD] </definition>
        <geneSynonyms>ANKTM1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119078 -->

    <owl:Class rdf:about="&dto;DTO_00119078">
        <rdfs:label>short transient receptor potential channel 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <geneSynonyms>TRP1</geneSynonyms>
        <symbol>TRPC1</symbol>
        <definition>A transient receptor potential cation channel TRPC that is a translation product of the human TRPC1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>P48995</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119079 -->

    <owl:Class rdf:about="&dto;DTO_00119079">
        <rdfs:label>short transient receptor potential channel 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <uniprot_xref>Q13507</uniprot_xref>
        <geneSynonyms>TRP3</geneSynonyms>
        <symbol>TRPC3</symbol>
        <definition>A transient receptor potential cation channel TRPC3/6/7 that is a translation product of the human TRPC3 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119080 -->

    <owl:Class rdf:about="&dto;DTO_00119080">
        <rdfs:label>short transient receptor potential channel 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <definition>A transient receptor potential cation channel TRPC with PDZ-binding motif that is a translation product of the human TRPC4 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>TRPC4</symbol>
        <uniprot_xref>Q9UBN4</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119081 -->

    <owl:Class rdf:about="&dto;DTO_00119081">
        <rdfs:label>short transient receptor potential channel 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <symbol>TRPC5</symbol>
        <geneSynonyms>TRP5</geneSynonyms>
        <uniprot_xref>Q9UL62</uniprot_xref>
        <definition>A transient receptor potential cation channel TRPC that is a translation product of the human TRPC5 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119082 -->

    <owl:Class rdf:about="&dto;DTO_00119082">
        <rdfs:label>short transient receptor potential channel 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <symbol>TRPC6</symbol>
        <geneSynonyms>TRP6</geneSynonyms>
        <uniprot_xref>Q9Y210</uniprot_xref>
        <definition>A transient receptor potential cation channel TRPC3/6/7 that is a translation product of the human TRPC6 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119083 -->

    <owl:Class rdf:about="&dto;DTO_00119083">
        <rdfs:label>short transient receptor potential channel 7</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <definition>A transient receptor potential cation channel TRPC3/6/7 that is a translation product of the human TRPC7 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <geneSynonyms>TRP7</geneSynonyms>
        <uniprot_xref>Q9HCX4</uniprot_xref>
        <symbol>TRPC7</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119084 -->

    <owl:Class rdf:about="&dto;DTO_00119084">
        <rdfs:label>transient receptor potential cation channel subfamily m member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <geneSynonyms>MLSN</geneSynonyms>
        <symbol>TRPM1</symbol>
        <geneSynonyms>MLSN1</geneSynonyms>
        <uniprot_xref>Q7Z4N2</uniprot_xref>
        <geneSynonyms>LTRPC1</geneSynonyms>
        <definition>A protein that is a translation product of the human TRPM1 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119085 -->

    <owl:Class rdf:about="&dto;DTO_00119085">
        <rdfs:label>transient receptor potential cation channel subfamily m member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <geneSynonyms>EREG1</geneSynonyms>
        <geneSynonyms>KNP3</geneSynonyms>
        <geneSynonyms>TRPC7</geneSynonyms>
        <uniprot_xref>O94759</uniprot_xref>
        <symbol>TRPM2</symbol>
        <geneSynonyms>LTRPC2</geneSynonyms>
        <definition>A protein that is a translation product of the human TRPM2 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119086 -->

    <owl:Class rdf:about="&dto;DTO_00119086">
        <rdfs:label>transient receptor potential cation channel subfamily m member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <geneSynonyms>KIAA1616</geneSynonyms>
        <geneSynonyms>LTRPC3</geneSynonyms>
        <uniprot_xref>Q9HCF6</uniprot_xref>
        <symbol>TRPM3</symbol>
        <definition>A protein that is a translation product of the human TRPM3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119087 -->

    <owl:Class rdf:about="&dto;DTO_00119087">
        <rdfs:label>transient receptor potential cation channel subfamily m member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <uniprot_xref>Q8TD43</uniprot_xref>
        <definition>A protein that is a translation product of the human TRPM4 gene or a 1:1 ortholog thereof. </definition>
        <symbol>TRPM4</symbol>
        <geneSynonyms>LTRPC4</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119088 -->

    <owl:Class rdf:about="&dto;DTO_00119088">
        <rdfs:label>transient receptor potential cation channel subfamily m member 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <geneSynonyms>LTRPC5</geneSynonyms>
        <uniprot_xref>Q9NZQ8</uniprot_xref>
        <definition>A protein that is a translation product of the human TRPM5 gene or a 1:1 ortholog thereof. </definition>
        <symbol>TRPM5</symbol>
        <geneSynonyms>MTR1</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119089 -->

    <owl:Class rdf:about="&dto;DTO_00119089">
        <rdfs:label>transient receptor potential cation channel subfamily m member 8</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <uniprot_xref>Q7Z2W7</uniprot_xref>
        <symbol>TRPM8</symbol>
        <geneSynonyms>LTRPC6</geneSynonyms>
        <definition>A protein that is a translation product of the human TRPM8 gene or a 1:1 ortholog thereof. TRPM8 is a member of the subfamily M of the transient receptor potential cation channels (TRPs). In common with other TRPs, these proteins have amino- and carboxyl-terminal intracellular domains separated by a domain containing six transmembrane helices (S1-S6) in which the last two helices (S5 and S6) flank a loop, called the pore loop, which determines ion selectivity.TRPM8 forms a nonselective cation channel that is activated by cold and by menthol and other substances that produce the sensation of coolness. These channels exhibit voltage-dependance and regulation by phosphatidylinositol-4,5-bisphosphate (PIP2). [PMID:15852009, PRO:CNA] </definition>
        <geneSynonyms>TRPP8</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119090 -->

    <owl:Class rdf:about="&dto;DTO_00119090">
        <rdfs:label>transient receptor potential cation channel subfamily v member 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <geneSynonyms>VR1</geneSynonyms>
        <symbol>TRPV1</symbol>
        <definition>A transient receptor potential cation channel TRPV that is a translation product of the human TRPV1 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <uniprot_xref>Q8NER1</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119091 -->

    <owl:Class rdf:about="&dto;DTO_00119091">
        <rdfs:label>transient receptor potential cation channel subfamily v member 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <geneSynonyms>VRL</geneSynonyms>
        <uniprot_xref>Q9Y5S1</uniprot_xref>
        <symbol>TRPV2</symbol>
        <definition>A transient receptor potential cation channel TRPV that is a translation product of the human TRPV2 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119092 -->

    <owl:Class rdf:about="&dto;DTO_00119092">
        <rdfs:label>transient receptor potential cation channel subfamily v member 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <uniprot_xref>Q8NET8</uniprot_xref>
        <definition>A transient receptor potential cation channel TRPV that is a translation product of the human TRPV3 gene or a 1:1 ortholog thereof. [PRO:CNA] </definition>
        <symbol>TRPV3</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119093 -->

    <owl:Class rdf:about="&dto;DTO_00119093">
        <rdfs:label>transient receptor potential cation channel subfamily v member 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <symbol>TRPV4</symbol>
        <definition>A transient receptor potential cation channel TRPV that is a translation product of the human TRPV4 gene or a 1:1 ortholog thereof. The functional subunits are ion-selective calcium permeant cation channel probably involved in osmotic sensitivity and mechanosensitivity. Activation by exposure to hypotonicity within the physiological range exhibits an outward rectification. [PRO:CNA, UniProtKB:Q9HBA0] </definition>
        <uniprot_xref>Q9HBA0</uniprot_xref>
        <geneSynonyms>VRL2</geneSynonyms>
        <geneSynonyms>VROAC</geneSynonyms>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119094 -->

    <owl:Class rdf:about="&dto;DTO_00119094">
        <rdfs:label>transient receptor potential cation channel subfamily v member 5</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <definition>A calcium-selective transient receptor potential cation channel TRPV that is a translation product of the human TRPV5 gene or a 1:1 ortholog thereof. [PRO:HJD] </definition>
        <geneSynonyms>ECAC1</geneSynonyms>
        <uniprot_xref>Q9NQA5</uniprot_xref>
        <symbol>TRPV5</symbol>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119095 -->

    <owl:Class rdf:about="&dto;DTO_00119095">
        <rdfs:label>transient receptor potential cation channel subfamily v member 6</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118749"/>
        <symbol>TRPV6</symbol>
        <geneSynonyms>ECAC2</geneSynonyms>
        <definition>A calcium-selective transient receptor potential cation channel TRPV that is a translation product of the human TRPV6 gene or a 1:1 ortholog thereof. [PRO:HJD] </definition>
        <uniprot_xref>Q9H1D0</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119096 -->

    <owl:Class rdf:about="&dto;DTO_00119096">
        <rdfs:label>protein tweety homolog 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118766"/>
        <symbol>TTYH1</symbol>
        <definition>A protein that is a translation product of the human TTYH1 gene or a 1:1 ortholog thereof. </definition>
        <uniprot_xref>Q9H313</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119097 -->

    <owl:Class rdf:about="&dto;DTO_00119097">
        <rdfs:label>protein tweety homolog 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118766"/>
        <definition>A protein that is a translation product of the human TTYH2 gene or a 1:1 ortholog thereof. </definition>
        <geneSynonyms>C17orf29</geneSynonyms>
        <symbol>TTYH2</symbol>
        <uniprot_xref>Q9BSA4</uniprot_xref>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119098 -->

    <owl:Class rdf:about="&dto;DTO_00119098">
        <rdfs:label>protein tweety homolog 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118766"/>
        <geneSynonyms>KIAA1691</geneSynonyms>
        <uniprot_xref>Q9C0H2</uniprot_xref>
        <symbol>TTYH3</symbol>
        <definition>A protein that is a translation product of the human TTYH3 gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
    


    <!-- http://www.drugtargetontology.org/dto#DTO_00119099 -->

    <owl:Class rdf:about="&dto;DTO_00119099">
        <rdfs:label>zinc-activated ligand-gated ion channel</rdfs:label>
        <rdfs:subClassOf rdf:resource="&dto;DTO_00118718"/>
        <geneSynonyms>ZAC</geneSynonyms>
        <geneSynonyms>LGICZ</geneSynonyms>
        <uniprot_xref>Q401N2</uniprot_xref>
        <geneSynonyms>LGICZ1</geneSynonyms>
        <geneSynonyms>L2</geneSynonyms>
        <symbol>ZACN</symbol>
        <definition>A protein that is a translation product of the human ZACN gene or a 1:1 ortholog thereof. </definition>
    </owl:Class>
</rdf:RDF>



<!-- Generated by the OWL API (version 3.4.2) http://owlapi.sourceforge.net -->

